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1 
Introduction: 
Background of Hereditary Breast and Ovarian Cancer 
 
 
 
‘My mother died from ovarian cancer when she was 52 years of age. Two of her sisters 
died from breast cancer before they reached the age of 60. Only one of my aunts survived 
breast cancer. My cousin developed breast cancer when she was 41 years of age. She and I 
are the same age. She sent me a so-called family letter after she was told to be a mutation 
carrier. That’s how I found out that the breast cancers and ovarian cancers in our family 
were of an hereditary origin.’ 
 
 
 
Breast cancer accounts for about a quarter of all female cancers. The majority of all breast 
cancers worldwide occur in the USA and Europe. Of 12,000 to 13,000 new breast cancer 
cases that are annually diagnosed in the Netherlands, mostly in women above the age of 
50 years, approximately 3,500 women (28%) die of the disease. The lifetime risk for breast 
cancer for a woman in the Netherlands is 12-13%. It is estimated that 5-10% of all breast 
cancer cases are caused by a definable genetic predisposition, which then is characterized 
by a young age at onset and a familial aggregation following a dominant inheritance 
pattern (www.cbo.nl).  
 Of 1500 cases of ovarian cancer that are yearly discovered in the Netherlands, 1100 
women (73%) die of the disease (www.oncoline.nl). The lifetime risk of ovarian cancer is 
1,5%. Ten percent of all discovered ovarian cancers are assumed to be of hereditary origin.  
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Since the cloning of the breast cancer susceptibility genes BRCA1 and BRCA2, in 1994 and 
1995 respectively, it became possible to identify families and individual women having a 
mutation in one of these genes. Mutations in those genes also explained the frequent 
association with ovarian cancer. Actually, it is estimated that BRCA1/2 mutations are 
involved in 2-3% of all breast cancers. Other identifiable breast cancer susceptibility genes 
associated with a significantly increased risk of breast cancer, such as TP53 and PTEN
∗
, 
occur less frequently
1,2
.  
 
1.1 Hereditary breast and ovarian cancer: the breast cancer risk 
Women with an identified BRCA1/2 mutation have a cumulative lifetime risk for breast 
cancer of 43-87% up to the age of 70 years, becoming relevant from age 25-30 years 
onwards
1-3
. Furthermore, after a history of unilateral breast cancer, mutation carriers face 
a significantly increased risk of 20-60% or 3% per year of developing contralateral breast 
cancer
4-6
. 
 Although genetic testing for BRCA1/2 and other susceptibility genes opened new 
perspectives for many families with breast cancer, in 75% of such families no causative 
breast cancer gene mutation is found. In such families, the individual risk of developing 
breast and ovarian cancer is estimated using pedigree data and genetic-epidemiological 
tables. For first degree relatives of breast cancer patients, the lifetime breast cancer risk 
will be significantly higher than the population risk, but not exceeding 50%
7,8
. 
 
1.2 Hereditary breast and ovarian cancer: the ovarian cancer risk 
Next to a significantly increased breast cancer risk, women with a BRCA1 or BRCA2 gene 
mutation have lifetime risks of respectively 40-62% and 15-20% of ovarian/fallopian tube 
cancer
3,9
, which is much higher than the population risk of 1,5%. The mean age at onset of 
ovarian/fallopian tube cancer is 50-54 years in BRCA1 and BRCA2 mutation carriers, 
respectively, some 10 years after the mean age of breast cancer at 41 years. The actuarial 
risk of developing ovarian cancer within a decade of breast cancer in BRCA1/2 carriers is 
13% and 7% respectively
10
. In hereditary breast/ovarian cancer (HBOC) families (having no 
identified causative breast cancer gene mutation) the risk for ovarian cancer depends on 
the family history of ovarian/fallopian tube cancer. 
 
For reasons of readability, BRCA1 and BRCA2 mutation carriers will be referred to as 
‘mutation carriers’ and women from HBOC families will be referred to as ‘50% risk carriers’ 
throughout this thesis. In combination, they will be referred to as ‘high-risk women’, with 
the exception of text where specifications about mutation status are necessary. 
 
1.3 Management options 
When a familial or genetic predisposition for breast and ovarian cancer is established in a 
woman, there are several management options, consisting of regular surveillance, 
chemoprevention or prophylactic surgery. 
                                            
∗
 Associated with resp. Li-Fraumeni syndrome and Cowden syndrome (cf. Oldenburg 2007). 
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1.3.1 Regular surveillance 
Regular surveillance of the breasts enables the early detection of breast cancer for high-
risk women, but that does not guarantee the detection and treatment of a tumor before 
metastasis has occurred. In the nineties, optimal breast cancer surveillance included a 
monthly breast self-examination, biannual clinical breast examination, and yearly imaging 
by mammography, starting at 25 years of age for a mutation carrier or 5 years earlier than 
the youngest case of breast cancer in the respective HBOC family. Recently, magnetic 
resonance imaging (MRI) was validated as superior compared to mammography for the 
early detection of invasive breast cancer in (inter)national studies, including the Dutch 
MRISC study
11,12
. The MRI scan for breast imaging is now part of the regular surveillance 
program for high-risk women in the Netherlands (www.ikcnet.nl/IKR). 
 Regular surveillance of the ovaries includes annual gynecological examination, serial 
transvaginal ultrasound examination and serum CA-125 assay. It starts at 35 years of age 
or 5 years younger than the earliest ovarian cancer case in the family, equally for mutation 
carriers and women from HBOC families
13
. Ovarian cancer may start in the ovaries, 
fallopian tubes, omentum or peritoneum and metastasizes very early, while the sensitivity 
and specificity of the screening techniques are relatively low. Therefore, the majority of 
screen-detected cases are diagnosed at a late and difficult or incurable stage
14
. A recent 
study in 3532 high-risk women has shown that screening did not differentiate between 
carriers and non-carriers. The authors concluded that periodic surveillance in high-risk 
women is ineffective in improving survival in BRCA1/2 mutation carriers
15
. In the 
Netherlands, gynecologists and other involved specialists will therefore generally advise 
prophylactic (bilateral) salpingo-oophorectomy (P(B)SO) as of 40 years onwards. 
 
1.3.2 Chemoprevention 
Chemoprevention by tamoxifen may reduce the breast cancer risk in high-risk women by 
approximately 50%. Tamoxifen also reduces the risk of (contralateral) recurrence of breast 
cancer in both BRCA1 and BRCA2 mutation carriers
16,17
 By its anti-estrogenic action, it is 
associated with side effects such as hot flashes, emotional mood disturbances and an 
increased risk of endometrial cancer
18
 in postmenopausal women. Studies on the effect of 
tamoxifen in high-risk women were of small sample sizes, while complete data on the 
hormonal receptor status of the breast tumors were generally unavailable
16,17
. Moreover, 
sufficient data on the value of the agent are lacking for very young women. Therefore, it is 
not yet recommended as a preventive measure for unaffected high-risk women or outside 
of a clinical trial in the Netherlands.  
 For premenopausal women not yet considering P(B)SO, the use of oral contraceptives 
remains a matter of debate as this has been shown to decrease the risk of ovarian cancer 
by 60% in mutation carriers
19
. However, it is unclear whether the benefits on the ovarian 
cancer risks outweigh the increased breast cancer risk associated with oral 
contraceptives
20
. 
 
1.3.3 Prophylactic mastectomy 
Prophylactic mastectomy (PM), i.e. the preventive removal of all fibroglandular breast 
tissue, is a radical risk-reducing strategy. It involves a bilateral PM in unaffected high-risk 
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women and breast cancer patients after breast conserving therapy, or a contralateral PM 
in breast cancer patients after unilateral mastectomy. In unaffected women, bilateral PM 
yields an approximate 95% risk reduction of breast cancer
12,20-22
. After unilateral cancer, it 
reduces the risk of cancer in the contralateral breast with >90%, however, without 
improving overall survival, as this mainly is dictated by the prognosis of the primary breast 
cancer
23
. 
 Initially, most women (94%) at our institution opted for immediate breast 
reconstruction (IBR) after PM
22
. Previously, the surgical technique of PM and IBR in our 
centre consisted of implantation of a silicone prosthesis into a pocket created below the 
pectoral muscles
24
. Actually, delayed breast reconstruction (BR) using several techniques 
including tissue expanders/prosthesis implantation and breast reconstruction by means of 
autologous tissue are generally used
25
, allowing a more individual approach for the 
respective women. Throughout this thesis, prophylactic mastectomy with or without 
(immediate) breast reconstruction will be referred to as PM/(I)BR unless further details on 
the actual procedure are relevant and specified. 
 Complications are experienced by nearly one-third of all women after PM/(I)BR, such as 
bleeding, capsular formation and poor cosmetic appearance
25-27
. These may lead to 
additional surgical interventions, or aesthetically unsatisfactory results. Furthermore, 
breast cancer treatment prior to (contralateral) PM might compromise the result of breast 
reconstruction. Radiotherapy was reported as a cause of early and late complications and 
unfavorable cosmetic outcome of PM/(I)BR
27
. Recent experience showed identical 
complication rates in unaffected women and women with a history of breast cancer 
(hereafter called ‘affected’) undergoing PM/(I)BR
23
.  
 
1.3.4 Prophylactic (bilateral) salpingo-oophorectomy 
Prophylactic (bilateral) salpingo-oophorectomy (P(B)SO) is preferably done by 
laparoscopic removal of the ovaries and the fallopian tubes. If during surgery problems 
arise, e.g. because of previous abdominal surgery or bleeding, the gynecologist has to 
convert to a laparotomy to perform the oophorectomy. P(B)SO reduces the risk of 
ovarian/fallopian tube cancer with approximately 80%
9
. Moreover, P(B)SO in 
premenopausal women gives a substantial risk reduction of breast cancer of 
approximately 50% 
28,29
. 
 The cancer risk cannot be eliminated completely by P(B)SO. The residual risk for an 
abdominal (peritoneal, omental) cancer is 2-4%
9
, as the peritoneal mesothelium shares its  
embryological origin with the  ovarian germinal epithelium. Therefore, women may still 
feel vulnerable after P(B)SO. 
 P(B)SO may be associated with surgical complications such as bleeding and infection, 
especially after an abdominal procedure, being the case in approximately 5-11,5% of all 
patients
29,30
. Other physical consequences of P(B)SO are related to the surgically induced 
menopause. Menopausal symptoms are more severe and of rapid onset when induced 
surgically
31
. Hormone replacement therapy (HRT) might alleviate menopausal complaints 
such as impaired quality of life and might postpone possibly unwarranted effects with 
respect to bone and cardiovascular health. However, HRT might in turn negate the risk 
reducing effect of P(B)SO on the development of breast cancer. 
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1.4 Uptake of prophylactic surgery 
There is a very wide variation in uptake of prophylactic surgery worldwide. In a recent 
survey, the largest uptake of PM/(I)BR is found in the USA (36,3%) and of P(B)SO in 
Norway (73,5%)
17
. 
 At our centre, the average uptake for PM/(I)BR and P(B)SO is 32,7% and 64,2% 
respectively, consisting of both affected and unaffected high-risk women
17
. One third of 
the total group of 358 women undergoing PM/(I)BR at our centre between 1994-2004 
were 50% risk carriers
25
. The uptake of prophylactic surgery for mutation carriers 
specifically was 35% of affected and 51% of unaffected mutation carriers for PM/(I)BR, 
and 49% of affected and 64% of unaffected mutation carriers for P(B)SO
32,33
.  
The majority (approximately 60%) of all women having PM/(I)BR also opted for P(B)SO
25,34
.  
 
1.4.1 Predictors of uptake of PM/(I)BR and P(B)SO 
Age and a family history of  breast and/or ovarian cancer were found to be predictive for 
the uptake of both PM/(I)BR and P(B)SO
32-37
. Younger age (<50 years) was related to the 
uptake of PM/(I)BR in both unaffected and affected mutation carriers
32,33
. (Older) age also 
proved to be predictive regarding the uptake of P(B)SO in both (namely unaffected) 
mutation carriers
32
 and in 50% risk carriers
37
. An explanation for age being predictive for 
the uptake of P(B)SO might be that physicians following ovarian cancer risk management 
guidelines would recommend P(B)SO to high-risk women aged 35 or older, and be less 
directive towards oophorectomy when younger women are concerned
38,39
. 
 
1.4.2 Predictors of uptake of PM/(I)BR 
Parenthood seemed to be a predictive factor for the uptake of PM/(I)BR (opted for by 61% 
of mothers vs. by 14% of childless women). Interestingly, this effect was even larger when 
combining age <50 years and parenthood, resulting in 70% of mothers aged <50 years 
opting for PM/(I)BR
32
. Though the authors made no attempt in explaining this finding, it 
might reflect a motivation for PM/(I)BR, namely the responsibility felt by women towards 
family members
40
.  
 Two studies reported on the effect of increased risk-perception in women opting for 
PM/(I)BR. Metcalfe et al.
41
 found that women with a limited or strong family history of 
breast cancer displayed ‘exaggerated’ perceptions of their breast cancer risk before 
surgery. Only mutation carriers were found to have an adequate estimate of their breast 
cancer risk. However, the retrospective nature of their study and the lack of a reference 
group weaken their results. Moreover, they do not explain what they considered as 
‘exaggerated’, so results and/or conclusions cannot be extrapolated. Bebbington Hatcher 
et al.
42
 found that women opting for PM/(I)BR had higher risk-perception than women 
who did not opt for PM/(I)BR (43% vs. 18% respectively). However, they did not report on 
possible differences between both groups on actual risks (that were probably known to 
the participants in their study, since they mentioned that genetic status was determined 
by the referring clinician in all before referral for surgery) and therefore this result is not 
founded for a solid conclusion. Further research is necessary in order to establish the 
effect of risk perception on the actual uptake of PM/(I)BR. 
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1.4.3 Predictors of uptake of P(B)SO 
A personal history of cancer was found to be predictive of the uptake of P(B)SO
36
. 
Expected relief from cancer worry predicted P(B)SO uptake for both affected and 
unaffected high-risk women
44
. Moreover, mutation carriers who were more likely to opt 
for P(B)SO had poorer perceived general health, believed in the incurability of ovarian 
cancer and had higher levels of perceived benefits of P(B)SO compared to mutation 
carriers who did not opt for this procedure
43
. The effect of these variables in 50% risk 
carriers remain yet to be investigated. 
 In a study on 160 mutation carriers opting for either P(B)SO (n=118) or regular 
surveillance (n=42), lower educational level was reported as strongly related to the uptake 
of P(B)SO
43
. Mutation carriers in the low, middle and high educational level opted for 
P(B)SO in 85%, 75% and 60%, respectively. The authors found that the low educational 
group had a good reported knowledge on the risks associated with the disease and the 
differences of between P(B)SO and surveillance. However, they started speculating on ‘too 
promptly’ following physician’s advice to decide for P(B)SO, and on missing the larger sets 
of considerations of deciding for or against P(B)SO, that might be open to mutation 
carriers with higher education. These speculations are distracting from the fact that the 
women in the low educational group potentially made perfectly reasonable and motivated 
choices in view of a realistic perception of their severe health risks. A more realistic 
conclusion would have been that the choice for the highest protection seemed to be the 
most difficult for the high educational group. 
 
PM/(I)BR and P(B)SO have been increasingly performed since the discovery of the 
BRCA1/2 gene mutations. Results of studies on the psychosocial impact of these 
prophylactic surgeries are discussed in Chapter 2. 
 
References 
1. Oldenburg RA, Meijers-Heijboer H, Cornelisse CJ, Devilee P. Genetic susceptibility for breast cancer: How 
many more genes to be found? Crit Rev Oncol/Hemat 2007; 63: 125-49. 
2. Stratton MR, Rahman N. The emerging landscape of breast cancer susceptibility. Nat Genet 2008; 40: 17-
22. 
3. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with 
BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 
22 studies. Am J Hum Genet. 2003; 72:1117-30. 
4. Verhoog LC, Brekelmans CTM, Seynaeve C, et al. Contralateral breast cancer risk is influenced by the age 
at onset in BRCA1-associated breast cancer. Br J Cancer 2000; 83: 384-6. 
5. Metcalfe K, Lynch HT, Ghadirian P, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation 
carriers. J Clin Oncol 2004; 22: 2328-35. 
6. Brekelmans, C.T.M., Tilanus-Linthorst, M.M., Seynaeve, C. et al. Tumour characteristics, survival and 
prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as 
compared to sporadic cancer cases. Eur J Cancer 2007; 43: 867-76. 
7. Van Asperen CJ, Jonker MA, Jacobi CE, et al. Risk estimation for healthy women from breast cancer 
families: new insights and new strategies. Cancer Epidemiol Biomarkers Prev 2004;13:87-93. 
8. Metcalfe KA, Finch A, Poll A, et al. Breast cancer risks in women with a family history of breast or ovarian 
cancer who have tested negative for a BRCA1 or BRCA2 mutation. Br J Cancer 2009;100:421-5. 
9. Finch A, Beiner M, Lubinski J et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube and 
peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 2006; 296: 185-92. 
10. Metcalfe KA, Lynch HT, Ghadirian P et al. The risk of ovarian cancer after breast cancer in BRCA1 and 
BRCA2 carriers. Gynecol Oncol 2005; 96: 222-6. 
11. Kriege M, Brekelmans, CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening 
in women with a familial or genetic predisposition. N Engl J Med 2004; 351: 427-37.  
  
7 Introduction 
12. Robson M, Offit K. Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J 
Med 2007; 357: 154-62. 
13. Masciari S, Garber, JE. Quality or quantity in the management of hereditary ovarian cancer risk: Is it really 
a trade-off? J Clin Oncol 2005; 23: 6817-9. 
14. Modugno F. Ovarian cancer and high-risk women – implications for prevention, screening, and early 
detection. Gynecol Oncol 2003; 91: 15-31 
15. Evans G, Baildam A, Brain A, et al. Risk reducing mastectomy: outcomes in 10 European Centres. J Med 
Genet 2008. 
16. Gronwald J, Tung N, Foulkes WD, et al. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 
carriers: an update. Int J Cancer 2006; 118: 2281-4. 
17. Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, et al. International variation in rates of uptake of 
preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 2008; 122: 2017-22. 
18. Swerdlow AJ, Jones ME. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-
control study. J Natl Cancer Inst 2005; 97: 375-84. 
19. Narod SA, Risch H, Moshlehi, R, et al. Oral contraceptives and the risk of hereditary ovarian cancer. New 
Engl J Med 1998; 339:424-8. 
20. Roukos DH, Briasoulis E. Individualized preventive and therapeutic management of hereditary breast 
ovarian cancer syndrome. Nat Clin Pract Oncol 2007; 4: 578-90. 
21. Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral 
mastectomy in women with a BRCA1 or BRCA2 mutation. New Engl J Med  2001; 345: 159-64. 
22. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in 
BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 2004; 22: 1055-62. 
23. Sprundel TC van, Schmidt MK, Rookus M, et al. Riskreduction of contralateral breast cancer and survival 
after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Brit J Cancer 
2005;93:287-92. 
24. Geel AN van. Prophylactic mastectomy: the Rotterdam experience. Breast 2003;12: 357-61. 
25. Heemskerk AM, Brekelmans CTM, Menke-Pluymers MBE, et al. Prophylactic mastectomy in BRCA1/2 
mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the 
Rotterdam Family Cancer Clinic. Ann Surg Oncol 2007; 14: 3335-44. 
26. Eisen A, Rebbeck TR, Wood WC, Weber BL. Prophylactic Surgery in Women With a Hereditary 
Predisposition to Breast and Ovarian Cancer. J Clin Oncol 2000; 18: 1980-95. 
27. Contant CME, Menke-Pluijmers MBE, Seynaeve C, et al. Clinical experience of prophylactic mastectomy 
followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a 
proven BRCA1 and BRCA2 germ-line mutation. Eur J Surg Oncol J 2002; 28: 627 – 32. 
28. Rebbeck TR, Lynch HT, Neuhausen SL et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 
mutations. N Engl J Med 2002;346:1616-22. 
29. Kauff ND, Satagopan JM, Robson ME et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 
or BRCA2 mutation. N Engl J Med 2002;346:1609-15. 
30. Meeuwissen PA, Seynaeve C, Brekelmans CT, Meijers-Heijboer HJ, Klijn JG, Burger CW. Outcome of 
surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian 
cancer. Gynecol Oncol 2005; 97: 476-82. 
31. Wild RA. Introduction to special issue on surgical menopause. Menopause 2007; 14: 556-61. 
32. Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT, et al. Presymptomatic DNA testing and prophylactic 
surgery in families with a BRCA1 or BRCA2 mutation. Lancet 2000; 355: 2015 – 20. 
33. Meijers-Heijboer EJ, Brekelmans CTM, Menke-Pluymers M, et al. Use of genetic testing and prophylactic 
mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or 
BRCA2 mutation. J Clin Oncol 2003; 1675 – 81. 
34. Metcalfe KA, Lubinski J, Ghadirian P, et al. Predictors of contralateral prophylactic mastectomy in women 
with a BRCA1 or BRCA2 mutation: the hereditary Breast Cancer Clinical Study Group. J Clin Oncol 
2008:26;1093-7. 
35. Frost MH, Schaid DJ, Sellers TA, et al. Long-term satisfaction and psychological and social function 
following bilateral prophylactic mastectomy. JAMA 2000; 284: 319-24. 
36. Babb SA, Swisher EM, Heller HN, et al. Qualitative evaluation of medical information processing needs of 
60 women choosing ovarian cancer surveillance or prophylactic oophorectomy. J Gen Counsel 2002; 1: 
81-97. 
37. Tiller K, Meiser B, Butow P, et al. Psychological impact of prophylactic oophorectomy in women at 
increased risk of developing ovarian cancer: a prospective study. Gynecol Oncol 2002; 86: 212-9. 
38. NHMRC. Familial aspects of cancer: a guide to clinical practice. Canberra: Australian Cancer Network; 
1999. 
39. Eisinger F, Alby N, Bremond A, et al. Recommendations for medical management of hereditary breast 
and ovarian cancer: The French National Ad Hoc Committee. Ann Oncol 1998; 9: 939-50. 
  
8 Chapter 1 
40. Bebbington Hatcher M, Fallowfield, LJA. A qualitative study looking at the psychosocial implications of 
bilateral prophylactic mastectomy. Breast 2003; 12: 1 – 9. 
41. Metcalfe KA, Goel V, Lickley L, Semple J, Narod SA. Prophylactic bilateral mastectomy: patterns of 
practice. Cancer 2002: 95; 236-42. 
42. Bebbington Hatcher M, Fallowfield L, A'Hern R. The psychosocial impact of bilateral prophylactic 
mastectomy: prospective study using questionnaires and semistructured interviews. BMJ 2001; 322: 1-6. 
43. Madalinska JB, van Beurden M, Bleiker EMA, et al. Predictors of prophylactic bilateral salpingo-
oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers. J Clin Oncol 
2007; 25: 301-7. 
44. Fry A, Rush R, Busby-Earle C, Cull A. Deciding about prophylactic oophorectomy: what is important to 
women at increased risk of ovarian cancer? Prev Med 2001; 33: 578-85. 
 
  
 
 
2 
Introduction: 
Literature Review of Psychosocial Aspects of Prophylactic 
Mastectomy and (Bilateral) Salpingo-Oophorectomy 
 
 
 
‘Surgery itself turned out better than I expected, but the cosmetic results are very 
disappointing. The worst thing of all is that my husband does not want to touch me 
anymore. Nothing is left of our sex life. When I turn emotional, he pretends to not see my 
crying. I really long for him to wrap his arms around me. I haven’t talked to him about it 
because he is not a talkative person. Moreover, I am afraid he will confirm my ugliness.’ 
 
 
 
As PM/(I)BR and/or P(B)SO are momentarily the most effective risk reducing strategies for 
high-risk women, better knowledge of the psychosocial consequences becomes 
increasingly important in order to adequately inform and support these women when 
considering and deciding for prophylactic surgery. Moreover, diligently exploring 
expectations and experiences of high-risk women and their partners might assist them in 
anticipating and jointly adapting to the outcomes of PM/(I)BR or P(B)SO. 
 In the past decade, data were presented on decision making regarding prophylactic 
surgery, satisfaction and regrets with the procedure and its consequences, distress in the 
period prior to and after prophylactic surgery, and the effect of prophylactic surgery on 
body image and sexuality. In the following paragraphs the data from the literature are 
reviewed.  
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2.1 The psychosocial impact of PM/(I)BR 
2.1.1 Population characteristics 
In the reported literature, the average age at time of PM/(I)BR in high-risk women was 35-
46 years (range 20-73)
1-12
. Most cohorts consisted of mutation carriers (13-100%) and/or 
50% risk carriers (55-100%), and the majority of women did not have a personal history of 
breast cancer (92-100%)
1,2,4,5,7,10,13,14
. Affected mutation carriers who opted for PM/(I)BR 
were more likely to have their breast cancer manifested after the identification of a 
BRCA1/2 mutation in the family
13
, or were more often treated with mastectomy instead of 
breast conserving therapy
15
. The majority (63-100%) of high-risk women had opted for 
(I)BR after PM
1-6,8,10,11,14,16
 and 14-63% of women who underwent PM/(I)BR also 
underwent P(B)SO
7,9,17,18
. 
 
2.1.2 Decision making  
High-risk women reported concurrent considerations for opting for PM/(I)BR. Nodular 
breasts and worrisome biopsies
3
 were strong motivators. Also, risk reduction
3
, expected 
relief of fear of developing breast/ovarian cancer
3,6
, the obligation felt by women towards 
family members
8,19
 and physician’s recommendation
3,6
 were found to be driving 
motivations for women to decide for PM/(I)BR.  
 
2.1.3 Satisfaction and regrets 
Most women (70-100%) reported being satisfied after PM/(I)BR
1-5,10,11,14,19
. Women who 
were satisfied with their decision to undergo PM/(I)BR were aged 50 years or older and 
had a limited family history of breast cancer
10
. Moreover, women who opted for PM/(I)BR 
because of their family history or women who opted against breast reconstruction, were 
more likely to be satisfied with the procedure
3
. When PM/(I)BR had had little or no impact 
on the sexual relationship
3
, such women were more likely to be satisfied with their 
decision. 
 Dissatisfaction or regrets about PM/(I)BR are reported in 5%
2
. These women more 
often indicated that they followed their physician’s advice
2,3
. They also reported lack of 
(emotional) support
3,6
 and insufficient information about the procedure and its possible 
consequences
3
. Post-surgery, they experienced pain
6
, surgical complications
3,6,20
 or 
prosthesis related complaints
6,20,21
. When the breasts were reconstructed, dissatisfied 
women were more likely to be worried that the implants would impede the detection of 
breast cancer
6
. Finally, women with regrets were also dissatisfied with the cosmetic 
results of PM/(I)BR or had a diminished self-image and experienced less sexual 
satisfaction
6
.  
 One study, that was conducted in Ontario during 1991-2000, addressed satisfaction 
with the cosmetic result of immediate breast reconstruction after PM
11
. Most women 
(97%) in their cohort of 60 women felt satisfied (17%) or extremely satisfied (80%) with 
their decision. Women with an increased risk perception before and after surgery, who 
experienced increased worry of developing breast cancer and a worsened body image 
after the procedure, and who reported a lasting experience of physical discomfort as a 
result were more likely to be dissatisfied with the cosmetic outcome of IBR. Type of PM 
(total 88% or subcutaneous 12%) and type of IBR (51% saline implants versus 49% 
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transverse rectus abdominis musculocutaneous (TRAM) flap) were unrelated to 
satisfaction with the cosmetic result of IBR
11
. 
 
2.1.4 Distress 
Generally, distress was increased in high-risk women prior to PM/(I)BR
8,16
. Increased 
distress before surgery seemed related to knowing of being at risk, approaching the age at 
which relatives had been diagnosed with cancer, the development of breast cancer in 
relatives, and/or parenthood
8
. These causes of distress were reported by several women, 
without attempts at quantification. 
 After PM/(I)BR, most women experienced a decrease in distress until it reached normal 
levels
3,6-10,14,16,22
. Interestingly, post-surgical distress remained at a stable level up to 3,5 
years
4
. However, not all women experienced a decrease in distress. Metcalfe et al.
10
 found 
that 8% of all women post-surgically experienced cancer-related distress at a clinical level. 
Women who experienced increased distress up to 5 years post-PM/(I)BR were more likely 
to be younger and at higher actual breast cancer risk
10
, to have children under the age of 
15 years, to experience a less open communication of cancer issues within their family and 
changes in relationships with relatives, or to doubt about the genetic test outcome
9
. They 
were often worried about their children’s risk or their personal risk of developing ovarian 
cancer
8
. Furthermore, they were more likely to have an inaccurate
4
 or continued 
increased risk-perception
3,10
. Finally, the level of cancer-related distress at baseline proved 
to be predictive of post-surgical distress, up to 5 years post-surgery
9
. 
 
2.1.5 Body image 
Inherent to the nature of PM/(I)BR one may expect changes of the body image after such 
radical surgery. Also after P(B)SO, especially in premenopausal women, the surgically 
induced menopause may cause symptoms associated with bodily changes. Accordingly, 
many studies
3,4,6,7-11,14,16,22
 analyzed effects on body image as an outcome variable.  
 Generally, a negative impact on body image after PM/(I)BR was reported. Five years 
after test disclosure, most mutation carriers opting for PM/(I)BR reported less satisfaction 
with general and breast-related body image than non-carriers
9
. More specifically, a 
quarter to nearly half or 12-53% of all women reported adverse effects on the appearance 
of their body (i.e. were self-conscious about their appearance, felt less physically 
attractive, were dissatisfied with their body, naked and dressed, all as a result of PM/(I)BR 
with and without breast reconstruction)
3,4,6,10,11,22
 and an equal proportion of women 
reported a change in feelings of femininity
3,4
. Dissatisfaction with the surgical scars was 
reported by a third to almost half of all women (33-44%)
4,22
. Moreover, women without 
breast reconstruction were less satisfied with their bodies than women with breast 
reconstruction
4,10
.  
 In a retrospective study on 370 high-risk women who underwent PM/(I)BR, 16% judged 
their cosmetic results as unacceptable
2
. However, this study collected cases from all over 
the United States between 1945 and 1996 and therefore reflected the experiences of 
several small and large centers of that period. Moreover, in analyzing retrospective data, 
one is also missing the expectations of the patient on the outcomes of PM/(I)BR on body 
image. Results of a prospective study performed in our centre
7
 have shown that mutation 
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carriers opting for PM/(I)BR reported having more problems with body image already prior 
to PM/(I)BR compared to mutation carriers who opted for regular surveillance. Though 
these first results ask for validation, it stresses the importance of pre-surgical assessments 
in order to be able to adequately interpret post-surgical results. 
 The effect of PM/(I)BR on body image was earlier analyzed in 79 high-risk UK women
16
 
reporting  no ‘detrimental’ effect on body image. However, they did not present pre-
PM/(I)BR levels to judge the meaning of the post-PM/(I)BR values. Their conclusion about 
unchanged body image seemed therefore not supported by their data. 
  In two studies of whom all participants had (I)BR after PM, an improved body image 
was reported by 64-87% 
5,1
. A positive effect on body image was also noted in the US 
retrospective series (1979-1999) by observing that 79% of women were somewhat to not 
at all self-conscious about their appearance after PM/(I)BR, while 58% of them were very 
much to quite a bit satisfied with their appearance when dressed
14
. The majority of 
women (84%) in that study had (I)BR following PM. However, a major limitation of that 
study is that the researchers administered a self-developed survey, based on a very 
limited amount of questions from existing questionnaires on satisfaction, distress, body 
image and sexuality
14
. The study might have been more valuable if their psychometric 
values had been validated. Still, these positive reports on body image support the 
hypothesis by Metcalfe et al.
10
 that breast reconstruction may improve body contours, but 
that scars and disfigurements may cause problems in intimate situations.  
 Finally, type of prophylactic mastectomy (total or subcutaneous) did not seem to have 
an impact on body image
10
, though this result was based on unequal percentages of both 
types of PM (88% total vs. 12% subcutaneous) in a relatively small sample (n=60). 
 
2.1.6 Sexuality 
Most women in studies on the effect of PM/(I)BR on sexuality were sexually active before 
(57%) and after (68-84%) PM/(I)BR
9,10,16
. Two prospective studies found no effect of 
PM/(I)BR on habit, discomfort or sexual activity
16,22
. Still, adverse effects of PM/(I)BR on 
sexuality were reported by several studies 
4,6,7,9,10,14,22
. One prospective study
16
 initially 
found no differences in quality of sexual life after PM/(I)BR, but together with their 
interview data
8
, the same problems were reported by some women as in other studies: 
problems with touching of the breasts because dislike of the sensation, and detrimental or 
positive effects for a few. The different outcomes reported from questionnaire or 
interview data of the same group of women is not unusual: traditionally, many 
respondents express themselves not easily on intimate matters in questionnaires, which 
explains their ‘average or unchanged scores’ for all these items. However, when asked 
confidentially in an in-depth interview, they are very willing to explain their sorrows. 
 Generally, half (48%-55%) of all women felt less sexually attractive after PM/(I)BR
4,22
 
and 32-69% of them experienced untoward changes in their sexual relationship
6,7,9,10,22
, 
such as difficulty in reaching an orgasm and less pleasure during intercourse. An estimated 
43% of high-risk women were satisfied with their post-PM/(I)BR sex lives
14
, which equals 
the 38% of women being under gynecologic surveillance, who expressed satisfaction with 
sexuality. Changes in the sexual relationship seemed independent of type of PM or 
presence or absence of breast reconstruction
10
. Some of the problems with sexuality 
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might have been present before prophylactic surgery or genetic testing, as was observed 
by Lodder et al.
7
. Unfortunately, further data of larger cohorts on possible pre-surgical 
intimacy problems are lacking. 
 
2.2 The psychosocial impact of P(B)SO 
2.2.1 Population characteristics   
Average ages of women opting for P(B)SO were 39-51 (range 31-70)
18,23-28
. Studied cohorts 
consisted of mutation carriers (40-100%)
17,18,26,28,29
 and/or 50% risk carriers (52-
93%)
23,24,26,27
. A third to all (29-100%) studied women were premenopausal prior to 
P(B)SO
17,18,23,25,26,28-30
, and 20-83% had a personal history of breast cancer 
17,18,23,25,26,28
. 
 Many studies compared women opting for P(B)SO with women choosing regular 
surveillance
17,18,23-25,28,31,32
. Women opting for P(B)SO were older (>35 yrs), were more 
likely to have children, and were more likely to have undergone PM/(I)BR than women 
opting for regular surveillance
17,18
. Moreover, women who opted for P(B)SO were more 
likely to have a personal history of breast cancer
17,23
, a strong family history of breast 
cancer
25
 or have a BRCA1/2 mutation
17
. Finally, women opting for P(B)SO were more likely 
to have a first degree relative who died from ovarian cancer than women who opted for 
surveillance (87% vs. 41%)
24
. Recent prospective data showed that mutation carriers 
opting for P(B)SO were more likely married and postmenopausal compared to mutation 
carriers opting for surveillance
18
. Furthermore, mutation carriers had poorer general 
health perceptions, higher levels of risk-perception levels, increased (ovarian) cancer 
worry for themselves and relatives at risk, experienced more intrusive thoughts, viewed 
ovarian cancer more often as an incurable disease and perceived P(B)SO as having more 
pros and regular surveillance as having less pros than mutation carriers opting for regular 
surveillance
18
. 
 
2.2.2 Decision making  
For P(B)SO similar motivations were reported as for PM/(I)BR, such as risk reduction
25,31
, 
expected relief of fear of developing breast/ovarian cancer
24,31
, the obligation felt by 
women towards family members
24,25,27
 and physician’s recommendation
25,27
.  
 Age was another important motivation for high-risk women opting for P(B)SO
25,31
, 
combined with childbearing issues
25
. Other motivations concerned the family history of 
ovarian cancer or one’s personal mutation status
31
, regular surveillance concerns (i.e. 
worries about effectiveness
25,31
 and aversion/inconvenience of attending the clinic on a 
regular basis
27
), cessation of menstruation
27,31
, and longing for relief of (benign) 
gynecological problems
25,27
. Also, the patient’s belief she will become affected by ovarian 
cancer was a powerful motivator, as was found in 35% of British women who had decided 
for P(B)SO
24
.  ‘Many’ other women in that study were motivated by the death of a mother, 
a sister or a relative in a similar generation (i.e. cousin). Finally, fear of dying from ovarian 
cancer is a clear motivator for deciding for P(B)SO
25
. 
 Medical indications for P(B)SO may occasionally arise during the decision process, like 
abnormal results of a screening test or abdominal pain. In the Hallowell study
24
, in one of 
five of such cases, ovarian carcinoma caused by a BRCA1/2 mutation was found. 
  
14 Chapter 2 
2.2.3 Satisfaction and regrets 
Most women (79-97%) reported being satisfied after P(B)SO
17,25-27,30,32,33
. Seven to thirteen 
percent of women reported regrets. The occurrence of sexual problems (i.e. painful 
penetration, lack of desire and arousal, difficulty in reaching an orgasm and vaginal 
dryness in 42%-58%) predicted lesser satisfaction with P(B)SO
26
. 
 
2.2.4 Distress 
Most high-risk women (96%) who opted for P(B)SO reported increased anxiety pre-
surgery
24
, which was influenced by their experiences with cancer in the family. After 
P(B)SO, most high-risk women experienced decreased cancer-related distress
17,26,30,33
, 
with distress levels equal or lower than in women who opted for regular surveillance
17,23
. 
Not surprisingly, given the effect of PM/(I)BR on levels of distress, levels of cancer worry in 
P(B)SO women who also had undergone PM/(I)BR were lower than those of women in the 
regular surveillance group who had undergone PM/(I)BR
17
. This relief of cancer worries 
also led to a decrease in cancer worries about the risks of relatives, and improved mood 
and functioning
17
.  
 P(B)SO did not eliminate distress in all women; a variable percentage of women (9-
21%) had continuing significant ovarian cancer-specific worries
17,26
, with some (9-26%) at 
clinical levels
17,18
. The factors that contributed to this ongoing distress were not clarified 
by the authors, and remain yet to be investigated. 
 
2.2.5 Body image  
The effect of P(B)SO on body image is unclear, with two studies reporting no effect
28,33
 
and two reporting adverse effects
23,27
. Recently, a one year follow up of 38 high-risk 
women opting for P(B)SO and 37 being on regular surveillance showed no differences in 
body image between both groups
28
. However, Fry et al.
23
 found a difference in body image 
at item level (‘I find it hard to look at myself naked’) in women after P(B)SO compared 
with women in the gynecologic surveillance group. This difference was suggested to be 
partly accounted for by previous diagnoses of breast cancer in the surgical group. 
However, when excluding this group of affected women, the difference remained 
significant. Unfortunately, the authors made no attempt at explaining this finding.  
 In an in-depth study of 14 women, most women (93%) reported no adverse effects of 
P(B)SO on feelings of femininity
33
. However, Hallowell et al.
27
 registered reduced feelings 
of femininity in 13% (n=3) of 23 women during a short period after P(B)SO. Scars, possibly 
related to concomitant – but non-standard – hysterectomy, were brought forward by the 
authors as a possible explanation for this observation, but they did not elaborate further 
on this subject. In the same study, some women reported a negatively altered body image 
due to premature aging, resulting in less firm breasts and more rounded bellies
27
. 
Unfortunately, exact numbers and percentages of women who reported about these 
adverse changes in body image were not given by the authors. 
 
2.2.6 Sexuality after P(B)SO 
The effect of P(B)SO on women’s sexuality will be experienced differently, depending on 
individual and social circumstances. For instance, a 40 year old woman who has been on 
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anti-estrogenic treatment for years because of breast cancer probably will experience 
P(B)SO differently compared to an unaffected woman of 40 years of age undergoing 
P(B)SO. Moreover, effects of an intervention on sexuality are difficult to document long 
after that intervention, especially if the information is collected by questionnaires only.  
 P(B)SO did not seem to have a lasting adverse impact on sexual activity, that seemed 
only to ‘dip’ for a short period after P(B)SO
28
, followed by a recovery to normal levels for 
most women
23,31
. A recent study performed in women undergoing a P(B)SO (n=38) versus 
women following a surveillance program (n=37) found that 67% of the women reported 
decreased sexual activity at one month following P(B)SO, while 24% of them did so pre-
surgery and 39% at 12 months post-surgery. Women under surveillance had similar figures 
at all assessments, and did not show the post-surgical dip as did the P(B)SO group
28
. The 
authors concluded that the adverse effects of P(B)SO were apparently temporarily. The 
Edinburgh group 
23,31
 questioned approximately 30 high-risk women after P(B)SO or 
gynecologic surveillance. They found worse results on the General Health Questionnaire in 
the P(B)SO group and apparent identical results on a ‘sexual activity scale’ with the 
surveillance group, but the P(B)SO group had significant evidence for body image 
problems. The conclusion of ‘identical level of sexual activity’ distracted from the real 
problems in the P(B)SO group, which might have been clarified by additional interview 
studies.  
 As for sexual functioning, women who had undergone P(B)SO reported more 
discomfort and less sexual pleasure during intercourse than women in the regular 
surveillance group, corroborating previous results
17,29
. These adverse affects of P(B)SO-
induced menopause were ascribed to estrogen deprivation (i.e. hot flashes and vaginal 
dryness)
17,28
 and occurred irrespective of HRT use
17,29
. A recent observation of increased 
frequency of estrogen-deprivation associated complaints in middle age women prior to 
P(B)SO
28
 suggested that a subgroup of them might be premenopausal; no information on 
anti-estrogenic cancer therapy was given, which is important because 30% of the  women 
in that study had a personal history of breast cancer.  
 Also positive effects of P(B)SO on sexuality were observed, sometimes despite 
interfering menopausal symptoms
26,33
. An Australian interview study (n=14) established 
that some premenopausal women reported an increased libido, possibly due to reduced 
cancer anxiety and no birth-control worries
33
. These women all started HRT after P(B)SO, 
which was suggested to mitigate the impact of the procedure on sexuality
33
. However, 
another study reported on an unspecified number of women reporting loss of libido 
following P(B)SO, despite HRT-use
27
. A post-P(B)SO questionnaire study in 59 US high-risk 
women showed that 65% experienced equal or better quality of their sexual lives, though 
42-58% of the total group had disturbing symptoms of estrogen deprivation (e.g. vaginal 
dryness, problems with orgasms, lack of desire and arousal, and painful penetration). 
Clearly reduced quality of sexuality was experienced by 13%
26
. 
 In conclusion, both positive and negative effects of P(B)SO on sexuality can be 
expected. Also, the impact of any previous breast cancer surgery or PM/(I)BR may also 
play a role in the studied groups. 
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2.3 The role of hormonal replacement therapy (HRT) 
Though hormonal replacement therapy (HRT) may increase the risk of developing breast 
cancer, 37%-100% high-risk women reportedly received HRT after P(B)SO
17,23,27,30
. High-
risk women who used HRT after P(B)SO were generally unaffected (73%), were more likely 
to have undergone PM/(I)BR (62%) and opted for P(B)SO at younger ages than non-HRT 
users (41 vs. 44 yrs).The majority (72%) started using HRT directly after P(B)SO
29
. 
Generally, HRT was reported to relieve the menopausal symptoms, that occurred more 
acute and intensively in women after P(B)SO than in women under gynecologic 
surveillance
29
. However, HRT was found being ineffective in controlling menopausal 
symptoms by 48% of premenopausal women undergoing P(B)SO
27
. Moreover, side effects 
of HRT, such as water retention, spots, itchy and blotchy skin and weight gain may induce 
a negative body image
27
. 
 
2.4 The role of previous breast cancer 
PM/(I)BR is expected to have its maximal advantage when done before the occurrence of 
breast cancer. After unilateral breast cancer, the prognosis and outcome are mainly 
determined by the tumor characteristics, the administered treatment and the individual 
patient. Quality of life and functioning on different levels may be affected by breast cancer 
therapy. This implies that a large number of risk profiles may be hidden under the 
diagnostic category ‘breast cancer’. 
 In one study on the effects of P(B)SO
28
, the authors acknowledged the possible 
inequality between the surgery group and the regular surveillance group regarding the 
percentages of affected women (29% and 11% respectively), but concluded that both 
groups were equal because a difference between both had not been reflected in most 
QOL scores. However, they did not acknowledge the possibility that a prior history of 
breast cancer, including possible physical and emotional effects of breast cancer 
treatment, might have resulted in an altered level of sexual activity and functioning before 
baseline measurement. It might have been noticed, that the two groups were different on 
their risk-management strategies and associated personal characteristics, which 
eventually might have affected the results of this study. Another example of inequality of 
groups can be seen in a study by Robson
26
 on 54 women who underwent a P(B)SO. The 
majority of the women (83%) had a history of breast cancer, and 50% were identified 
mutation carriers. They compared the overall health related quality of life (HRQL) of the 
patients (all belonging to the highest social-developmental level) to scales representing 
the general population or long-term breast cancer survivors. Finding equal scores for their 
patients as in the comparison groups, the authors concluded that there was no effect of 
breast cancer on their cohort’s HRQL. However, patients may have adapted their internal 
standards to any physical changes (‘response shift’), thereby stabilizing quality of life
28,34
. 
This might explain in part the similarity of HRQL values in apparently life-stricken groups 
like cancer patients in general and the cancer patients in this study. In our opinion, this 
concept should be taken into account in future research. Interestingly, Fry et al.
31
 found 
that a history of breast cancer was never reported on the questionnaire by the women 
who opted for P(B)SO. Additional analyses showed that a history of breast cancer did not 
alter the results, leaving the authors to conclude that prior breast cancer was not 
  
17 Introduction 
significant for high-risk women when considering either P(B)SO or regular surveillance
31
. 
However, this should be further investigated in prospective studies with larger cohorts. 
 
2.5 Limitations of the reviewed studies 
Though these results has led to an increase in knowledge on the psychosocial aspects 
regarding prophylactic surgery in the past decade, many limitations of the conducted 
studies are interfering with comparisons and interpretations of results. Most studies were 
retrospective
2-6,9-12,14,19,20,23-26,31,33
, while one combined retrospective and prospective 
study designs
30
. Moreover, most studies had sample sizes of ≤30 patients
1,5-7,9,19,23-25,27,30-
33
, a number had cohorts sized between 37 and 81 women
4,8,10-12,16,20,22,26,28
 and relatively 
few studies were done on large samples  (with sample sizes ranging from 106 to 572 high-
risk women)
2,3,14,17,18,29
. Three of these large retrospective studies
2,3,14
 investigated 
satisfaction with and distress around prophylactic mastectomies that were performed 
between 1960 and 1999, when surgical techniques might not have been as refined as they 
have been in the past decade. In contrast, high-risk women in the retrospective part of the 
cross-sectional study by Madalinska et al.
17,29
 underwent P(B)SO between 1996 and 2001 
with median time between study and surgery being 2 years. To our knowledge, only two 
studies combined a median to large sample size with a prospective design (n= 81-118) 
18,22
. 
 
In conclusion, several studies have contributed to a growing knowledge of the 
psychosocial impact of PM/(I)BR and P(B)SO in high-risk women. However, differences in 
study design and lack of variables such as previous breast cancer make these results 
unrepresentative  and only partially fit for extrapolation to the clinical setting. Therefore, a 
study called the ‘PREVOM-B study’ was conducted in our centre, including unaffected and 
affected high-risk women opting for PM/(I)BR and/or P(B)SO. The research questions and 
study design of this study are addressed in Chapter 3. 
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3 
Introduction: 
Scope and Outline of this Thesis 
 
 
 
‘The decision for preventive surgery was made by me alone. I want to have it done so I can 
live the rest of my life like a normal, healthy person. My husband still has to get used to the 
idea. He thinks it’s a very radical surgery. I am sorry that he is not backing me up, but it’s 
my decision and I will go through with it anyway. I expect him to come to terms with the 
decision eventually.’ 
 
 
 
In 1999, an observational study started on the psychosocial outcomes of prophylactic 
surgery in women at risk for breast and ovarian cancer, called the PREVOM-B study. Data 
on the psychosocial effects of prophylactic surgery in Dutch women were limited, while a 
growing number of high-risk women was opting for this risk-reducing procedure (for 
details see Chapter 1). The observational study had a retrospective and a prospective part. 
It was funded by the Netherlands’ Organization for Health Research and Development 
(grant no. 210-00-013) and approved by the Medical Ethics Committee of the Erasmus 
Medical Centre (MC) Rotterdam (protocol no. DDHK 98-15). The study was performed at 
the Department of Medical Psychology and Psychotherapy of the Erasmus MC, in close 
collaboration with the Departments of Medical Oncology, Surgery and Psychiatry of the 
Daniel den Hoed Family Cancer Clinic (Erasmus MC), the Department of Obstetrics and 
Gynecology, division of Gynecologic Oncology (Erasmus MC) and the Department of 
Clinical Genetics (Erasmus MC). All patients received their oncological, genetic, 
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psychological and surgical care at the Daniel den Hoed Family Cancer Clinic, except for 
some women who underwent P(B)SO. 
 
3.1 Aims of the study 
The PREVOM-B study aimed at uncovering the psychosocial impact of prophylactic surgery 
on high-risk women, being either BRCA1/2 mutation carriers or women from a hereditary 
breast/ovarian cancer (HBOC) family.  
The main research questions in this thesis were: 
1. What is the satisfaction with the cosmetic outcomes of PM/(I)BR (Chapter 4)?  
2. What are the motivations of high-risk women for undergoing prophylactic surgery and 
what is their effect on emotional distress (Chapter 5)?  
3. What are the levels and courses of emotional distress in high-risk women opting for 
prophylactic surgery (Chapter 6) and their partners (Chapter 7)? 
4. What are the predictors of emotional distress in high risk women who underwent 
prophylactic surgery (Chapter 8)? 
5. What is the effect of coping on emotional distress after undergoing prophylactic 
surgery (Chapter 9)? 
 
3.2 Retrospective study 
Retrospectively, we explored satisfaction with the cosmetic outcomes of PM/(I)BR in 136 
women who underwent this procedure at our centre between 1994 and 2002
1
. All women 
were either a BRCA1 or BRCA2 mutation carrier, or a 50% risk women from a hereditary 
breast/ovarian cancer (HBOC) family whereby genetic testing had not yet identified a 
mutation. In 92% of all women, (I)BR was done by means of a subpectorally implanted 
silicone prostheses, as this was the preferred breast reconstruction technique during that 
period of time. A minority of women (8%) underwent (I)BR by another technique because 
of a previous unilateral mastectomy. Sixty-five women (57%) also underwent P(B)SO, 
while 31 women (27%) used HRT at any time. Consenting women filled out a 
questionnaire containing 16 questions covering four domains: 1) general and PM/(I)BR-
specific satisfaction; 2) feeling informed about the procedure and its possible 
consequences; 3) peri- and postoperative complications, physical complaints and 
limitations due to PM/(I)BR; and 4) effects of PM/(I)BR on body image and sexuality. 
Eighty four percent of the women (n=114) completed and returned the questionnaire by 
mail. Since our main objective was to investigate the level of satisfaction in these women 
irrespective of interpersonal medical differences, we adjusted for i) age at the time of 
PM/(I)BR; ii) years elapsed since PM/(I)BR; iii) history of breast cancer; iv) PBSO; and v) 
HRT. Each predictor variable was tested on the outcome variable separately, including the 
variables that were adjusted for. Results of this study are described in Chapter 4. 
 
3.3 Prospective study 
Between August 1999 and February 2003, 129 high-risk women who decided to undergo 
PM/(I)BR and/or P(B)SO at the Family Cancer Clinic of the Erasmus MC-Daniel den Hoed 
Cancer Centre were approached for participation in the prospective part of the PREVOM-B 
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study. Eligible women were either BRCA1/2 mutation carrier or women from a HBOC 
family without an identified BRCA1/2 mutation, without signs or suspicion of breast 
cancer or ovarian cancer at pre-surgical examination (performed within 3 months prior to 
prophylactic surgery).  
 Consenting women were assessed within a month prior to prophylactic surgery 
(baseline; T0), at six months (T1) and twelve months after prophylactic surgery (T2). At all 
three assessments, participants were asked for completion and return of the completed 
questionnaire, that were sent to them by mail. Also the partners of all participating 
women were approached for study participation. After consent, the same questionnaires 
were sent to the partners at the same assessment moments as their wives. 
 At T0, data on demographic (e.g. age, marital status, parenthood) and medical data 
(e.g. carrier status, history of breast cancer) were collected. Also at T0, neuroticism was 
assessed by use of the neuroticism (N-)scale of the Amsterdam Biographical Questionnaire 
(ABQ)
2
, thus assessing vulnerability to psychological distress
3
. 
 At T0, T1 and T2, coping strategies were assessed by the Utrecht Coping List (UCL)
4,5
, a 
general coping questionnaire that addresses active coping, palliative and passive reaction 
patterns, seeking social support, expression of emotions and the habit to reassure oneself 
by comforting thoughts. Cancer-related distress was assessed by means of the Impact of 
Events Scale  (IES)
6-9
, an established instrument for measuring feeling overwhelmed by 
intrusive and avoidant thoughts and feelings related to a traumatic event, and the 
tendency to adapt one’s behaviour to these thoughts and feelings. In our study, these 
thoughts, feelings and behaviour were anchored to breast cancer and/or ovarian cancer. 
General distress was measured with the Hospital Anxiety and Depression Scale (HADS)
10
. 
The Hospital Anxiety and Depression Scale has two scales for anxiety and depression, 
respectively. 
 Further, all participants (high-risk women and partners) were interviewed separately at 
their homes at T0, T1 and T2. The interviews were of a semi-structured nature with topics 
concerning risk-perception, motivations for deciding for prophylactic surgery, expectations 
about prophylactic surgery, support from family members and relatives, experience of and 
need for social support, body image, sexual relationship and global assessment of 
functioning. Except for results on motivations (Chapter 5), the interview data will be 
presented elsewhere. 
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4 
Satisfaction with Prophylactic Mastectomy and Breast 
Reconstruction in Genetically Predisposed Women 
 
 
 
Background Prophylactic mastectomy (PM) with breast reconstruction (BR) is a risk-reducing strategy for 
women at increased risk of breast cancer. It remains a very radical intervention while long-term data on 
satisfaction are insufficiently available. In the present follow-up study, we assess satisfaction with PM and BR 
and its impact on the sexual relationship. 
Methods Retrospective study using a short self-report questionnaire in 114 genetically predisposed women 
who underwent PM and BR mainly by subpectorally implanted silicone prostheses, performed at one 
institution.  
Results The median follow-up time between PM/BR and completion of the questionnaire was 3 years. Sixty 
percent of all participants were satisfied with the result of PM/BR. Satisfaction was significantly and 
negatively correlated with: perceived lack of information, experienced complications, ongoing complaints, 
whether or not the reconstructed breasts feel ‘like your own’, and not choosing this type of BR again. Adverse 
effects in the sexual relationship were strongly correlated with perceived lack of information, discrepant 
expectations, ongoing complaints and limitations, whether or not the reconstructed breasts feel ‘like your 
own’, altered feelings of femininity, partner's negative perception on femininity and sexuality, and not 
choosing this type of BR again. 
Conclusions In spite of adverse effects of PM/BR, the majority of women would opt for PM/BR again. 
However, having experienced adverse effects and untoward changes in the perception of the sexual 
relationship due to PM/BR need to be addressed and explored in the counselling of women at high risk to 
optimise an informed choice, and enable adequate adjustment after PM/BR. 
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4.1 Introduction 
Women identified with a BRCA1/2 mutation have a cumulative lifetime risk for breast 
cancer of 39-85% and for ovarian cancer of 11-63% at age 70 years
1-4
. Furthermore, the 
lifetime risk of contralateral breast cancer for genetically predisposed women after a 
history of breast cancer is 48-64%
5
. At this moment, bilateral or contralateral prophylactic 
mastectomy (PM) is the most effective, although radical, strategy to reduce the risk of 
breast cancer in high-risk women
6, 7
. 
 At the Family Cancer Clinic of the Erasmus Medical Centre - Daniel den Hoed Cancer 
Centre in Rotterdam, between 35 and 51% of the identified mutation carriers opt for 
prophylactic mastectomy with breast reconstruction (PM/BR)
6, 8
. Satisfaction with PM has 
been reported to vary between 70%
9, 10
 and (nearly) 100%
11-15
.  However, major 
limitations of the published studies were that satisfaction with (immediate) breast 
reconstruction after prophylactic mastectomy was either not a primary focus of the 
study
12, 13, 16
 or it was investigated in a small (sub)sample
10, 16
.  
 In the present study, we assessed satisfaction with breast reconstruction after 
prophylactic mastectomy in the longer term in 114 women at increased risk of 
(contralateral) breast cancer due to a BRCA1/2 mutation or a supposed genetic 
predisposition. 
 
4.2 Patients and Methods 
4.2.1 Study population 
From the database of a follow-up study on the medical effects of PM in genetically 
predisposed and high-risk women, we approached all women (n=136) who underwent 
bilateral or contralateral PM/BR at our institution between 1994 and 2002. PM/BR was 
performed because of an increased risk of (a new) breast cancer due to either a BRCA1 or 
BRCA2 mutation, or a 50% risk carrier status in women from hereditary breast/ovarian 
cancer families. All women were from families with cancer following an autosomal 
dominant pattern of inheritance and were offered genetic testing before undergoing PM. 
Some of these women remain at increased risk of breast and/or ovarian cancer without 
the possibility that this risk can be specified further. They may however opt for PM.  
 Reconstruction was done by means of subpectorally implanted silicone prostheses, as 
has been described in detail elsewhere
17
. A history of breast cancer was not an exclusion 
criterion. Women who previously underwent unilateral mastectomy for a primary breast 
cancer (n=9) were at that side reconstructed with another technique. Follow-up was 
performed at the Family Cancer Clinic of the Erasmus MC-Daniel den Hoed Cancer Centre 
in Rotterdam. The institutional review board approved the study. Written informed 
consent from participants was obtained. 
 Sixty-five women also underwent a prophylactic bilateral salpingo-oophorectomy 
(PBSO), which was performed either before, simultaneously with, or after PM/BR. P(B)SO 
was not necessarily performed at our institute. Thirty-one women used hormone 
replacement therapy (HRT) at any time during the follow-up period. 
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4.2.2 Questionnaire  
We developed a brief self-report questionnaire based on clinical experience with high-risk 
women and on questionnaires that are currently used in follow-up studies, in order to 
measure the satisfaction of women with the outcome of PM and BR. 
 Sixteen questions covered four domains: 1) general and PM/BR-specific satisfaction 
(three questions); 2) feeling informed about the procedure and its possible consequences 
(two questions); 3) peri- and postoperative complications, physical complaints and 
limitations because of PM/BR (three questions); and 4) effects on body image and 
sexuality (eight questions). All questions addressed BR specifically. Three questions 
concerning body image and sexuality addressed the perception of the women about their 
partners’ satisfaction. 
 Answers were rated on a five-point scale ranging from Yes!, Yes, ? (neutral), No, to No!. 
Questions that implicated the presence of a partner could also be scored as 'not 
applicable'. 
 
4.2.3 Procedure 
The questionnaire was mailed to all patients who met the inclusion criteria. Two patients 
apparently moved without giving notice of their new address. Eighty four percent of the 
women (n=114) completed and returned the questionnaire by mail. 
 
4.2.4 Statistical analysis 
We present the frequencies and percentages for the responses on the questionnaire. 
Given that women with a history of breast cancer may have had different priorities when 
considering PM with BR, we performed analyses not only on the complete sample, but 
also on women with and without previous breast cancer separately. Furthermore, logistic 
regression analyses were performed with 1) satisfaction and 2) adverse effects in the 
sexual relationship as outcome variables. Hereto, we dichotomised the original 5-point 
scale by combining the 'Yes!' and 'Yes' answers on the one hand and the '?', 'No' and 'No!' 
answers on the other hand for the outcome variables alone. This kind of dichotomization 
was performed to study more specifically the satisfied versus the remaining (‘non-
satisfied’) patients. The influence of each of the other questions of the questionnaire on 
the outcome variable was investigated. Since our main objective was to investigate the 
level of satisfaction in these women irrespective of interpersonal medical differences, we 
adjusted for i) age at the time of PM/BR; ii) years elapsed since PM/BR; iii) history of 
breast cancer; iv) PBSO; and v) HRT. Each predictor variable was tested on the outcome 
variable separately, including the variables that were adjusted for. A p-value ≤ 0.05 (two-
tailed) was considered as statistically significant. 
 
4.3 Results 
4.3.1 Sample Characteristics 
Of 136 women who received the questionnaire, 114 participated in this study (84%). Two-
third of these women (n=77) were unaffected BRCA1/2 mutation-carriers (n=63) or 50% 
risk carriers (n=14); 22 women had previously been treated for breast cancer by either 
breast conserving therapy (n=13) or unilateral mastectomy (n=9). Fifteen women decided 
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for bilateral mastectomy with reconstruction when breast cancer was diagnosed. None of 
these women experienced a recurrence of breast cancer in the years after surgery until 
time of assessment. Thirteen out of 37 women with a history of breast cancer were 
proven BRCA1/2 mutation-carriers. 
 
Table 1 
General characteristics of 114 participants who underwent prophylactic mastectomy (PM) and breast 
reconstruction (BR) from 1994 – 2002 
 
    
 Unaffected women
 1 
(N=77) 
Affected women
2
 
(N=37) 
Total group  
(N=114) 
 Median Range Median Range Median Range 
Age 41 25-59 46 30-65 44 25-65 
Age at time of PM/BR 38 23-55 43 26-59 40 23-59 
Follow-up in years 3 0-8 4 0-8 3 0-8 
 n % n % n % 
Living with a partner 68 90 32 86 100 88 
Risk status       
BRCA1/2 mutation carriers 63 82 13 35 76 67 
Women at >50% risk
3 
14 18 24 65 38 33 
Additional       
PBSO* 48 62 17 46 65 57 
HRT* 30 39 1 2 31 27 
       
 
*PBSO: prophylactic bilateral salpingo-oophorectomy; HRT: hormone replacement therapy 
1
Women without a history of breast cancer. 
2
 Women with a history of breast cancer. 
3
 Based on a family history suggestive for a breast/ovarian cancer syndrome. 
 
Some women did not answer all questions, resulting in different totals. Median follow-up 
after surgery for the complete sample was three years (range two months-eight years). 
Respondents and non-respondents (n=22) did not differ demographically. Characteristics 
of the participants are presented in Table 1.  
 
4.3.2 Overall evaluation 
Women with and without a history of breast cancer differed not significantly in responses 
on the questionnaire. Therefore, we performed the analyses on the total sample.  
 As is shown in Table 2, 68 (60%) women were satisfied with the result of PM and BR. 
One hundred and six (95%) women would opt for PM again, would they have to choose 
again, 89 (80%) women would choose for the same type of BR again, and 95 (85%) women 
felt sufficiently informed.  
 Forty-eight women (43%) reported peri- and/or postoperative complications, and 35 
women (32%) mentioned that they experienced ongoing physical complaints in one or 
both reconstructed breasts. Twenty-eight women (25%) reported to experience 
limitations in daily life due to (the aftermath of) PM/BR. 
 The sensation of the breasts altered in nearly all women (97%), fifty-eight (51%) 
women rated their breasts as not feeling 'like their own', and 32 (29%) women reported 
altered feelings of femininity after PM/BR, while only 8 women (8%) thought their 
partners found them less feminine. Ten women (13%) experienced positive changes in 
their sexual relationship due to PM/BR. Forty women (44%) reported an adverse change in 
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their sexual relationship due to PM/BR. Finally, 10 of the partners (13%) were thought to 
have experienced a positive change in the sexual relationship, whereas 27 partners (35%) 
were thought to have experienced an adverse change in the sexual relationship. 
 
Table 2 
Women's experience with prophylactic mastectomy and breast reconstruction
1 
 
     
Answers on N
2
 
YES! and YES ? (neutral) NO and NO! 
n % n % n % 
Being satisfied with result PM/BR 113 68 60 13 12 32 28 
Would opt for PM again 112 106 95 5 5 1 1 
Would opt for BR again 112 89 80 12 11 11 10 
Feeling sufficiently informed 112 95 85 1 1 16 14 
Surgery did not meet expectations 112 35 31 8 7 69 62 
Complications
3
  113 48 43 2 2 63 56 
Ongoing complaints 111 35 32 5 5 71 64 
Limitations in daily life 112 28 25 6 5 78 70 
Change in feeling of the breasts 114 111 97 0 0 3 3 
Breasts do not feel 'like your own' 113 58 51 7 6 48 43 
Changes in femininity
4
 111 32 29 4 4 75 68 
Positive effects in sexuality
4
 77 10 13 11 14 56 73 
Adverse effects in sexuality
4
 90 40 44 9 10 41 46 
Partner’s perceptions        
Lessened femininity
4
 100 8 8 3 3 89 89 
Positive effects in sexuality
4
  79 10 13 11 14 58 73 
Adverse effects in sexuality
4
 77 27 35 10 13 40 52 
        
 
1
 Row totals deviating from n=114 indicate missing data. 
2
 N = sample size; number of women who had a response on this item. 
3
 I.e. self-reported complications, including secondary reconstructive surgery. 
4
 due to PM/BR 
 
4.3.3 Satisfaction 
We dichotomised the total group into satisfied patients (n=68) and the non-satisfied 
patients (n=45), based on the question: ‘Are you satisfied with the result of breast 
reconstruction?’ The answers were analysed taking into account various confounders as 
described in the methods section. Significant differences were found between satisfied 
patients and non-satisfied patients, as is shown in Table 3.  
 Non-satisfied patients felt significantly less informed than satisfied patients (p=.02). 
They also reported significantly more complications (p=.01) and more physical complaints 
(p=.001) than satisfied patients. Moreover, non-satisfied patients reported significantly 
more than satisfied patients that their breasts do not feel like belonging to their body 
(p=.02). Finally, non-satisfied patients reported significantly more often that they would 
not opt for BR again (p=.01). 
 
4.3.4 Impact on perception of sexual relationship 
Nearly half of the women who filled out the questions about the sexual relationship 
(n=90) reported that (the result of) PM/BR had negatively affected their sexual 
relationship (44%). Therefore, we performed a logistic regression analysis with as outcome 
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variable the impact on the sexual relationship. We adjusted for the same confounders as 
described in the methods section. Results are shown in Table 4. 
 
Table 3 
The relationship between satisfaction and women's experience with prophylactic mastectomy and breast 
reconstruction
1 
 
    
 Non-satisfied patients 
(n=45) 
Satisfied patients  
(n=68) 
 
 N
2
 n % N
2
 n % p
3
 
Feeling insufficiently informed 43 10 23 68 6 9 .02
 
Surgery did not meet expectations 45 17 38 67 18 27 .08 
Complications 44 23 52 68 24 35 .01 
Complaints 42 26 62 68 9 13 .001 
Limitations in daily life 43 13 30 68 15 22 .33 
Change in feeling of the breasts 45 45 100 68 65 96 .75 
Breasts do not feel ‘like your own’ 44 28 64 68 30 44 .02 
Change in feelings of femininity 44 14 32 66 17 26 .53 
Positive effects sexual relationship 26 5 19 50 5 10 .70 
Adverse effects sexual relationship 32 18 56 57 22 39 .31 
Would not opt for PM again 44  1 2 67  0 0 .28 
Would not opt for BR again 43 10 23 68  1 2 .01 
Partner’s perception        
Decrease wife’s femininity 37 4 11 62 4 7 .94 
Positive effect on sexual relationship 28 6 21 50 4 8 .07 
Adverse effect on sexual relationship 26 13 50 50 14 28 .06 
      
 
1
Logistic regression analysis, adjusted for: i) age at the time of PM/BR; ii) years since PM/BR; iii) history of breast cancer; iv) PBSO; and 
v) HRT.  
2
 N = sample size; number of women who had a response on this item.  
3
 A p-value ≤ 0.05 (two-tailed) was considered as statistically significant. 
 
Table 4 
The relationship between adverse effects on the sexual relationship and women's experience with 
prophylactic mastectomy and breast reconstruction
1 
 
    
 No effect (n=50) Adverse effect (n=40)  
 N
2
 n % N n % p 
Does not feel sufficiently informed 50  2 4 40 12 30 .01 
Surgery did not meet expectations 48 9 19 40 18 45 .001 
Complications 49 18 37 40 20 50 .34 
Complaints 48 8 17 40 18 45 .01 
Limitations in daily life 50 7 14 39 18 46 .01 
Non-satisfied result reconstruction 50 14 28 40 18 45 .07 
Changed feeling in one or both breasts 50 49 98 40 38 95 .48 
Breasts do not feel 'like your own' 50 18 36 40 27 68 .01 
Change in feelings of femininity 49 9 18 39 20 51 .01 
Would not opt for PM again 49  0 0 39  1 3 .25 
Would not opt for BR again 50  0 0 39 7 18 .01 
Partner’s perceptions        
Decrease in his wife’s femininity 50  1 2 36 7 19 .04 
Adverse effect on sexual relationship 48 6 13 27 20 74 .001 
       
 
1
 Adjusted for: i) age at the time of PM/BR; ii) years since PM/BR; iii) history of breast cancer; iv) PBSO; and v) HRT. 
2
 N = sample size; number of women who had a response on this item.  
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Women who reported adverse changes in their sexual relationship stated more likely that 
they felt insufficiently informed about the procedure and its possible consequences 
(p=.01), that surgery had not met their expectations (p=.001), that they were experiencing 
more complaints (p=.01) and more limitations in daily life (p=.01). They were also more 
likely to report that the reconstructed breasts do not feel ‘like their own’ (p=.01), that they 
experienced altered feelings of femininity (p=.01), and a decrease in their partner's 
perception of his wife’s femininity (p=.04). They were more likely to perceive an adverse 
change in the way the partner experienced their sexual relationship (p=.001). Finally, they 
were more likely to report that they would not opt for BR again (p=.01). 
 
4.4 Discussion 
This is the first study that addresses impact of both prophylactic surgery and breast 
reconstruction in a large sample of genetically predisposed women. 
 PM/BR was not regretted by the vast majority of women, which is in accordance with 
other studies
9, 11-15
. Yet, only 60% of the women were satisfied with the results of the 
breast reconstruction. This is less than observed in other studies 
12, 13, 16
.  Higher distress or 
cancer worry has been found in women opting for PM compared with those who favoured 
surveillance, while the distress had significantly decreased 6 months after surgery 
9, 14, 18
. 
Therefore, we speculate that relief from anxiety of developing (a new) breast cancer 
characterizes the short-term outcome after PM. Thereafter the growing awareness of the 
profound consequences of the surgery might have affected the satisfaction with the 
eventual results. Indeed, significantly more non-satisfied women would not opt for BR 
again compared to satisfied women. 
 Frost et al.
9
 found in their study (mean follow-up 14.5 years) that 80% of the surveyed 
women were satisfied with PM. However, they did not explicitly study the satisfaction 
with BR after PM. Moreover, the mean age of their group at the time of the study was 
much higher (57 years of age) than in our study. While their findings suggest a positive 
adjustment on the long term, our data suggest that a favourable outcome of PM/BR and 
therefore persistent sexual attractiveness may be more valued by younger women. 
 The level of satisfaction about PM/BR in our study was associated with various factors 
such as peri- and postoperative complications of PM/BR, and ongoing physical complaints 
and limitations in daily life. This has been found in previous research
10, 13, 19, 20
. Fewer 
women reported ongoing complaints in our study, compared with the study by 
Bebbington Hatcher et al.
15
. In their cohort, half of all women reported ongoing problems 
due to surgery, even at 18 months after the intervention. Since their study group has been 
recruited from 20 different centres, the type of surgery or the experience of the surgeons 
may not have been similar for all women, which might explain the different outcome. 
Moreover, our follow-up period is longer, which may be an explanation for our lower 
number of ongoing complaints.  
 Also the feeling of the reconstructed breasts as belonging to one’s body and the type of 
reconstruction clearly influence the women’s satisfaction with the procedure. As was 
pointed out by Contant et al.
19
, the expectation of an unaltered body image is often 
reported to be a motivation for undergoing BR. When expectations considering body 
image are not met, this might well be the explanation of dissatisfaction with the outcomes 
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of surgery. Unfortunately, the design of this study is not such that it explores the women’s 
presurgical attitudes.  An ongoing study at our institution, relating the outcome of PM/BR 
as perceived by both women and a number of experts, will hopefully provide more data 
on this issue. 
 Most studies on the psychological effects of prophylactic mastectomy reported few or 
no detrimental effects on body image and sexuality in the majority of women
12, 15, 16, 18, 19, 
21, 22
. Lodder et al.
14
 did find some effects, but concluded that the differences in body 
image and sexuality pre- and postoperatively were not due to PM/BR. Two follow-up 
studies found comparable effects of PM and BR on the sexual relationship. Recently, Van 
Oostrom et al.
23
 reported that a high percentage of women had experienced untoward 
changes in their relationship due to PM. Frost et al.
9
 found that prophylactic mastectomy 
could result in adverse effects on the sexual relationship (23%) and feelings of femininity 
(25%), which is consistent with our findings. However, those studies did not focus on 
breast reconstruction specifically. In our study, though not related to satisfaction with 
PM/BR, nearly half of all women experienced untoward changes in their sexual 
relationship due to PM/BR. This finding was significantly associated with perceived lack of 
information, expectations that were not met, ongoing physical complaints and limitations 
in daily life, altered feelings of femininity and body image, and perception of the partner’s 
negative view on his wife’s sexual attractiveness. Indeed, women may have experienced 
pain or hindrance, and therefore the sexual relationship will not be as uncomplicated as it 
was before surgery.  
 The absence of a relationship between satisfaction with prophylactic mastectomy and 
breast reconstruction on the one hand, and changes in the sexual relationship on the 
other hand is noticeable. We speculate that satisfaction with the result of prophylactic 
surgery in this group of high-risk women is complex, and may be related with changes in 
the sexual relationship through as yet unknown variables. 
 This study has several limitations. First, our sample was heterogeneous with respect to 
medical history and treatment. We adjusted for the effect of demographic variables by 
using the method of logistic regression analysis. Due to small subsamples we were not 
able to perform additional analyses. However, most demographic variables do have an 
effect on the responses of this sample, and it is advisable to investigate the importance of 
these variables in a larger population. Second, the questions of the questionnaire aimed at 
PM/BR and did not take into account the fact that it may be impossible to distinguish 
between breast reconstruction and the prophylactic mastectomy. Third, the number of 
women in our sample who had their breasts reconstructed with another type of 
reconstruction (e.g. TRAM flap or expander based implants) was very low, so no 
comparison could be made on the level of satisfaction with these other types of 
reconstruction. In a recent study done by Fogarty et al.
24
, no differences were found 
between the outcome after autologous and nonautologous breast reconstructions, which 
is reassuring. However, we realise that this issue should be further investigated. Fourth, 
the instrument we developed has not been tested for reliability or validity. Its sole 
purpose was to provide insight into possible determinants of (un)satisfaction with the 
results of PM/IBR, using one item per factor.  Currently, a prospective study is conducted 
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at our institution that investigates the motivations and implications of prophylactic 
surgery and breast reconstruction.  
 
4.5 Clinical Implications 
Although other studies have shown that PM/BR obviously serves to decrease cancer-
related anxiety in the short term, the long-term impact on quality of life and especially on 
the quality of the sexual relationship should not be underestimated. Because the women 
in our group show few regrets and most of them feel sufficiently informed, we anticipate 
that the absence of regrets despite the awareness of adverse consequences reflect that 
the urge to reduce anxiety, remain healthy and to survive predominates any ambivalence 
regarding the possible (negative) outcomes of PM/BR on the long term. Though physicians 
must extensively inform their patients about the long-term ramifications of PM/BR, they 
should be aware that this information is given at the moment that the urge to survive 
predominates. Therefore, it is important to pay attention to the way the information is 
processed and assimilated.  
 Careful exploration of the possible impact upon body image and the sexual relationship 
enables the women at risk and their partners to recognize the potential risk factors for 
inadequate coping. If there are any such factors, additional professional attention from a 
psychologist or social worker may be of help to anticipate untoward experiences after 
treatment. If needed, follow-up support can be offered after PM/BR.  
 Finally, it should be further studied which women and/or couples are at high risk for 
maladjustment and inadequate coping. The subjective well being of these persons may 
benefit in the long term if the pre-surgical counselling and information has been 
comprehensively offered and correctly assimilated. 
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5 
Motivations and Distress in Genetically Predisposed 
Women Opting for Prophylactic Mastectomy or (Bilateral) 
Salpingo-Oophorectomy 
 
 
 
Background This study addresses the self reported of motivations for prophylactic surgery (PS) of the breasts 
and/ or ovaries and uterine tubes, and their association with emotional distress in 36 women at increased 
risk of hereditary breast and ovarian cancer either because of a BRCA1/2 mutation or family history. 
Methods Thirty-six high risk women were interviewed at 2-4 weeks pre-PS and again at six months and 
twelve months post-PS. The motivations for PS were isolated from the transcripts and categorized. At these 
assessments, women filled out a demographic questionnaire, the Impact of Events Scale (IES) and the 
Hospital Anxiety and Depression Scale (HADS). 
Results Motivations were characterised as cognitive (C) or emotional-cognitive (EC). The EC group (n=20) had 
‘fear for breast or ovarian cancer’ and ‘supporting daughters’ as their principal motivations, together with 
the cognitive items as risk reduction, uncertainty despite regular surveillance, etc. The C group (n=16) had 
only the latter set of motivations. Both groups had similar courses of cancer-related and general distress 
from pre-PS to 1 year post-PS, with no clinically relevant levels for cancer related (intrusion/avoidance) or 
general (anxiety/depression) distress as measured by IES and HADS, respectively. A separate analysis of 17 
women expressing fear of cancer as their principal motivation as compared with 19 otherwise motivated risk 
carriers showed more depression pre-PS in the cancer-fearing group. After PS, both groups had similar levels 
of depression. The courses of intrusion differed in both groups with a greater relief of intrusion within 6 
months post-PS in the cancer-fearing group, whereas the group of women whose motivations were others 
than fear showed relief of intrusion after 6 months post-PS. 
Conclusions Pre- and post-operative counselling might particularly focus on women with a predominantly 
fear-driven choice for PS to assist them in handling potentially enhanced distress in that period. 
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5.1 Introduction 
The BRCA1 and BRCA2 breast cancer susceptibility genes associated with hereditary breast 
and ovarian cancer were identified in 1994 and 1995 respectively
1,2
. Female mutation-
carriers have a cumulative lifetime risk for breast cancer of 39-85%, and for ovarian cancer 
of 11-63% at age 70 years
3-6
. Additionally, mutation-carriers with a history of unilateral 
breast cancer have an increased lifetime risk of contralateral breast cancer, estimated 
between 20-60% or 3% annually
7,8
. 
 Regular surveillance by mammography, MRI and clinical breast examination
9
 aim at 
early detection of breast cancer, which is much less feasible for ovarian cancer
10
. 
Prophylactic surgery (PS) of the breasts as well as the ovaries/fallopian tubes (defined as 
surgical removal in the absence of clinical signs of cancer) is highly effective with respect 
to cancer risk reduction. Data on the efficacy of prophylactic mastectomy with or without 
(immediate) breast reconstruction (PM/(I)BR) showed that the remaining risk of 
developing a primary breast cancer after PM/(I)BR is very low
11
. After prophylactic 
(bilateral) salpingo-ovariectomy (P(B)SO), it was estimated that only a small residual risk of 
developing extra-ovarian, peritoneal cancer remains
12
. Furthermore, a P(B)SO reduces the 
risk of developing breast cancer
13,14
. 
 Psychosocial studies on PS have clarified the motivations of high-risk women for such a 
far-reaching decision
15-21
. Also, levels and courses of distress have been investigated, with 
results that indicated that the levels of distress in women opting for PS usually decreased 
after PS
16,18,19,22-30
. Still, a subgroup of women reported continuing general and cancer-
related distress
16,24,31,32
. 
 The present study addresses the possible associations between motivations for PS and 
the level and course of (ongoing) emotional distress. We used Leventhal’s model of self-
regulation
33
 as a theoretical framework for the relationship between motivations and 
emotional distress. According to this model, objective-cognitive processes (e.g. medical 
information on breast and/or ovarian cancer, specific risks provided by the geneticist, etc) 
are processed in interaction with subjective-emotional processes (e.g. personal 
experiences with the disease in relatives) resulting in causal beliefs on the disease (e.g. the 
role of heredity in developing breast and ovarian cancer). These causal beliefs will be the 
basis for a mental cognitive representation of the health threat in question. Contributing 
factors for this representation are self-esteem, experienced susceptibility and experienced 
control. Parallel to this cognitive process, an emotional response (i.e. emotional distress) 
is invoked, based upon the experienced threat to one’s health, cognitive beliefs and 
behavioural intentions. The cognitive representation leads to problem-focused coping, 
whereas the emotional response leads to emotion-focused coping. Both problem-focused 
coping and emotion-focused coping are subject to regular appraisal. Emotion-focused 
coping may facilitate problem-focused coping in the short term; it can lead to a decrease 
of extreme emotional distress, so energy is available for problem-focused coping 
strategies (e.g. decision-making). However, in the long term, emotion-focused coping may 
interfere with problem-focused coping, for example when it undermines activities like 
gathering information, weighing the options and adherence to surveillance. 
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Decruyenaere et al.
34
 observed that risk-reducing actions like PS are predominantly 
cognitively controlled. Based on this principal, emotional responses, i.e. anxiety and 
emotional distress, will facilitate the (cognitive) decision for PS, because PS reduces the 
risks of developing breast and ovarian cancer and allows regaining control over the health-
threat. Subsequently, this process may lead to reduction of distress.  
 As motivations reflect both the cognitive representation of the health threat and the 
invoked emotional response, we expect that women with combined cognitive and 
emotional motivations will benefit more from PS (experience greater relief) than women 
with pure cognitive motivations: the latter will experience the emotional relief to a lesser 
degree.  
 This study is a prospective exploration of motivations for PS and emotional distress 
addressing two research questions: 1) What is the nature of motivations of women to 
undergo PS? and 2) Do women with a combined emotional and cognitive motivation 
experience a larger reduction in emotional distress after PS than women with a 
predominantly cognitive motivation? 
 
5.2 Patients and Methods 
5.2.1 Study population 
Between August 1999 and February 2003, 129 women being at increased risk of 
hereditary breast and ovarian cancer who decided to undergo PM/(I)BR and/or P(B)SO as 
risk reducing procedure at the Family Cancer Clinic of the Erasmus MC-Daniel den Hoed 
Cancer Centre were invited to participate in a psychological follow-up study (PREVOM-B 
study) on the psychological impact of PS. All women (hereafter called ‘high-risk women’) 
belonged to families with an apparent autosomal dominant transmission pattern, and 
therefore had an associated elevated risk of developing breast and ovarian cancer. The 
majority of these women were BRCA1/2 mutation carriers (hereafter called ‘mutation 
carriers’). For women from a hereditary breast and ovarian cancer family without an 
identified BRCA1/2 mutation (hereafter called ‘risk carriers’), the request for PM/(I)BR or 
P(B)SO was reviewed at the multidisciplinary working party on hereditary cancer of our 
institution. The decision to proceed to PM/(I)BR and/or P(B)SO was made after extensive 
and repeated information and counselling, including a consultation with the institutional 
psychologist. Factors taken into account into the decision-making process with respect to 
PS were age, history of breast cancer, risk estimation for (contralateral) breast cancer and 
ovarian cancer, and consistency of the patient’s request and its underlying arguments.  
 Eligibility criteria for the study were: no signs or suspicion of breast and ovarian cancer 
at pre-surgical examination (physical and imaging examination, plus Ca125 analysis) 
performed within 3 months prior to PS. For women with a history of breast cancer, 
recurrent disease or a new primary tumour had to be ruled out by physical and 
imaging/dissemination examination (mammography, gynaecological examination and 
ultrasound, chest X-ray, ultrasound liver, bone scan, liver-function tests, and Ca125/Ca153 
analysis), also performed within 3 months prior to PS.  
Three women (7,5%) who were originally classified as 50% risk carriers eventually were 
identified as non-carriers of the family BRCA1/2 mutation. These women were included 
into analyses for they already had undergone PS at test disclosure. Therefore, we assumed 
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that their worries and motivations regarding their alleged increased risk of developing 
cancer were similar to the other women who were included into the study. 
Physicians introduced the PREVOM-B study to eligible patients by means of verbal and 
written information. After written informed consent, participants received questionnaires 
by mail 2-4 weeks before (T0), and 6 and 12 months after PS (T1 and T2 respectively). The 
researcher of the project (PB) interviewed women at all three measurement moments at 
home. For the current analysis the pre-surgery interviews were used. Due to logistics (e.g. 
the eligible woman and/or researcher were informed too late, making it impossible to 
meet for an interview prior to surgery) or electronic problems (e.g. the interview being not 
clearly audible on tape due to circumstantial noise), not all interviews were suitable for 
transcription or analysis. Finally, 36 pre-surgery interviews were included into the analysis. 
 
5.2.2 Biographical and medical data 
Age, marital status, offspring, religious affiliation, educational level, profession, carrier 
status, history of breast cancer, and type of surgery were recorded at T0 by means of a 
questionnaire. 
 
5.2.3 Cancer-related distress 
The Impact of Events Scale (IES) is an established instrument
35-38
 for measuring feeling 
overwhelmed by intrusive and avoidant thoughts, and feelings related to a traumatic 
event, and the tendency to adapt one’s behaviour to these thoughts and feelings. In our 
study, these thoughts, feelings and behaviour were anchored to breast- and/or ovarian 
cancer. The response categories are: not at all (0); seldom (1); sometimes (3); and often 
(5). The score range for the intrusion scale is 0-35 and for the avoidance scale 0-40. 
Reliability and validity are satisfactory
35-38
. No norms or cut-off scores are available for the 
general population. However, from two studies conducted in a clinical setting
39,40
, cut-off 
scores equal or higher than 13 on the intrusion subscale and equal or higher than 11 on 
the avoidance subscale were reported to be clinically relevant. In the present study, these 
cut-off values were considered as clinically relevant. 
 
5.2.4 General distress 
General distress was measured with the Hospital Anxiety and Depression Scale (HADS)
41
. 
The HADS has two scales for anxiety and depression, respectively. Every item has four 
response categories, anchored to that specific item. The scores range from 0 – 21 for both 
scales. Validity and reliability have proven to be sufficient
42,43
. A score between 8 and 10 
on each subscale represents a doubtful case of either anxiety or depression. A score of 11 
or higher per subscale is indicative of a clinically relevant level of distress. 
 
5.2.5 Motivations 
During the pre-surgery interview, the women were asked about their motivations for 
undergoing PM, P(B)SO or both. Due to the semi-structured nature of the interview, the 
motivations could be named in any order, and expressed at any time in the interview. The 
complete transcriptions of the interviews were examined for the expression of 
motivations for undergoing PS. No ranking was applied.  
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The reported motivations were conceptually categorized by three authors (AVG, PB, AT) 
into two groups: 1) the cognitive motivations group (C group) and 2) the emotional-
cognitive motivations group (EC group). Women in the C group reported one or more of 
the following motivations: for risk reduction, uncertainty of screening, knowledge of one’s 
mutation status, physician’s advice, nearing or already in menopause, keeping control 
over one’s health situation, taking precautions, suffering from benign gynaecological 
problems, having a choice, not wanting cancer (again), not wanting any more children, for 
peace of mind, for cosmetic advantage (i.e. breast reduction), feeling that regular 
surveillance is troubling. Women in the EC group reported one or more of the following 
motivations: fear for breast cancer and/or ovarian cancer, wanting to support daughter in 
the future, and getting rid of insecurity whether one gets cancer or not. These women also 
reported one or more of the above cognitive motivations. Three women who reported 
only emotional motivations were categorized into the EC group. 
 
5.2.6 Statistical Analysis 
The motivations that were reported in the pre-surgery interviews, were categorized and 
put into a database using SPSS 11.0 statistical package  (SPSS Inc., Chicago).  
 Chi-square analysis was used to reveal possible interrelations between the motivations. 
Frequency analysis was used on the biographic and medical variables, as well as on the 
motivations that were reported by the interviewees. We performed a SQUARE ROOT on 
the distress variables to correct for their skewness. ANOVA was used to determine 
differences between the E/C-group and the C-group. General Linear Modelling (GLM) was 
used to determine the effect of emotion-based versus cognitive based motivations on the 
course of distress. In order to get an insight into the influence of the separate motivations 
on the level and course of distress, we performed General Linear Modelling on sufficiently 
large subsamples. 
 
5.3 Results 
Of 97 women who consented to participate in the PREVOM-B study between September 
1999 and January 2003, transcriptions of 36 pre-surgery interviews were available for this 
analysis (40%). The latter group had identical biographic and medical characteristics as the 
other women in the pre-surgery group (data not shown). Also, the biographic and medical 
variables of the EC group and the C group (Table 1) were identical for age, mutation carrier 
status, history of breast cancer, type of prophylactic surgery, marital status, offspring, 
religious affiliation, educational level, and/or employment. 
 Ages ranged from 25 to 60, with means of 43,5 and 45 years of age (E/C-group and C-
group respectively). Most interviewees were BRCA1/2 mutation carriers (64%). Sixty-one 
percent of all interviewees (61%) were unaffected women (e.g. had no history of breast 
cancer or ovarian cancer). Most of the women (69%) had opted for PM/(I)BR, either 
PM/(I)BR only (31%), or performed simultaneously with (19%) or after (19%) P(B)SO. Most 
women were married or cohabiting (92%) and had children (89%). The largest part of the 
interviewees had an average level of education (53%) and over half of them (69%) were 
employed. Nearly half of all participants (47%) mentioned to be religious. 
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Table 1 
Emotional-Cognitive (EC) versus Cognitive (C) motivated  women opting for PS: medical and demographical 
variables 
 
• h     
  EC group (N=20) C group (N=16)  
  M (Sd)  Range  M (Sd)  Range  p  
Age at surgery  43,5 (9) 25-60 45 (6) 35-56 ns 
• h       
  N  %  N  %  p  
Carrier status  BRCA 1/2  11 55 12 75 ns 
50% risk carrier  9 45 4 25 
History of 
breast cancer  
Yes  7 35 7 44 ns 
No  13 65 9 56 
Type of surgery
1
  PM/(I)BR  5 25 6 37,5 ns 
P(B)SO  5 25 6 37,5 
PM/(I)BR+P(B)SO 5 25 2 12,5 
PM/(IBR) before P(B)SO 0 0 0 0 
PM/(I)BR after P(B)SO 5 25 2 12,5 
Marital status  Married or cohabiting  18 90 15 94 ns 
Single or divorced  2 10 1 6 
Children  Yes  18 90 14 87,5 ns 
No  2 10 2 12,5 
Education  Low  7 35 2 12,5 ns 
Average  10 50 9 56 
High  3 15 5 31 
Employment  Yes  13 65 12 75 ns 
No  7 35 4 25 
Being religious Yes  10 50 7 44 ns 
No  10 50 9 56 
       
 
1
PS: prophylactic surgery; PM/(I)BR: prophylactic mastectomy; P(B)SO: prophylactic (bilateral) salpingo-oophorectomy; PM/(I)BR 
+P(B)SO: prophylactic mastectomy and salpingo-oophorectomy simultaneously performed; PM/(I)BR before/after P(B)SO: prophylactic 
mastectomy performed before/after oophorectomy (time elapsed undefined) 
 
Table 2 
Self-reported motivations for PS in EC and C motivated women 
 
   
 EC group (N=20) C group (N=16) 
Emotional motivations N  %  N  %  
Fear for BC/OC 17 85 0 0 
Wants to support daughter in the future 8 40 0 0 
Feeling insecure about BC/OC 3 15 0 0 
Cognitive motivations     
For risk reduction 7 35 11 69 
Uncertainty screening 7 35 6 37,5 
Knowledge of one’s mutation status 4 20 5 31 
Physician’s advice 5 25 2 12,5 
Nearing or already in menopause 4 20 1 6 
Relief of benign gynecological issues 0 0 1 6 
Having a choice 0 0 1 6 
Don’t want cancer (again) 1 5 1 6 
For cosmetic reasons 0 0 1 6 
Dislike of screening  0 0 1 6 
Taking precautions 1 5 0 0 
Wanting peace of mind 1 5 0 0 
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Sixteen women (44%) reported two different motivations for undergoing PS (range 0-5). 
Six women (17%) reported one motivation; fourteen women (39%) reported 3, 4 or 5 
motivations (22%, 6% and 11% resp.).  
 Table 2 presents an overview of the number and percentages of emotional motivations 
and cognitive motivations in the EC group and the C group. Sixteen participants (44%) 
reported only cognitive-based motivations. Seventeen participants (47%) expressed both 
cognitive-based and emotion-based motivations. Three participants (8%) expressed only 
emotion-based motivations and were included in the EC group. Most women in the EC 
group (n=17, 85%) reported that fear of developing breast and/or ovarian cancer was a 
motivation to undergo PS. Two-thirds of the women in the C group (N=11; 69%) stated 
that they decided for PS because it was considered the most effective risk-reductive 
strategy opposed to one-third of the women in the EC group (N=7; 35%). Women who 
named fear for developing breast or ovarian cancer as a driving motivation also reported 
more frequently that they opted for PS because they wanted to support their daughter in 
the future (p=.01). No other relationships between the motivations were found.  
 Table 3 presents the means, standard deviations and significances between the EC-
group and the C-group on the course of cancer-related distress (IES) and general distress 
(HADS). The groups did not differ on level or course of intrusion, avoidance, anxiety or 
depression at either assessment. 
 
Table 3 
 Levels and courses of intrusion/avoidance (IES) and anxiety/depression (HADS) prior to, 6 months and 12 
months after PS in EC and C motivated women 
 
      
  EC group (N=20) C group (N=16)   
  Mean Sd Mean Sd Plevel Pcourse 
Cancer-related distress Intrusion T0 12,8 10,6 9,9 6,7 ns ns 
T1 6,6 8,2 5,8 5,4 ns 
T2 7,6 8,4 8,5 7,3 ns 
Avoidance T0 10,8 10,9 9,1 5,2 ns ns 
T1 6,1 8,6 8,4 8,8 ns 
T2 6,5 9,0 4,3 4,3 ns 
General distress Anxiety T0 8,6 5,1 5,9 3,6 ns ns 
T1 5,2 4,0 4,3 4,0 ns 
T2 5,8 4.0 4,8 3,4 ns 
Depression T0 5,2 4,2 3,1 2,5 ns ns 
T1 3,3 3,3 2,6 2,7 ns 
T2 4,1 3,0 3,3 2,8 ns 
         
 
 
Because of small subsamples, separate motivations could not be analysed for their effects 
on levels and courses of distress. Only the group of women who reported ‘fear for 
developing breast cancer and ovarian cancer’ was sufficiently large for such an analysis. 
Results are shown in Table 4 and in Figure 1. The 17 women who reported fear as a 
motivation to decide for PS were at baseline averagely more depressed than the other 
women (p=.02), and had a different course of avoidance (p=.02). 
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Table 4 
Fear for breast cancer and ovarian cancer (n=17) versus otherwise motivated (n=19) PS utilizing women: 
course of distress prior to and 6 and 12 months after PS 
 
     
  Fear for cancer  Other motivations  
  Mean Sd Mean Sd Plevel Pcourse 
       L Q 
Cancer-related distress Intrusion T0 14.6 10.5 8.7 6.8 ns ns ns 
T1 7.6 8.5 5.1 5.3 ns 
T2 8.1 8.8 7.9 7.2 ns 
Avoidance T0 12.5 11.0 7.9 5.6 ns ns .02 
T1 6.9 9.1 7.4 8.4 ns 
T2 7.6 9.4 3.6 4.2 ns 
General distress Anxiety T0 9.1 5.2 6.0 3.7 ns ns ns 
T1 5.4 3.9 4.4 4.1 ns 
T2 6.1 3.6 4.7 3.8 ns 
Depression T0 5.8 4.3 2.9 2.4 .02 ns ns 
T1 3.5 3.5 2.6 2.6 ns 
T2 4.5 3.0 3.2 2.7 ns 
          
 
 
 
Figure 1 
Course of avoidance (IES) for women who report fear for breast cancer and/or ovarian cancer (N=17) and 
women who report other motivations (N=19) 
 
 
 
 
5.4 Discussion 
This paper presents our findings regarding the nature of motivations to undergo PS in 
women at an increased risk of hereditary breast/ovarian cancer due to either a BRCA1/2 
mutation or family history, and the effect of these motivations on the course of emotional 
distress. According to the theory of self-regulation, emotional responses will facilitate 
cognitive processes, that predominantly control risk-reducing actions like PS, which 
eventually will lead to distress reduction. 
 The motivations that were reported by the women in this study corroborate earlier 
findings; six of the seven motivations that were identified in this study were reported in 
previous studies, namely fear of developing breast and ovarian cancer, risk reduction, the 
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obligation felt by women towards family members, physician’s advice, worries about 
effectiveness of regular surveillance, and genetic testing
15-21,44
. Though the motivation 
‘nearing or already in menopause’ was not reported previously, higher age has been found 
to be a factor for opting for P(B)SO
17,45
. 
 We could not confirm our hypothesis that women whose motivations were both 
cognitive and emotional benefit more from PS in terms of emotional distress reduction 
than women whose motivations do not have an emotional component. This leads us to 
two considerations.  
 First, the report of motivations by the C group may have been influenced by the 
appraisal of the problem-focused coping, i.e. the decision for PS. This appraisal may have 
then reduced the previous anxiety and distress as a conscious motivation to decide in 
favour of PS. Consequently, women may not have experienced anxiety at a conscious level 
when asked for their motivations to undergo PS, shortly before PS.  
 A second explanation is that women in the C group were unable or unwilling to report 
their emotions. They might have repressed them in favour of their cognitions. If that was 
the case, ‘hidden’ emotions might surface in intensive pre-operative counselling when 
focussed hereon. However, they seemed to benefit from PS with regard to emotional 
distress as much as women who did report emotional motivations. Therefore, suppression 
of emotional responses in the preoperative period might serve a beneficial function in the 
waiting period prior to PS.  
 Interestingly, when categorizing the total cohort into women who reported fear for 
cancer versus women who reported no such fear, we found that the cancer-fearing group 
were more likely to experience a reduction in avoidant thoughts and behaviour within six 
months after PS.  
 This result raised the question whether or not the categorization as used for analysis in 
this study was correct. Still, lack or suppression of emotional responses did not seem to 
have a negative effect on these women, as far as emotional distress was concerned. 
Research in a larger sample with a longer follow-up should shed additional light on this 
speculation. 
 The present study dealt with a number of limitations. Because the observations were 
made in a small sample, results provided us with an insight into the processes regarding 
decision-making and the effects on emotional distress, but  might not always uncover all 
the processes that were going on in these women. Moreover, follow-up was thirteen 
months at its most. In order to determine the emotional effects of the decision for PS in 
the longer run, future research should focus on larger samples over longer periods of 
time.  
 A final remark should be made on the women who did not report any other 
motivations but fear. Fry et al.
19
 suggested that when fear is predominant in women who 
opt for PS, psychotherapy might be more beneficial than such a radical operation. Based 
on our results, we cannot answer the question whether or not PS is an adequate option 
for these women. Only three women in our cohort did not report other motivations 
except fear, a number far too small for analyses. Psychological counselling may be offered 
to women who experience extreme fear prior to PS and/or ongoing fear after PS in order 
to support them in making an informed decision regarding regular surveillance or PS. 
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Considering the fact that fear for developing cancer proved to be a source of enhanced 
distress, as our results indicate, we are in favour of extensive research on this topic. 
In conclusion, women who reported fear for developing cancer as a motive for undergoing 
PS experienced enhanced distress prior to PS. Pre- and post-operative counselling might 
particularly focus on women with a predominantly fear-driven choice for PS to assist them 
in handling potentially enhanced distress in that period. Women who did not report 
emotional motivations had mean levels of distress within normal range prior to PS and 
had experienced a decrease in distress a year after PS. If emotions are suppressed in these 
women, this might lead to emotional problems in the longer run. In pre-operative 
counselling of these women, their motivations and levels of distress should be addressed 
in order to possibly uncover suppressed emotions in order to avoid future emotional 
problems. Finally, future research should focus on unravelling the longer-term processes 
that lead to emotional or cognitive motivations. 
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6 
The Course of Distress in Women at Increased Risk of 
Breast and Ovarian Cancer Due to an (Identified) Genetic 
Susceptibility Who Opt for Prophylactic Mastectomy 
and/or Salpingo-Oophorectomy 
 
 
 
Background The levels and course of psychological distress before and after prophylactic mastectomy (PM) 
and/or prophylactic salpingo-oophorectomy (PSO) were studied in a group of 78 women.  
Methods General distress was measured through the Hospital Anxiety and Depression Scale (HADS), cancer-
related distress using the Impact of Events Scale (IES). Measurement moments were: baseline (2 to 4 weeks 
prior to prophylactic surgery), and 6 and 12 months post-surgery. 
Results After PM, anxiety and cancer-related distress were significantly reduced, whereas no significant 
changes in distress scores were observed after PSO. At one year after prophylactic surgery, a substantial 
amount of women remained at clinically relevant, increased levels of cancer-related distress and anxiety. 
Conclusions We conclude that most women can undergo PM and/or PSO without developing major 
emotional distress. More research is needed to further define the characteristics of the women who continue 
to have clinically relevant increased scores after surgery, in order to offer them additional counselling. 
 
6.1 Introduction 
Women with an identified BRCA1/2 mutation have a cumulative lifetime risk (i.e. up to the 
age of 70 years) for breast cancer of 39-85%, and for ovarian cancer of 10-63%.  
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Furthermore, after a history of breast cancer, the life-time risk of contralateral breast 
cancer is 35-64%
1
. Female 50% risk carriers from families with an autosomal dominant 
transmission pattern of breast and/or ovarian cancer without an identifiable BRCA1/2 
mutation also have an increased risk. In these women, the risk of developing breast cancer 
is estimated by means of genetic-epidemiological tables
2
. 
 Unaffected mutation carriers and 50% risk carriers can either opt for regular 
surveillance of the breasts and ovaries, or for prophylactic mastectomy (PM) and/or 
prophylactic salpingo-oophorectomy (PSO). Mutation carriers who have been treated for 
breast cancer may opt for (bi- or contralateral) PM and/or PSO in selected cases. Both 
types of prophylactic surgery are associated with substantial risk reduction with respect to 
the development of a primary breast or ovarian cancer
3-8
, while prospective data on the 
benefit regarding overall survival are not yet available. However, prophylactic mastectomy 
is associated with the loss of healthy breasts and normal sensation, and is an irreversible 
procedure
9
. Further, breast reconstruction, either immediate or at a later stage, may 
require re-operation(s), usually for implant-related issues
9,10
. Research
11,12
 pointed out 
that balanced information is of importance for careful decision making regarding PSO.  
 Favorable effects of prophylactic surgery on a woman’s distress level
13-22
 and quality of 
life
3
 in the year following these interventions have been reported
23
. Apparently, the 
disease-induced fear was relieved after surgery. Most of these observations were 
obtained from retrospective studies in small samples of women
15,22,24
. To our knowledge, 
a prospective exploration of the levels and the courses of distress in women undergoing a 
PM versus a PSO has not been performed yet. Within the framework of a prospective 
study on the medical and psychosocial effects of prophylactic surgery that started in 1999 
at the Family Cancer Clinic of the Erasmus MC in Rotterdam, the levels and courses of 
general and cancer-related distress were analyzed in women undergoing either a PM 
and/or PSO.  
 Our research questions were the following: 1) do women opting for prophylactic 
surgery experience higher distress levels prior to surgery then women adhering a regular 
breast cancer surveillance program, 2) is there a relief of distress after PM and/or PSO, 
and 3) are the scores and the levels of distress different between women opting for PM, 
and respectively for PSO? Moreover, we explored the frequency of scores considered to 
indicate clinically relevant distress. 
 
6.2 Patients and Methods 
6.2.1 Study population 
Between August 1999 and February 2003, 129 high-risk women who decided to undergo 
PM and/or PSO as risk reducing procedure at the Family Cancer Clinic of the Erasmus MC-
Daniel den Hoed Cancer Centre were invited to participate in a psychological follow-up 
study (PREVOM-B study) on the psychological impact of prophylactic surgery. All women 
came from families with an apparent autosomal dominant transmission pattern, and 
therefore had an associated elevated risk of breast/ovarian cancer. The majority of these 
women were BRCA1/2 mutation carriers (hereafter called ‘mutation carriers’). 
 For women from hereditary breast-(/ovarian) cancer families without a detectable 
BRCA1/2-mutation (hereafter called ‘risk carriers’), the request for PM/PSO was reviewed 
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at the multidisciplinary patient meeting of the working party on hereditary cancer of our 
institution. The decision to proceed to prophylactic surgery was made after extensive and 
repeated information and counselling. Factors taken into account were age, previous 
history of cancer, risk calculation to develop breast cancer and/or ovarian cancer, and 
consistency of the patient’s request and its underlying arguments. 
 Only women having prophylactic surgery at the Erasmus MC-Daniel den Hoed Clinic in 
Rotterdam were eligible for this study. Also, no signs or suspicion of breast/ovarian cancer 
should be present in unaffected women at pre-surgical examination (physical and imaging 
examination, plus Ca125 analysis) performed within 3 months prior to surgery. Women 
with a history of breast/ovarian cancer were to have no signs of recurrent disease or a 
new primary after physical and imaging/dissemination examination consisting of: 
mammography, gynecological ultrasound, chest X-ray, ultrasound liver, bone scan, liver-
function tests, and Ca125/Ca153 analysis; also performed within 3 months prior to 
surgery. 
 The participation rate was 75% (n=97). Data of 15 women were excluded from the 
analyses because less than 75% of the items on the questionnaires were filled out. Based 
on clinical experience, we expected different levels and courses of distress for women 
who opted for PM or for PSO. Therefore, the sample was subdivided into a PM and a PSO 
group. Four women, having PSO first, opted for PM within 3-9 months during the follow-
up period of the study. In view of the difficulty to attribute their responses to either one of 
the types of prophylactic surgery, their data were not used in the analyses. So, the final 
sample included 78 participants. 
 Physicians introduced the study to eligible patients with verbal and written 
information. After written informed consent, participants received questionnaires by mail 
2-4 weeks before (T0), and 6 and 12 months after prophylactic surgery (T1 and T2 
respectively). The questionnaire included demographic data, and self-rating scales on 
general
25
 and cancer-related
26
 distress. The self-rating scales were administered at every 
measurement moment. Results of in-depth interviews, conducted at T0, T1 and T2, are 
not included in this analysis. 
 
6.2.2 Reference group 
To interpret the levels of distress before surgery, women with comparable increased risks, 
but opting for regular screening, were selected as a reference group. They participated in 
a national, prospective study (MRISC study) investigating the value of the magnetic 
resonance imaging scan (MRI)
27
. 
 The surveillance program consisted of a physical examination twice a year, a 
mammography and MRI once a year within a 6-weeks period, while women were advised 
to perform breast self examination (BSE) once a month. For comparison with the PM/PSO 
group we used the day of the control visit at the clinic as we assumed this moment as the 
most stressful during the surveillance period. All complete datasets of women who 
participated in that particular measurement moment were selected for reference, 
resulting in a 2:1 ratio of either mutation carriers (nprevom=54: nmrisc=27) and a 1:7 ratio of 
risk carriers (nprevom=24: nmrisc=170) from HBOC-families. Identical self-rating scales were 
used to assess psychological distress. 
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6.2.3 Procedure of dividing the study sample into a PM and a PSO group 
Of all women in our sample, 34 opted for merely PM and 18 for merely PSO. The 
remaining 26 women could be divided into five separate categories: 
1. PM and PSO were performed simultaneously (n=9); 
2. Participant was included before PM, and had undergone PSO prior to PM (n=7); 
3. Participant was included before PM, and underwent PSO during or after the follow-up 
period of the study (n=1); 
4. Participant was included before PSO, and had undergone PM prior to PSO (n=5); 
5. Participant was included before PSO, and underwent PM during or after the follow-up 
period of the study (n=4). 
 For statistical reasons, we did not want to exclude this heterogeneous group, nor view 
it as a separate group. Therefore, we assigned participants to one of the groups based on 
the time elapsed between both types of surgery. Guided by clinical experience, we 
assumed that PM would have greater physical and psychological impact. Therefore, 
participants who were included in the study because of PM and who underwent PSO prior 
to (n=7), simultaneously (n=9) or in the year after PM (n=1), were classified in the PM 
group. For women who were assigned to category 2 and 3, the time that had elapsed 
between both types of prophylactic surgery varied between 6,5 and 65 months, with an 
average of 26 months. One participant, who underwent PM within two months after PSO, 
was included in the PM group. The remaining participants of category 4 and 5 (n=8) were 
assigned to the PSO group. For these women, the time that had elapsed between both 
types of prophylactic surgery varied between 12 and 41 months, with an average of 24 
months. 
 
6.2.4 Biographical and medical data 
Age, marital status, offspring, religious affiliation, educational level, profession, carrier 
status, history of breast cancer, and type of surgery were recorded at T0. 
 
6.2.5 Cancer-related distress 
The Impact of Events Scale (IES) is an established instrument
26,28-30
 for measuring feeling 
overwhelmed by intrusive and avoidant thoughts, and feelings related to a traumatic 
event, and the tendency to adapt one’s behavior to these thoughts and feelings. In our 
study, these thoughts, feelings and behavior were anchored to breast- and/or ovarian 
cancer. The response categories are: not at all (0); seldom (1); sometimes (3); and often 
(5). The score range for the intrusion scale is 0-35 and for the avoidance scale 0-40. 
Reliability and validity are satisfactory
28-31
. No norms or cut-off scores are available for the 
general population. However, from two studies conducted in a clinical setting
32-33
 cut-off 
scores equal or higher than 13 on the intrusion subscale and equal or higher than 11 on 
the avoidance subscale were reported to be clinically relevant. In the present study, these 
cut-off values were considered as clinically significant. 
 
6.2.6 General distress 
General distress was measured with the Hospital Anxiety and Depression Scale (HADS)
25
. 
The HADS has two scales for anxiety and depression, respectively. Every item has four 
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response categories, anchored to that specific item. The scores range from 0-21 for both 
scales. Validity and reliability have proven to be sufficient
34,35
. A score between 8 and 10 
on each subscale represents a doubtful case of either anxiety or depression. A score of 11 
or higher per subscale is indicative of a clinically relevant level of distress. 
 
6.2.7 Statistical Analysis 
The data were analyzed using the SPSS 11.0 statistical package (SPSS Inc., Chicago). 
Missing values were estimated through multiple imputation. Frequency analysis was used 
to determine the characteristics of the participants and to calculate means for each 
subscale per group. Univariate analysis of variance determined differences on biographical 
variables and medical variables. T-test for independent samples was used to test for 
differences between the study sample and the reference group. Finally, MANOVA was 
used to determine whether the courses between the PM group and the PSO group were 
different. When the courses turned out to be different, it was tested whether the courses 
differed linearly and/or quadratically. A quadratic course means that the in-between 
assessment differed from the straight line between the first and the final assessment. All 
statistical testing took place at 0.05 level of significance (two-sided). 
 
Table 1 
Characteristics of the study population (SP; n=78), the prophylactic mastectomy group (PM; n=52) and the 
prophylactic oophorectomy group (PSO; n=26) 
 
      
  SP (n=78) PM (n=52) PSO (n=26)  
  M Sd M Sd M Sd P
1
 
Age (in years) 43 8.6 40 8.0 47 7.6 .001 
  n % n % n %  
Marital status Married or co-habiting 69 89 45 87 24 92 ns 
 Single or divorced 9 11 7 13 2 8 
Children Yes 64 82 41 79 23 88 ns 
 No 14 18 11 21 3 12 
Religious Yes 31 40 19 37 12 46 ns 
 No 47 60 33 63 14 54 
Education Low/average 59 76 42 81 17 65 ns 
 High 18 23 10 19 8 31 
 Missing 1 1 - - 1 4 
Current job Yes 53 68 37 71 16 62 ns 
 No 25 32 15 29 10 39 
Carrier status BRCA1/2 mutation 54 69 36 69 18 69 ns 
 50% risk carrier 24 31 16 31 8 31 
History of cancer No 50 64 35 67 15 58 ns 
 Breast cancer 27 35 16 31 11 42 
 Ovarian cancer 1 1 1 2 - - 
Type of surgery PM 34 44 34 66 - - .04 
 PSO 18 23 - - 18 69 
 PM+PSO 9 11 9 17 - - 
 PM prior to PSO 6 8 1 2 5 19 
 PM after PSO 11 14 8 15 3 12 
         
 
1
 comparison of means of  the PM group with the PSO group 
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6.3 Results 
6.3.1 Patients characteristics 
Characteristics of all respondents, and the PM and PSO group separately are shown in 
Table 1. Both groups were identical on most biographical and medical data, except that 
women in the PM group were significantly younger than women in the PSO group 
(p<.001). 
 
6.3.2 Baseline levels of distress between the study sample and the reference group 
Table 2 presents the baseline levels on the outcome variables of the IES and the HADS in 
women who opted for prophylactic surgery (PREVOM-B study, this study) and women who 
adhered to regular breast cancer surveillance (MRISC-study).  
 
Table 2 
Baseline levels on the Impact of Events Scale (IES) and the Hospital Anxiety and Depression Scale (HADS) of 
women who opted for prophylactic surgery (PREVOM-study) and women who opted for regular surveillance 
(MRISC-study) 
 
     
  PREVOM-study (n=78) MRISC-study (n=197)  
  M Sd M Sd p 
General distress Anxiety 6.36 4.4 5.13 3.9 .02 
Depression 3.66 3.5 2.56 3.0 .01 
Cancer-related distress Intrusion 10.58 8.9 5.05 6.4 <.001 
Avoidance 9.35 8.4 4.45 6.3 <.001 
 
 
Figure 1 
Mean scores on the HADS and IES at baseline, 6 months follow-up and 12 months follow-up for women who 
opt for PM (n=52) and PSO (n=26) 
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The samples only differed on carrier status. The PREVOM-group comprised of twice as 
much mutation carriers than the MRISC-group, whereas the MRISC-group consisted of 
seven times as much risk carriers. The samples differed significantly on all measures of 
distress, whereby the women in the PREVOM-B study consistently had a higher score on 
the distress variables. 
 
Table 3 
Course of general and cancer-related distress for the PM group (n=52) and the PSO group (n=26) 
 
 
   Mean Median Range Sd p (time) 
PM group (n=52)       L
1
 Q
1
 
General distress  Anxiety T0 6.98 6 0-19 4.5 <.001 ns 
T1 4.63 4 0-15 3.8 
T2 4.47 4 0-14 3.1 
Depression T0 4.04 3 0-14 3.8 ns ns 
T1 3.03 2 0-14 3.1 
T2 3.27 2 0-11 2.9 
Cancer-related distress Intrusion T0 11.63 9 0-35 9.3 <.001 ns 
T1 6.66 4 0-31 7.1 
T2 7.20 6 0-34 7.2 
Avoidance T0 10.29 9 0-40 8.8 <.001 ns 
T1 7.22 5 0-34 8.4 
T2 5.56 4 0-38 7.0 
PSO group (n=26)         
General distress  Anxiety T0 5.12 5 0-12 3.9 ns ns 
T1 5.25 5 0-12 3.7 
T2 5.14 5 0-12 3.5 
Depression T0 2.88 3 0-9 2.5 ns ns 
T1 2.98 3 0-9 2.6 
T2 2.97 3 0-9 2.3 
Cancer-related distress Intrusion T0 8.48 7 0-24 7.6 ns ns 
T1 6.60 6 0-23 6.4 
T2 7.91 8 0-26 7.2 
Avoidance T0 7.46 6 0-23 7.1 ns ns 
T1 7.97 8 0-36 8.8 
T2 6.67 5 0-23 7.2 
    
PM versus PSO   p
2
 (means) p(time*type of surgery) 
    L Q 
General distress  Anxiety T0 ns .003 ns 
T1 ns 
T2 ns 
Depression T0 ns ns ns 
T1 ns 
T2 ns 
Cancer-related distress Intrusion T0 ns ns ns 
T1 ns 
T2 ns 
Avoidance T0 ns .02 ns 
T1 ns 
T2 ns 
      
 
 1
 L=Linear, Q=Quadratic 
2
 p-value of means per assessment between groups/type of surgery 
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6.3.3 Comparison of levels and course of distress  
Table 3 presents the means, medians, ranges, and standard deviations of cancer-related 
and general distress in the PM and PSO group, at baseline, T1 and T2 respectively. Also, 
the courses per subscale and the relations between the groups on the means per subscale 
and over time are shown in Table 3, and are graphically shown in figure 1.  
 In the PM group, intrusion, avoidance and anxiety showed a significant linear decrease 
over time. However, in the PSO group, no significant changes in the distress levels were 
observed before and after surgery. 
 
Table 4 
Number, means and standard deviations of scores on intrusion, avoidance, anxiety and depression of 
women in the PM group and women in the PSO group, who scored above cut-off scores. 
 
     
   PM group (n=52) PSO group (n=26) 
 Cut-off  N % Mean Sd N % Mean Sd 
General distress  Anxiety 
>8 
T0 13 26 13.62 2.76 6 22 10.33 1.21 
T1 9 18 10.91 2.07 5 19 10.60 1.14 
T2 5 10 11.03 2.33 5 19 10.29 1.49 
Depression 
>8 
T0 8 15 10.90 2.00 1 4 9.00 - 
T1 4 8 11.00 2.00 1 4 9.00 - 
T2 3 6 10.06 0.91 1 4 9.00 - 
Cancer-related 
distress 
Intrusion 
>12 
T0 20 39 21.85 5.88 8 30 18.25 3.33 
T1 11 22 17.95 5.17 4 15 17.00 4.08 
T2 10 19 18.78 6.12 7 27 17.29 4.61 
Avoidance 
>10 
T0 21 41 18.57 7.80 8 30 16.25 4.33 
T1 10 20 21.44 8.76 11 41 15.65 7.82 
T2 10 20 16.46 8.11 6 22 18.00 3.29 
           
 
Figure 2 
Percentages of women in the PM group and the PSO group who scored above the cut-off score of the HADS 
and the IES at baseline, 6 months follow-up and 12 months follow-up 
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6.3.4 Clinical ‘cases’ of distress 
Table 4 shows the clinically relevant cut-off scores per subscale, the percentages per 
group of women who scored above these cut-off scores, as well as the mean scores for 
this subgroup on each measurement moment. The percentages of women scoring above 
the threshold value at either baseline or follow-up are also graphically illustrated in Figure 
2. At all time points, substantial percentages of women scored above the cut-off point of 
both subscales of the IES and above the cut-off point of the anxiety subscale of the HADS. 
At one year follow-up, 10% of all women who opted for PM, scored above the cut-off 
score on anxiety, and 6% scored clinically high on depression, compared to resp. 19% and 
4% in the group of women who opted for PSO. As for cancer-related distress, 19% of all 
women who opted for PM, scored above the cut-off score on intrusion, and 20% scored 
clinically high on avoidance, compared to 27% and 22% resp. of the women who opted for 
PSO. 
 
6.4 Discussion 
The current paper describes the levels of general and cancer related distress and the 
courses of these measures in genetically predisposed women who opted for either PM or 
PSO up to 12 months after prophylactic surgery. 
 Firstly, we observed that levels of distress were increased prior to surgery in our 
sample as compared to a reference group of women who opted for breast cancer 
surveillance. This might indicate that the women who opt for prophylactic surgery 
experienced overall more distress, which might have played a role in their decision for 
prophylactic surgery instead of surveillance. Of course, other factors, e.g. anxiety related 
to upcoming surgery, may have played a role in the observed difference. For instance, 
most of the women who opted for either PM or PSO were mutation carriers, whereas in 
the reference group the majority were risk carriers from HBOC families. Mutation carriers 
received information on a higher cancer risk assessment, and consequently on the option 
of PM/PSO. In addition, one can speculate that the women in the group who chose to 
undergo surgery might have had more experience with witnessing cancer and death of 
family members. An impressive family history may also influence the physician’s advice to 
encourage the patient to undergo prophylactic surgery. 
 Our second research question concerned the levels and course of distress in the PM 
and the PSO group after prophylactic surgery. As for the course of distress, we found 
significant decreases with respect to anxiety, avoidance and intrusion in women who 
underwent PM. This is in accordance with the findings in other studies
13,15,18
. Our results 
support our clinical impression that women can undergo this type of surgery without 
further developing emotional distress. The decline of distress in the PM group might 
indicate that PM has diminished the fear of getting cancer. Moreover, after PM no further 
breast self examination is needed, and consequently results in less direct physical 
confrontations with being at high risk of developing breast cancer. In addition, the 
frequency of surveillance at the clinic is diminished, and there is no further need for 
regular mammography and/or MRI examinations. 
 Contrary to earlier findings
22
, no measurable changes were found in the distress levels 
of women who underwent PSO. Again, this indicates that women can undergo this type of 
  
54 Chapter 6 
surgery without further developing emotional distress. The levels of distress in the PSO 
group were not exceptionally high prior to surgery, which might explain why distress did 
not decrease after PSO, as was observed in the PM group. Because the majority of women 
who underwent PSO were either nearing menopause or already postmenopausal, the 
physical consequences of this type of surgery might not have been of importance with 
respect to the decision for PSO. Moreover, the women who underwent PSO were older 
and in a different phase of their lives as compared to the women who opted for PM. 
Starting a family and/or raising young children was no longer an issue in the PSO group. 
 Our third research question addressed the comparison of the PM group and the PSO 
group on both the levels and the courses of all measures of distress. Clinically, PM and 
PSO are different types of surgery regarding the impact on body image, cosmesis, and 
morbidity. Both types of surgery are performed in different age groups, as is illustrated in 
Table 1. The decision to separate PM and PSO women as a basis for the main analysis was 
taken on these clinical grounds. Though the course of distress appeared to be different for 
the two groups, we could not demonstrate any significant differences between the mean 
scores of the PM and the PSO group. We speculate that this lack of significance is due to 
the small sample size, but doubt if investigating a larger group would yield relevant 
differences between these groups. 
 Finally, we explored the frequency of scores considered to indicate clinically relevant 
distress. Substantial percentages of women at baseline and during follow-up scored in the 
clinical range of both subscales of the IES and the anxiety scale of the HADS. One 
explanation concerns the anchoring of the variables of the IES to breast and ovarian 
cancer. Intrusive thoughts on breast cancer might reflect one’s concerns with the breast 
cancer process in relatives, instead of the personal risks. This explanation is supported by 
the findings of Van Dooren and colleagues
36
, who found that high scores on the IES around 
surveillance appointments were related to the involvement in the care for relatives with 
cancer. Another explanation is that having children or lacking a stable partnership can 
cause increased distress after prophylactic surgery, as was found in an earlier follow-up 
study done in our institute
37
. Further analyses of factors that are predicting enhanced 
scores on distress are in progress. 
 To our knowledge, our study is to the first to present prospective data from a group of 
high-risk women opting for prophylactic surgery. It provides insight into the level and 
course of general and cancer-related distress of women who opt for PM compared to 
women who opt for PSO. Moreover, the distress levels of women who opted for 
prophylactic surgery are compared to the distress levels of women who opted for regular 
surveillance. 
 Prophylactic surgery is an irreversible procedure, that is performed in healthy high-risk 
women on parts of the body that conceivably are related to self-image, sexual 
attractiveness and perception, etc. Our results show that women can undergo this type of 
surgery without developing emotional distress to a relevant degree. Further, prophylactic 
mastectomy even decreased distress. More research is needed to further define the 
characteristics of the women who continue to have clinically relevant increased scores 
after surgery, in order to identify them and offer them additional counselling. So far, we 
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suggest inclusion of a referral to a psychologist or psychosocial worker as part of the 
preoperative work up for women considering a PM. 
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7 
Distress in Partners of High-Risk Women Opting for 
Prophylactic Mastectomy and/or (Bilateral) Salpingo-
Oophorectomy 
 
 
 
Background The levels and courses of psychological distress before and after prophylactic mastectomy with 
or without (immediate) breast reconstruction (PM/(I)BR) and/or prophylactic (bilateral) salpingo-
oophorectomy (P(B)SO) were studied in 61 partners of women at increased risk for breast and ovarian 
cancer, most of the latter being carriers of a BRCA1 or BRCA2 mutation.  
Methods General distress was measured through the Hospital Anxiety and Depression Scale (HADS), and 
cancer-related distress using the Impact of Events Scale (IES). Measurement moments were: baseline (2 to 4 
weeks prior to prophylactic surgery), and 6 and 12 months post-surgery. Intrusive thoughts decreased after 
prophylactic surgery (PS).  
Results A small proportion of partners continued to have increased scores on general and cancer-related 
distress up to one year after prophylactic surgery. Higher distress scores were associated with BRCA1/2 
mutation status, previous cancer of the wife, fatherhood and having a high-level of education. 
Conclusions The care for families opting for genetic testing and prophylactic surgery might include adequate 
monitoring of the need for psychological support for both high-risk women and their partners, when either or 
both show increased general or cancer-related distress levels. 
 
7.1 Introduction 
The BRCA1 and BRCA2 breast cancer susceptibility genes associated with hereditary breast 
and ovarian cancer were identified in 1994 and 1995 respectively
1,2
. Female mutation 
carriers have a cumulative lifetime risk of 39-85% for breast cancer. 
 
Submitted 
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Moreover, their lifetime risk for ovarian/fallopian cancer is 11-63% at 70 years of age
3,6
. 
Additionally, mutation carriers with a history of unilateral breast cancer have an increased 
lifetime risk of contralateral breast cancer, estimated between 20-60%, being 
approximately 3% annually
7,8
. 
 Regular surveillance by mammography, magnetic resonance imaging (MRI) scan, and 
clinical breast examination
9
 aims at early detection of breast cancer, while regular 
surveillance by means of the current modalities fails to detect ovarian cancer at an early 
stage
10
. So, ablation of the breasts (i.e. prophylactic mastectomy with or without 
(immediate) breast reconstruction: PM/(I)BR) as well as resection of the ovaries/fallopian 
tubes (i.e. prophylactic (bilateral) salpingo-oophorectomy: P(B)SO) in the absence of signs 
of cancer is a preventive measure, which is highly effective with respect to cancer risk 
reduction. Studies on the efficacy of PM/(I)BR showed that the remaining risk of 
developing a primary breast cancer after surgery is very low
11
. Also, after P(B)SO, only a 
small residual risk of developing extraovarian, peritoneal cancer is remaining
12
. 
Furthermore, a P(B)SO is estimated to half the risk of developing breast cancer
13,14
. 
 The psychological impact of risk management options was earlier especially addressing 
BRCA1/2 mutation carriers and women with similar risks resulting from their family history 
(hereafter called ‘high-risk women’)
15-28
. However, the threat of developing breast and 
ovarian cancer and the consequences of prophylactic surgery may also be distressing for 
their partners. Only few studies have focused on partners of high-risk women. Generally, 
partners seemed to adjust well to the increased risk for breast and ovarian cancer of their 
wives
30-32
. Still, high post-test anxiety scores were reported by 20% of the mutation 
carriers and 35% of their partners
29
. Moreover, partners of high-risk women reported that 
decision-making on prophylactic surgery was the most challenging aspect of dealing with 
their wife’s high risk of developing cancer
21,30
.  
 The present study addresses the psychosocial impact of prophylactic surgery in 
partners of high-risk women. The objectives were to 1) estimate the levels and courses of 
distress, and 2) identify the factors that contributed to increased distress, before as well 
as after prophylactic surgery. 
 
7.2 Patients and Methods 
7.2.1 Study population 
Between August 1999 and February 2003, 129 high-risk women who decided to undergo 
PM/(I)BR and/or P(B)SO at the Family Cancer Clinic of the Erasmus MC-Daniel den Hoed 
Cancer Centre were invited to participate in a psychological follow-up study (PREVOM-B 
study) on the psychological impact of prophylactic surgery. Also their partners were 
invited to participate. All women were at increased risk of hereditary breast/ovarian 
cancer, and were either BRCA1/2 mutation carriers or belonged to a hereditary breast and 
ovarian cancer (HBOC) family wherein genetic testing did not identify a BRCA1/2 
mutation. For women from a HBOC family, the request for PM/(I)BR and P(B)SO was 
evaluated by the multidisciplinary working party on hereditary cancer of our institution. 
Only women undergoing prophylactic surgery at the Erasmus MC-Daniel den Hoed Clinic 
in Rotterdam were eligible for the present study. Other eligibility criteria included: for 
unaffected women no signs or suspicion of breast/ovarian cancer at pre-surgical 
  
59 Distress in Partners of High-Risk Women 
examination (physical and imaging examination, plus Ca125 analysis) performed within 3 
months prior to surgery; for women with a history of breast/ovarian cancer no signs of 
recurrent disease or a new primary cancer by means of physical and 
imaging/dissemination examination (including mammography, gynaecological ultrasound, 
chest X-ray, ultrasound of the liver, bone scan, liver-function tests, and Ca125/Ca153 
analysis), also performed within 3 months prior to prophylactic surgery.  
 
7.2.2 Procedure 
After signed informed consent of the high-risk women and their partners, all participants 
received questionnaires by mail 2-4 weeks before (T0), and 6 and 12 months after 
prophylactic surgery (T1 and T2 respectively). The questionnaires included a survey on 
demographic data, and self-rating scales on general and cancer-related distress. The 
demographic questionnaire was filled out at T0, while the self-rating scales were 
administered at every assessment. 
 Of the 97 participating high-risk women, 86 (89%) had a partner. Sixty-one of these 
partners (72%) agreed to participate in our study. All partners of the high-risk women in 
the present study were male. We were able to obtain demographical data on all 
participating partners. However, 28 (46%) partners failed to fill out one or more distress 
measures at T0. We compared the distress scores at T1 and T2 of the partners who failed 
to fill out the questionnaires at T0 with the distress scores on T1 and T2 of the partners 
who had completed the baseline survey. No differences  between both groups were found 
(data not shown). Therefore, we considered both groups as equal and present results on 
distress of the remaining 33 partners who completed the distress questionnaires at all 
assessments. 
 
7.2.3 Biographical and medical data 
AT T0, the following data of the partner were collected: age, offspring, educational level, 
and employment. Characteristics of the high-risk women undergoing prophylactic surgery 
including carrier status, history of breast cancer, and type of prophylactic surgery were 
also used for analyses. 
 
7.2.4 Cancer-related distress 
The Impact of Events Scale (IES) is an established instrument
33-36
 for measuring feeling 
overwhelmed by intrusive and avoidant thoughts, and feelings related to a traumatic 
event, and the tendency to adapt one’s behaviour to these thoughts and feelings. In our 
study, these thoughts, feelings and behaviour were anchored to breast- and/or ovarian 
cancer. The response categories are: not at all (0 points); seldom (1 point); sometimes (3 
points); and often (5 points). The score range for the intrusion scale is 0-35 and for the 
avoidance scale 0-40. Reliability and validity are satisfactory
34-37
. No norms or cut-off 
scores are available for the general population. However, from two studies conducted in a 
clinical setting
38,39
 cut-off scores equal or higher than 13 on the intrusion subscale and 
equal or higher than 11 on the avoidance subscale were reported to be clinically relevant. 
In the present study, these cut-off values were considered as clinically relevant. 
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7.2.5 General distress 
General distress was measured with the Hospital Anxiety and Depression Scale (HADS)
40
. 
The HADS comprises two scales, one assessing anxiety and the other assessing depression. 
Every item has four response categories, anchored to that specific item. The scores range 
from 0-21 for both scales. Validity and reliability have proven to be sufficient on each 
subscale
41,42
. A score between 8 and 10 is considered doubtful; a score of 11 or higher per 
subscale is indicative of a clinically relevant level of distress.  
 
7.2.6 Statistical Analysis 
Frequency analysis was used to determine the characteristics of the participants and to 
calculate means for each subscale per group. To investigate the course of distress, 
Multivariate analysis of variance (MANOVA) was applied. Analysis of variance (ANOVA) 
tested differences between biographical and medical variables on the one hand and 
distress on the other hand. All statistical testing took place at 0.05 level of significance 
(two-sided). The data were analysed using the SPSS 11.0 statistical package (SPSS Inc., 
Chicago). 
 
Table 1 
Characteristics of partners (N=61) of high-risk women opting for prophylactic surgery
1
. 
 
   
 M (Sd)  Range  
Age 46 (10)  28-68 
Demographic variables of partners N % 
Children
2
 Yes  47 77 
No  9 15 
Education  Low  7 11,5 
Average  12 20 
High  27 44 
Employment  Yes  47 77 
No  2 3 
Medical variables of the spouses undergoing prophylactic surgery N % 
Carrier status BRCA1/2 mutation carrier 42 69 
50% risk carrier  19 31 
History of breast cancer Yes  21 34 
No  40 66 
Type of surgery
3
 PM/(I)BR  22 36 
P(B)SO  15 24.5 
PM/(I)BR+P(B)SO 7 11.5 
PM/(I)BR before P(B)SO 6 10 
PM/(I)BR after P(B)SO 11 18 
    
 
1 
Percentages in some categories do not add up to 100% because of missing values (not reported in table) 
2 
19% of all men did not fill out this question. We were able to retrieve 11% of these missing values by using the responses of their 
spouses. 
3
 PM/(I)BR + P(B)SO, prophylactic mastectomy and salpingo-oophorectomy simultaneously performed; PM/(I)BR before/after P(B)SO, 
prophylactic mastectomy performed before/after oophorectomy (time elapsed undefined). 
 
7.3 Results 
7.3.1 Patient characteristics 
Table 1 shows the characteristics of the 61 partners of high-risk women who were 
included in the present analyses. 
  
61 Distress in Partners of High-Risk Women 
Partners varied in age between 28 and 68 years, with an average age of 46. Over two-
thirds (69%) of the partners had a wife being an identified mutation carrier, and 33% of 
the women opting for prophylactic surgery had a history of breast cancer. Most women 
(65%) underwent a PM/(I)BR during the course of the present study. Most couples (77%) 
had children. Nearly half of the men (44%) were highly educated, and most (77%) of them 
were employed. 
 
7.3.2 Levels and courses of general and cancer-related distress 
Table 2 shows general and cancer-related distress in the 33 partners who completed the 
questionnaires. Scores on intrusion gradually decreased (p=.002) over the one year period 
after prophylactic surgery. The courses of avoidance, anxiety and depression showed no 
changes between subsequent phases. 
 
Table 2 
Cancer-related and general distress in partners
1
 prior to and after prophylactic surgery of the spouse 
 
         
 N Mean Median Sd Range
2
 p course
3
 N % 
Cancer-related distress      L Q ≥ cut-off  
Intrusion 
(cut-off ≥13) 
T0 50 5.7 4.0 6.5 0-25 
.002 ns 
7 14 
T1 55 3.4 1.0 5.2 0-22 4 7 
T2 50 1.9 0.0 3.2 0-16 1 2 
Avoidance 
 (cut-off ≥11) 
T0 49 4.1 2.0 5.1 0-22 
ns ns 
4 8 
T1 54 3.7 0.0 6.0 0-26 7  13 
T2 48 3.1 0.0 5.0 0-18 4 8 
General distress           
Anxiety  
(cut-off ≥11) 
T0 50 4.9 4.0 4.0 0-14 
ns ns 
6 12 
T1 56 4.1 3.0 3.5 0-13 5 9 
T2 48 4.3 4.0 3.6 0-12 5 10 
Depression  
(cut-off ≥11) 
T0 51 4.7 4.0 3.8 0-14 
ns ns 
5 10 
T1 53 3.9 3.0 3.7 0-16 5 9 
T2 48 3.7 2.5 4.0 0-17 4 8 
            
 
1
 Means, medians, standard deviations and ranges are based on varied numbers of partners (range 48 – 56); significances of the courses 
of intrusion, avoidance, anxiety and depression, respectively, were based on 33 cases completely filling out the questionnaires. 
2
 Observed range 
3 
L = linear course; Q=quadratic course 
 
At all assessments, a relatively small number of partners scored above the threshold 
value. At baseline, seven partners (14%) scored above cut-off on intrusion and four 
partners (8%) scored above cut-off on avoidance. A year after surgery, 2% and 8% of the 
men (n=1 and 4 resp.) still scored above cut-off on intrusion and avoidance respectively. 
 As for general distress, six men (12%) scored above cut-off on anxiety at T0. At T2, still 
five men (10%) scored above cut-off on anxiety. Depressive scores were present in 5 men 
(10%) at T0; while at T2, the scores of four men remained (8%) above cut-off. 
 
7.3.3 Factors associated with increased distress 
Table 3 and table 4 show the relationships between the distress measures and the 
biographical and medical variables. The age of the spouse at time of prophylactic surgery 
was positively related to increased anxiety in partners prior to prophylactic surgery (p=.04) 
and increased avoidant thoughts and behaviour in partners at 6 and 12 months post-
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surgery (p =.03 and .01 resp.). Partners whose spouses had a history of breast cancer 
experienced more cancer-related distress, consisting of more intrusion at all assessments 
(p=.04, .03 and .04 resp.), and more avoidant thoughts and behaviour at both 6 months 
(p=.000) and 12 months after prophylactic surgery (p=.01). Having children appeared to be 
related to higher cancer-related distress scores as well. Higher scores on intrusion at T0 
(.01) and on avoidance at T0 (p=.003) and T1 (p=.001) were related to fatherhood. 
Additionally, we found that partners with a higher level of education and partners whose 
wife was a mutation carrier tended to score higher on depression at T2 (p=.04). 
 
Table 3 
Factors associated with distress in partners (♂) of high-risk women (♀) opting for prophylactic surgery (PS): 
demographic variables 
 
       
   Age ♂ Children  Education  ♂ Employment ♂ 
Cancer-related distress 
Intrusion 
T0 ns .01 ns ns 
T1 ns ns ns ns 
T2 ns ns ns ns 
Avoidance 
T0 ns .003 ns ns 
T1 ns .001 ns ns 
T2 ns ns ns ns 
General distress 
Anxiety 
T0 ns ns ns ns 
T1 ns ns ns ns 
T2 ns ns ns ns 
Depression 
T0 ns ns ns ns 
T1 ns ns ns ns 
T2 ns ns .04* ns 
       
 
Table 4 
Factors associated with distress in partners (♂) of high-risk women (♀) opting for prophylactic surgery (PS): 
characteristics of the high-risk spouses 
 
       
   Age ♀ BRCA  ♀ BC ♀ Type of PS ♀  
Cancer-related distress 
Intrusion 
T0 ns ns .04 ns 
T1 ns ns .03 ns 
T2 ns ns .04 ns 
Avoidance 
T0 ns ns ns ns 
T1 .03 ns .000 ns 
T2 .01 ns .01 ns 
General distress 
Anxiety 
T0 .04 ns ns ns 
T1 ns ns ns ns 
T2 ns ns ns ns 
Depression 
T0 ns ns ns ns 
T1 ns ns ns ns 
T2 ns .04* ns ns 
       
 
7.4 Discussion 
The present study is the first to present data on the emotional wellbeing of partners of 
women at risk of hereditary breast and ovarian cancer who opt for either PM/(I)BR and/or 
P(B)SO, covering the time period from 2-4 weeks before until 1 year after prophylactic 
surgery. Most partners experienced normal levels of distress prior and after surgery of 
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their wife. Clinically relevant levels of distress were experienced by relatively few partners. 
Having a wife with a history of cancer and fatherhood were related to elevated levels of 
cancer-related distress in partners, while a high level of education and having a wife with a 
BRCA1/2 mutation were associated with higher general distress at 1 year after the wife’s 
prophylactic surgery. 
 Most of the partners had normal levels of distress prior to and after prophylactic 
surgery, although it is known that before the decision on prophylactic surgery is made, the 
couple has gone through a stressful period of recognition of the genetic nature of cancer 
in the family, the impact for the women and her family, decisions for genetic testing in 
view of the different risk management decisions, and the consequences of the test result
 
29,31
 . We speculate that once the decision for prophylactic surgery was made, distress 
levels may have well regained normal levels. In other words, shortly before prophylactic 
surgery (at T0), most men appeared to have adjusted well to their spouse’s increased risk 
of breast and ovarian cancer and the decision for prophylactic surgery. Clinically relevant 
levels of distress were experienced by relatively few partners, which is also observed after 
genetic testing for a BRCA1/2 mutation
30,32
.  
 The factors that contributed to elevated levels of distress in the partners were age at 
prophylactic surgery of the spouse when prophylactic surgery was performed, having a 
spouse with a BRCA1/2 mutation or with a history of cancer, fatherhood, and education 
level. 
 Prior to prophylactic surgery, higher age of the spouse at time of prophylactic surgery 
was positively related to increased anxiety in partners. Apparently, these partners were 
well informed about the risks of developing breast and ovarian cancer that increases with 
age. The association between (higher) age of the spouse and increased avoidant thoughts 
and behaviour in partners up to a year post-surgery is more difficult to explain. This 
relationship might reflect the awareness about the vulnerability when developing breast 
or ovarian cancer at an increased age, combined with the knowledge that PM/(I)BR and 
P(B)SO do not protect 100% against the development of a primary cancer or recurrent 
disease
44-47
. Though anxiety related to increased age in wives disappears after 
prophylactic surgery, knowing that to date prophylactic surgery is the most effective risk-
reducing strategy, avoiding confrontations with anything that had to do with the 
remaining risks of developing this threatening disease might have been the only way to 
cope for these partners. The knowledge that prophylactic surgery does not provide 
definite security might also explain the increased distress in partners whose wife had a 
BRCA1/2 mutation or a history of breast cancer. Especially having a spouse who had been 
treated for breast cancer in the past was strongly distressing. Given the strong 
associations between cancer-related distress and having a spouse with a history of breast 
cancer at all assessments safe avoidance at baseline, we speculate that the absence of a 
relationship between these two variables is an artifact, possibly due to small sample size 
or other related  factors that have yet to be investigated.  
 Fatherhood was an additional factor associated with increased cancer-related distress, 
which is in accordance with the findings in other studies on partners
30,31
. The genetic 
transmission of a BRCA1/2 mutation, or other highly penetrant unidentified mutations is 
rather straightforward, and therefore worries about future development of cancer in 
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one’s children are realistic and understandable. Moreover, this result may also have 
reflected the fear of losing the mother of one’s children to breast or ovarian cancer. 
 Further, higher educational level in partners was associated with more depressive 
thoughts and feelings, but only at one year after prophylactic surgery. This seemingly 
contradicts the observation that a higher educational level enhances adjustment to the 
spouse’s increased risk of developing cancer
31
. The full perception of the risks for the 
beloved wife and the family may lead to a realistic feeling of hopelessness in the partner. 
Though overall levels of distress were generally within normal values in the present 
cohort, a small group of well informed partners may benefit from additional support. 
Future research should shed light on this observation. 
 A major limitation of the present study concerns the sample size. The small number of 
partners who completed the periodic questionnaires may partly reflect problems in 
handling emotional distress. Three-quarters of the partners consented to participate in 
the present study, but only half of them completed the questionnaires at all assessments. 
Though we did not find differences at T1 and T2 between partners who did and did not fill 
out the questionnaires at T0, there might have been a selection bias. Emotional distress in 
the partners may have interfered with reflecting on emotions prior to the prophylactic 
surgery of their wife, and therefore they might have avoided filling out the 
questionnaires
43
. Unfortunately, we were unable to study the motivations of non-
responders. 
 In conclusion, the contact between women at risk, their partners and health care 
professionals mainly focuses on the physical and psychosocial aspects of prophylactic 
surgery in the woman. The partner is usually pictured only as a source of social and 
practical support for the patient. The results of our study show that distress levels of 
partners of high-risk women were generally within normal limits. The modest proportion 
of about 10% of partners having clinically relevant distress levels one year after 
prophylactic surgery of their spouses might indicate that the provided general 
information, counselling and support is effective and sufficient. Still, the present findings 
suggest that some partners of high-risk women opting for prophylactic surgery are at risk 
for increased emotional distress and therefore might be in need of additional support 
themselves. Therefore, we underscore that the value of distress screening in both high-
risk women and their partners is equally relevant for the patient’s psychosocial guidance 
as well as for possible couple interventions
31,48
. Special attention might be warranted for 
higher educated partners of an identified mutation carriers; feelings of depression in these 
partners might surface in the longer run. 
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8 
Who is Prone to High Levels of Distress after Prophylactic 
Mastectomy and/or Salpingo-Ovariectomy? 
 
 
 
Background The present study aimed to assess predictors of distress after prophylactic mastectomy (PM) 
and salpingo-oophorectomy (PSO), in order to enable the early identification of patients who could benefit 
from psychological support. 
Methods General distress and cancer related distress were assessed in 82 women at increased risk of 
hereditary breast and/or ovarian cancer undergoing PM and/or PSO, before and six and twelve months after 
prophylactic surgery. Neurotic lability and coping were assessed before surgery. 
Results Cancer-related distress and general distress at both follow-up moments were best explained by the 
level of cancer-related and general distress at baseline. Being a mutation carrier was predictive of increased 
cancer-related distress at 6-months follow-up (but not anymore at 12 months), and of lower general distress 
at 12-months after prophylactic surgery. Also, coping by comforting thoughts was predictive of less cancer-
related distress at 6-months follow-up. 
Conclusions Genetically predisposed women who are at risk of post-surgical distress can be identified 
through any or more of the predictors that were found in this study. Exploration of and/or attention for 
cancer related distress and coping style before prophylactic surgery may help physicians and psychosocial 
workers to identify women who might benefit from additional post-surgical support. 
 
8.1 Introduction 
Germline mutations in BRCA1 and BRCA2 account for approximately 3-5% of all breast and 
ovarian cancers. Women with a BRCA1/2 mutation have a significantly increased 
cumulative lifetime risk for breast cancer of 39-85%, and for ovarian cancer of 10-63%
1-3
.  
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Furthermore, for mutation carriers with a history of breast cancer, the life-time risk of 
developing a contralateral breast cancer is 35-64%
4
. The majority of families with a 
significant aggregation of breast/ovarian cancer remain genetically unidentified. Women 
from these families remain at increased risk of developing breast and/or ovarian cancer. 
Their lifetime risk is less clear but lower than for mutation carriers. For both groups, 
management options are regular surveillance of the breasts and ovaries and (bilateral) 
prophylactic mastectomy ((B)PM) and/or prophylactic (bilateral) salpingo-oophorectomy 
(P(B)SO). Both prophylactic procedures result in a substantial risk reduction with respect 
to the occurrence of breast and ovarian cance
3,5-9
. Favourable effects of PM and/or P(B)SO 
on a woman’s distress level in the year following these interventions have been 
reported
10-17
. In mostly all retrospective studies, post-surgical distress was related to 
surgical complications
18
, psychiatric history, perceived risk of breast cancer
14
, level of 
cancer-related distress at baseline, having children under the age of 15 years, less open 
communication of cancer issues within the family, having doubts about the genetic test 
outcome, and changes in relationships with relatives
19
. No data are available on factors 
that are possibly predisposing for persisting increased distress in this group of women. 
Previously, we published results of a prospective study comprising this sample of women 
on the levels and course of distress after prophylactic surgery
20
. We found that anxiety 
and cancer-related distress were clearly diminished up to one year after prophylactic 
surgery. However, a subgroup remained at clinically significant levels of anxiety and 
cancer-related distress. In the present analysis, we investigated factors that might be 
predictive for increased distress at 6 months and 12 months post prophylactic surgery.  
 
8.2 Patients and Methods  
8.2.1 Study population 
At our Family Cancer Clinic, prophylactic surgery consisting of either PM, P(B)SO or both, is 
discussed with mutation carriers and sometimes with women from hereditary breast 
(and/or ovarian) cancer families (HB(O)C) without an identified mutation. Women opting 
for either PM and/or P(B)SO were invited to participate in a psychological follow-up study. 
Previously unaffected women with a clinical diagnosis or suspicion of cancer before 
prophylactic surgery were not eligible for participation. In women with a history of breast 
cancer, absence of recurrent disease before surgery was established by dissemination 
examination (chest X-ray, ultrasound liver, bone scan, liver functions and determination of 
Ca15.3/Ca125). The institutional review board approved of the study. 
 
8.2.2 Procedure 
After written consent, patients completed the first questionnaire a week before surgery. 
This questionnaire contained questions on demographic data, general and cancer related 
distress, coping, and neuroticism. The second and third questionnaire, containing the 
outcome measures, was completed six and twelve months after surgery. 
 
8.2.3 Biographical and medical data  
Data were obtained on age, marital status, offspring, educational level, profession, and 
carrier status, history of breast /ovarian cancer, and type of prophylactic surgery. 
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8.2.4 Neuroticism 
The neuroticism (N-scale) of the Amsterdam Biographical Questionnaire ABQ
21
 assessed 
the vulnerability to experience psychological distress
22
. The subscale contains 30 items. 
Reliability for the neuroticism subscale in men and women between the age of 20-59 has 
been proven good (respectively .95 and .84)
21
. 
 
8.2.5 Coping 
Coping was assessed by the Utrecht Coping List (UCL)
23
. This instrument contains 47 items 
divided into seven scales: Active Dealing (i.e. taking action to solve a problem), Palliative 
Reaction (i.e. seeking distraction), Avoidance, Social Support Seeking, Passive Reaction (i.e. 
not taking or not feeling able to take action), Expression of Emotions, and reassuring 
oneself by having Comforting Thoughts. The scales are sufficiently consistent and 
independent, and cover most areas of coping. The validity and reliability have been found 
to be good
24
. 
 
8.2.6 Cancer-related distress  
Cancer-related distress was assessed with the Impact of Event Scale (IES)
25,26
. The scale 
has been used extensively in studies on adjustment to genetic susceptibility testing and 
has satisfactory psychometric properties. The IES measures intrusive and avoidant 
thoughts, feelings, and behaviour, related to breast- and/or ovarian cancer. The score 
range for the total scale is 0-75. 
 
8.2.7 General distress  
General distress was measured with the Hospital Anxiety and Depression Scale (HADS)
27
. 
The HADS consists of two scales for anxiety and depression, respectively. The scores range 
from 0–21 for both scales. The total scale of the HADS has been widely used as a screening 
instrument in samples with minor psychiatric disorders. Validity and reliability have 
proven to be sufficient
28
.  
 
8.2.8 Statistical Analysis 
The data were analysed using the SPSS 11.0 statistical package (SPSS Inc., Chicago). 
Missing values were estimated using the ‘multiple imputation’ method. Significant 
differences on biographical variables (i.e. age, level of education, marital status, 
employment, children and being religious) and medical variables (i.e. carrier status, type 
of surgery, history of breast cancer) between participants and drop-outs were determined 
through Pearson’s χ2 tests. Data were analysed through an elimination process when 
performing multiple linear regression in MPlus 3.1 program. All possible predictive 
variables (i.e. demographic variables, neuroticism, coping and mean baseline scores on 
general and cancer-related distress) were tested for their predictive quality per measure 
of distress and time of follow-up. The predictive variables ‘carrier status’ and ‘history of 
breast cancer’ were dichotomised (mutation carriers or women with a history of breast 
cancer were assigned a score of ‘1’; risk carriers or women without a history of breast 
cancer were assigned a score of ‘0’). The variables were categorized into candidate 
predictor variables on the four outcome variables (cancer-related and general distress at 6 
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and 12 months after prophylactic surgery). Candidate predictor variables were only 
eligible if the regression coefficient was significant at the 0.20 level of significance. The 
candidate predictor variables meeting the eligibility criteria were entered simultaneously 
into the regression model. Finally, the candidate predictor variables that were significant 
contributors (p=.05) in estimating the outcome were maintained in the final model. 
Variables were eliminated from the analysis if the relevant unstandardized regression 
coefficients were insignificant at the 0.05 level of significance. To gain insight into the 
robustness of the instrument, the quality of the prognostic instrument (i.e. the 
‘performance’ of the instrument) was measured by tenfold cross-validation. Parameters 
for the individual variables were the unstandardized regression coefficient (B), the 
standardized regression coefficient (β), and the standard error of the unstandardized 
regression coefficient (
ErrorStd
B
.
). As measures of overall performance, R
2
 was used in 
case of continuous outcome variables. R
2
-adjusted indicates the adjustment for shrinkage. 
 
Table 1 
Characteristics of the women opting for prophylactic surgery (study sample, and 16 ‘drop-outs’)
1
 
 
    
 
Participants 
(n=82) 
Drop-outs 
(n=16) 
 
M Sd M  Sd df F p 
Age (in years) 43 ±8.6 43 ±8.9 96 .22 ns 
 n % n % df χ2 p 
Marital state Married or co-habiting 73 89 13 81 3 6.44 ns 
 Single or divorced   9 11 3 19 
Children Yes 68 83 11 73 1 .77 ns 
 No 14 17 4 27 
Religious  33 40 - - - - - 
Education Low/Average 61 75 - - - - - 
 High 20 25 - - 
Current job Yes 55 69 9 82 1 .79 ns 
 No 25 31 2 18 
Carrier status BRCA1/2 mutation 58 71 12 80 4 1.51 ns 
 50% risk carrier 24 29 3 20 
Previous cancer No 52 63 10 63 2 5.23 ns 
 Breast cancer 30 37 5 31 
 Ovarian cancer 0 0 1 6 
Type of PS
2
 PM 34  42 4 27 4 1.64 ns 
 P(B)SO 19 23 4 27 
 PM+P(B)SO 9 11 3 20 
 PM before P(B)SO 5 6 1 7 
 PM after P(B)SO 15 18 3 20 
         
 
1
 Numbers deviating from n=82 or n=16 resp. indicate missing data. 
2
 PS: prophylactic surgery; PM: prophylactic mastectomy; P(B)SO: prophylactic (bilateral) salpingo-oophorectomy; PM+P(B)SO: 
prophylactic mastectomy and salpingo-oophorectomy simultaneously  performed; PM before/after P(B)SO: prophylactic  mastectomy 
performed before/after oophorectomy (time  elapsed undefined) 
 
8.3 Results  
8.3.1 Sample characteristics 
Between August 1999 and January 2003, 100 out of 129 eligible women enrolled in the 
study (78%). Two women were excluded because breast cancer was diagnosed between 
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enrolment and PM. Further, the data of sixteen women (drop-outs) filling out less than 
75% of all items in the three questionnaires were excluded from the analysis. Accordingly, 
the final study group included 82 women. The study group and the drop-out group were 
not significantly different with respect to most biographical and medical data (Table 1). 
The mean age at the time of PM and/or P(B)SO was 43 years. Most women in our study 
had a partner-relationship (89%), and children (83%). The majority of both participants 
and drop-outs reported having a job (69% and 82%, respectively). A quarter of the 
participants in the final study sample finished higher education (vocational training or 
university) and 40% reported to have an active religious involvement. Most women were 
mutation carriers (71% and 80%, respectively), a history of breast cancer had occurred in 
37% and 31%, respectively, and the majority (77% and 74% respectively) had opted for 
PM. Coping strategies and neuroticism scores at baseline (Table 2) were compared with 
those of control women from the same age group. Mean scores of the participants in our 
study were in the average range
21,24
. Table 3 shows the levels of general and cancer-
related distress pre-surgery (T0), and at 6 months (T1) and 12 months (T2) post-surgery. 
The decrease in general and cancer-related distress after prophylactic surgery was 
quadratically significant (p=.000 for both)
20
. 
 
Table 2 
Means and standard deviations of coping strategies and neuroticism at baseline in the study sample (n=82) 
 
     
Time Questionnaire Mean Sd Range of the average scores 
for women (age 18-65) 
T0 Active Coping (UCL) 18.7 3.4 16-20 
Palliative Reaction (UCL) 18.7 3.7 14-19 
Avoidance (UCL) 15.2 3.0 12-16 
Social Support (UCL) 14.0 3.8 12-16 
Passive Reaction (UCL) 11.1 2.4 9-11 
Expression Emotions (UCL) 5.9 1.5 5-6 
Comforting Thoughts (UCL) 12.9 2.3 10-13 
Neuroticism (ABQ) 44.5 21.5 39-66 
     
 
Table 3 
Means and standard deviations of the outcome variables (general and cancer-related distress) at baseline, 6-
months and 12-months follow-up 
 
   
 General distress (HADS) Cancer-related distress (IES) 
 Mean Sd Sign. over time* Mean Sd Sign. over time* 
T0 10.0 7.3 .000 20.3 15.2 .000 
T1 7.7 6.1 13.9 13.2 
T2 7.8 5.4 13.1 11.8 
       
 
*Quadratic relation  
 
8.3.2 Predictive model 
Analysis of the data provided a final prognostic model for every separate outcome 
variable. Table 4 presents the factors that explained increased or decreased general and 
cancer-related distress at 6 and 12 months follow-up. General distress at baseline was 
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predictive of general distress at both follow-up assessment moments. Being a mutation 
carrier was predictive of decreased general distress at 12-months follow-up. Three factors 
were found predictive for cancer-related distress at 6-months follow-up: the level of 
cancer-related distress at baseline and being a mutation carrier were positively associated, 
while coping by use of comforting thoughts was negatively associated. Only cancer-related 
distress at baseline was predictive of cancer-related distress one year after prophylactic 
surgery. Though adopted in the predictive model, neuroticism and history of breast cancer 
did not predict for general or cancer-related distress at any measurement. General 
distress at baseline was predictive of general distress at both follow-up assessment 
moments (B=.25 and .43 respectively). Being a mutation carrier was predictive of less 
general distress (B=-3.53) at 12-months follow-up. 
 
Table 4 
Predictive factors of general distress and cancer-related distress at 6-months and 12-months follow-up 
 
  
Predictors General distress (6 months follow-up) 
B β B/std. error Sig. 
General distress (T0) .25 .30 1.98 .05 
Cancer-related distress (T0) -.09 .22 1.84 .07 
Neuroticism -.05 .18 1.47 .13 
 General distress (12 months follow-up) 
General distress (T0) .43 .58 6.78 .000 
BRCA 1/2 carrier status* -3.53 -.30 -3.51 .001 
 Cancer-related distress (6 months follow-up) 
Cancer-related distress (T0) .46 .54 5.87 .000 
BRCA 1/2 carrier status* 5.89 .20 2.23 .03 
History of breast cancer* 4.53 .17 1.72 .08 
Coping by comforting thoughts -1.16 -.20 -2.20 .03 
 Cancer-related distress (12 months follow-up) 
Cancer-related distress (T0) .41 .53 5.66 .000 
     
 
*identified BRCA1/2 mutation carrier or history of breast cancer: score=1; otherwise: score=0. 
 
8.3.3 Performance of the prognostic instrument 
The explained variances of the predictive models before and after cross-validation showed 
predictive qualities with R
2
 ranging between .27 and .42. The corresponding values of R
2
 
after cross-validation are similar, indicating that the findings are robust. General distress 
at 12-months follow-up had the highest R
2
 (.42). 
 
8.4 Discussion 
To our knowledge, this is the first study to prospectively investigate predictors of distress 
after PM and/or P(B)SO in women opting for this type of surgery because of an increased 
risk of hereditary breast and/or ovarian cancer. The follow-up period extended up to one 
year after prophylactic surgery. In general, cancer specific and general distress significantly 
decreased after prophylactic surgery
20
. However, increased levels of general and cancer-
related distress at both 6- and 12-months after prophylactic surgery were found to be 
predicted by their respective baseline levels. Consistent with previous findings
17,20 
we 
observed a decline of general and cancer related distress after surgery. However, it 
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appears that women who experienced high distress levels prior to prophylactic surgery 
tended to continue to experience high distress scores after prophylactic surgery. Possibly, 
their distress is not only related to the event of undergoing prophylactic surgery or the 
increased risk of developing cancer, but also to other factors, such as specific personality 
traits, coping strategies or life circumstances. Moreover, they need to learn to live with 
the possible (physical) consequences of surgery. Alleviation of distress could be related to 
post-operative counselling. However, we do not have any quantative data on additional 
counselling in other echelons of health care. Reassurance by having comforting thoughts 
proved in this study a favourable coping strategy at six months after prophylactic 
mastectomy/salpingo-oophorectomy, which was also observed in our study in women at 
increased risk for breast cancer adhering to surveillance
29
. No information is available on 
the contents of the comforting thoughts, and more research is needed before such coping 
strategy could be facilitated or offered to specific women in clinical practice. For example, 
clinical experience has shown that women with young children are highly motivated to opt 
for far-reaching strategies in order to see their children grow up, which motivation might 
serve as a comforting or reassuring thought. The role of mutation carrier status as 
predictive factor was more difficult to interpret. Mutation carriers seem to benefit more 
after 12 months with regard to lower general distress than risk carriers. However, at 6-
months follow-up mutation carriers remained to experience more cancer related distress, 
which fortunately was not found anymore at 12 months. From previous studies it is known 
that mutation carriers opting for PM experience higher distress levels than those opting 
for surveillance, which is likely influenced by several factors (more/longer awareness of 
the genetic cancer susceptibility in the family, younger age, more often young 
children)
16,30
. It may be possible that our observation reflects the vulnerability of the 
group of mutation carriers opting for PM, possibly influenced by personality traits, which 
is not altered by surgery over a short follow-up period. Certainly, it remains warranted to 
further address and explore this issue in future studies.  
 This study underscores that a subgroup of women continues to show signs of mild 
psychological distress, even after prophylactic surgery. However, it also supports our 
clinical impression that women take their decision well-informed and not based on forms 
of maladaptive coping. Our results are relevant in helping to decide which patients might 
benefit from additional psychological counselling. Further research is warranted to 
elucidate the factors underlying continuous high levels of distress, and to evaluate 
possibilities for therapeutic intervention. While the uptake of prophylactic surgery in the 
Netherlands is quite high amongst at-risk women or mutation carriers, in other Western 
countries, it is not always a favorable option
8
. However, prophylactic surgery is becoming 
a relevant risk-reducing management option that can be performed in many different 
ways (e.g. skin-sparing mastectomy, TRAM flap procedure, DIEP flap procedure), 
depending on a woman’s preference. Therefore, there is a strong need for further studies 
in this field. 
 
References  
1. Antoniou A, Pharoah PD, Narod S, et al. Average Risks of Breast and Ovarian Cancer Associated With BRCA1 or 
BRCA2 Mutations Detected in Case Series Unselected for Family History: a Combined Analysis of 22 Studies. 
Am J Hum Genet 2003; 72: 1117-30. 
  
74 Chapter 8 
2. Ford D, Easton DF, Stratton M, et al. Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 
Genes in Breast Cancer Families. The Breast Cancer Linkage Consortium. Am J Hum Genet  1998; 62: 676-89. 
3. Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast Cancer After Prophylactic Bilateral Mastectomy in 
Women With a BRCA1 or BRCA2 Mutation. New Engl J Med 2001; 345: 159-64. 
4. Verhoog LC, Brekelmans CT, Seynaeve C, et al. Contralateral Breast Cancer Risk Is Influenced by the Age at 
Onset in BRCA1-Associated Breast Cancer. Brit J Cancer 2000; 83: 384-86. 
5. Grann VR, Jacobson JS, Sundararajan V, et al. The Quality of Life Associated With Prophylactic Treatments for 
Women With BRCA1/2 Mutations. Cancer J Sci Am 1999; 5: 283-92. 
6. Hartmann LC., Schaid DJ, Woods JE, et al. Efficacy of Bilateral Prophylactic Mastectomy in Women With a 
Family History of Breast Cancer. New Engl J Med 1999; 340: 77-84. 
7. Hartmann LC, Sellers TA, Schaid, DJ, et al. Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 
Gene Mutation Carriers. J Natl Cancer Inst 2001; 93: 1633-37. 
8. Meijers-Heijboer EJ, Verhoog LC, Brekelmans, CT, et al. Presymptomatic DNA Testing and Prophylactic Surgery 
in Families With a BRCA1 or BRCA2 Mutation. Lancet 2000; 355: 2015-20. 
9. Schrag D, Kuntz KM, Garber JE, Weeks JC. Decision Analysis--Effects of Prophylactic Mastectomy and 
Oophorectomy on Life Expectancy Among Women With BRCA1 or BRCA2 Mutations. New .Engl J Med 1997; 
336: 1465-71. 
10. Bleiker EM, Hahn DE, Aaronson NK. Psychosocial Issues in Cancer Genetics: Current Status and Future 
Directions. Acta Oncol. 2003; 42: 276-86. 
11. Dowdy SC, Stefanek M, Hartmann LC. Surgical Risk Reduction: Prophylactic Salpingo-Oophorectomy and 
Prophylactic Mastectomy. Am J Obstet Gynecol 2004; 191: 1113-23. 
12. Frost MH, Schaid DJ, Sellers TA, et al. Long-Term Satisfaction and Psychological and Social Function Following 
Bilateral Prophylactic Mastectomy. J Amer Med Ass 2000; 284: 319-24. 
13. Bebbington Hatcher M, Fallowfield L, A'Hern R. The Psychosocial Impact of Bilateral Prophylactic Mastectomy: 
Prospective Study Using Questionnaires and Semistructured Interviews. Brit Med J 2001; 322: 76e. 
14. Hopwood P, Keeling F, Long A, et al. Psychological Support Needs for Women at High Genetic Risk of Breast 
Cancer: Some Preliminary Indicators. Psycho-Oncology. 1998; 7: 402-12. 
15. Lloyd S, Watson M, Waites B, et al. Familial Breast Cancer: a Controlled Study of Risk Perception, Psychological 
Morbidity and Health Beliefs in Women Attending for Genetic Counselling. Brit J Cancer 1996; 74: 482-87. 
16. Lodder LN, Frets PG, Trijsburg RW, et al. One Year Follow-Up of Women Opting for Presymptomatic Testing for 
BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or 
Prophylactic Surgery). Breast Cancer Res Treat  2002; 73: 97-112. 
17. Metcalfe KA, Esplen MJ, Goel V, Narod, SA. Psychosocial Functioning in Women Who Have Undergone Bilateral 
Prophylactic Mastectomy. Psycho-Oncology. 2004; 13: 14-25. 
18. Bresser PJC, Seynaeve C, Van Gool AR, et al. Satisfaction With Prophylactic Mastectomy and Breast 
Reconstruction in Genetically Predisposed Women. Plast Reconstr Surg 2006; 117: 1675-82. 
19. Oostrom I van, Meijers-Heijboer H, Lodder LN, et al. Long-Term Psychological Impact of Carrying a BRCA1/2 
Mutation and Prophylactic Surgery: a 5-Year Follow-Up Study. J Clin Oncol 2003; 21: 3867-74. 
20. Bresser PJC, Seynaeve C, Van Gool AR, et al. The Course of Distress in Women at Increased Risk of Breast and 
Ovarian Cancer Due to an (Identified) Genetic Susceptibility Who Opt for Prophylactic Mastectomy and/or 
Salpingo-Oophorectomy. Eur J Cancer 2007; 435: 95-103 
21. Wilde GJS. Amsterdamse Biografische Vragenlijst (ABV). Amsterdam: van Rossen; 1963. 
22. Te Nijenhuis J, Van der Flier H, Van Leeuwen L. The Use of a Test for Neuroticism, Extraversion, and Rigidity for 
Dutch Immigrant Job-Applicants. Applied Psychology: an international review 2003; 52: 630-47. 
23. Schreurs PJG, Willige G van de, Tellegen B, et al. Handleiding Utrechtse Coping Lijst: UCL. Lisse: 
Swets&Zeitlinger; 1988. 
24. Schreurs PJG, Willige G van de, Brosschot JF, et al. De Utrechtse copinglijst: UCL (Dealing with problems and 
events). Lisse: Swets & Zeitlinger; 1993. 
25. Horowitz M, Wilner N, Alvarez, W. Impact of Event Scale: a Measure of Subjective Stress. Psychosom Med 
1979; 41: 209-18. 
26. Joseph S. Psychometric Evaluation of Horowitz's Impact of Event Scale: a Review. J Trauma Stress 2000; 13: 
101-113. 
27. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-70. 
28. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The Validity of the Hospital Anxiety and Depression Scale. An 
Updated Literature Review. J Psychosom Res 2002; 52: 69-77. 
29. Pieterse K, van Dooren S, Seynaeve C, et al. Passive Coping and Psychological Distress in Women Adhering to 
Regular Breast Cancer Surveillance. Psycho-Oncology in press. 2007 DOI:10.1002/pon.1135. 
30. Meiser B, Butow P, Friedlander M, et al. Intention to Undergo Prophylactic Bilateral Mastectomy in Women at 
Increased Risk of Developing Hereditary Breast Cancer. J Clin Oncol 2000; 18: 2250-57. 
 
  
 
 
9 
The Impact of Coping on Psychological Distress Before and 
One Year After Prophylactic Mastectomy and/or Salpingo-
Oophorectomy 
 
 
 
Background The effect of coping on distress was studied in 82 women at increased risk of hereditary breast 
and/or ovarian cancer before and after prophylactic mastectomy (PM/(I)BR) and/or bilateral (salpingo) 
oophorectomy (PBSO).  
Methods The Utrecht Coping List (UCL), the Hospital Anxiety and Depression Scale (HADS), and the Impact of 
Events Scale (IES) were completed 2-4 weeks before (baseline), and 6 and 12 months after prophylactic 
surgery.  
Results Passive coping, palliative coping, and lack of seeking social support were associated with higher 
levels of distress before prophylactic surgery. Furthermore, passive coping was associated with less decrease 
of distress at one year after prophylactic surgery.  
Conclusions Coping strategies should be assessed in the working-up before prophylactic surgery. Especially 
women who have adopted a passive coping strategy may benefit from additional psychosocial support.  
 
9.1 Introduction 
In spite of ongoing research and development of better treatment methods, breast cancer 
and ovarian cancer are still life threatening diseases. The lifetime risk to develop breast 
cancer is 12-13% for the Dutch female population (www.cbo.nl). In 15%, these breast 
cancers are of hereditary origin, whereas in 5% of all cases, a BRCA1/2 mutation will be 
found present. 
 
Submitted 
 
Bresser PJC, Duivenvoorden HJ, Seynaeve C, Van Gool AR, Niermeijer MF, Menke-
Pluijmers MB, Geel AN van, Klijn JGM, Tibben A 
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Moreover, of 1500 ovarian cancers that are yearly discovered in the Netherlands, 10% are 
assumed to be of hereditary origin. Women identified with a BRCA1/2 mutation have a 
cumulative lifetime risk (up to the age of 70 years) of invasive breast cancer of 39-85% and 
of ovarian cancer of 11-63%
1-4
. After a history of breast cancer, the life-time risk of 
contralateral breast cancer ranges between 35 and 64%
5,6
.  
 Because of these risks, mutation carriers may consider prophylactic surgery. This may 
consist of either (bilateral or contralateral) prophylactic mastectomy with or without 
(immediate) breast reconstruction (PM/(I)BR) and/or prophylactic (bilateral) salpingo-
oophorectomy (P(B)SO). Retrospective studies have shown a reduction of the risk of 
developing breast cancer of 95% . After P(B)SO, women have a residual risk up to 4% of 
developing peritoneal cancer
9,10
. 
 The uptake of PM/(I)BR in our institution is 35% for previously affected mutation 
carriers
8
 and 51% for unaffected mutation carriers
11
. The uptake of P(B)SO in our 
institution is 49% for previously affected mutation carriers
8
 and 64% for unaffected 
mutation carriers
11
. Parenthood, age and development of breast cancer were related to 
the decision to undergo prophylactic surgery
8,11
.  
 Since DNA research is evolving and the techniques of PM/(I)BR and P(B)SO are 
improving, we expect that the uptake of prophylactic surgery will be increasing in the 
coming years. Therefore, it is crucial to thoroughly investigate the psychosocial impact of 
these radical procedures. Until now, a limited amount of studies are conducted in this 
field. 
 High-risk women who face the decision to undergo prophylactic surgery experienced 
high levels of psychological distress related to the threat of developing cancer
12-16
. Studies 
have shown a favourable effect of prophylactic surgery on distress
13,17,18
. The elevated 
levels of distress prior to surgery decreased or disappeared in the year after prophylactic 
surgery
13,17,18
. However, a subgroup of women continued to experience increased distress 
after PS
18-20
. This distress was positively related to the occurrence of surgical 
complications and levels of distress prior to surgery
19,20
. Briefly stated, distress played an 
important role both before and after prophylactic surgery. Although coping and distress 
are different psychological constructs, they often occur simultaneously and are mutually 
dependent
21
. In order to understand the dynamics of coping and distress and to support 
our expectations regarding coping and distress in women who opted for prophylactic 
surgery, the Common Sense Model (CSM) of self-regulation
22
 provided us with a 
conceptual framework. The CSM implies that coping responses, health behaviour and 
well-being are determined by their personally appraised health representations. The 
perceived health threat is cognitively coped with by using problem-focused coping 
strategies (i.e. acting out to alleviate, modify, avoid or minimise the threatening situation), 
whereas the emotions that accompany the health threat is coped with by using emotion-
focused coping strategies (i.e. regulation of the emotions that accompany the threatening 
situation, by use of comforting thoughts, relaxation, denial or wishful thinking). Though 
both strategies are employed simultaneously by people, the predominance of one 
strategy over the other is individually and circumstantially determined
23
. 
To our knowledge, only two prospective studies have focused on coping strategies in 
relation to prophylactic surgery in high-risk women
13,20
. Bebbington Hatcher et al.
13
 found 
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that women who opted for PM/(I)BR used more problem-focused coping prior to surgery 
than women who did not opt for PM/(I)BR. In our cohort of women who underwent 
prophylactic surgery, we previously found that emotion-focused coping (specifically: 
coping by comforting thoughts) was predictive of less cancer-related distress at 6-months 
after prophylactic surgery
20
. Though we found only use of comforting thoughts as being 
predictive of the decrease of distress in women who underwent prophylactic surgery, we 
assume that other coping strategies are related to the level of distress at baseline and 
follow-up. 
 High-risk women cannot cognitively control the threat of breast cancer and/or ovarian 
cancer. They can only act on the contemporary options of regular surveillance and/or 
prophylactic surgery. Being at increased risk while awaiting surgery, and facing a residual 
risk after surgery, women can try to moderate their emotions and subsequently manage 
the threat. Based on Leventhal’s CSM we therefore hypothesized that emotion-focused 
coping strategies would predominate at both baseline and follow-up, in order to alleviate 
the general and cancer-related distress that accompanies the (residual) threat of 
developing breast cancer and ovarian cancer. In this study we aimed to get solid insight 
into the impact of different coping strategies on distress. 
 
9.2 Patients and Methods 
9.2.1 Study Population 
At the Family Cancer Clinic of the Erasmus MC - Daniel den Hoed Cancer Centre 
(Rotterdam, the Netherlands), women at increased risk of hereditary breast and ovarian 
cancer are offered a surveillance program
24
. High-risk women are identified BRCA1/2 
mutation carriers and 50% risk carriers from familial/hereditary breast and ovarian cancer 
families (HBOC) in which a mutation is not found. Both PM/(I)BR and P(B)SO are discussed 
as an option with mutations carriers, while P(B)SO is discussed with 50% risk carriers from 
HBOC families. In earlier days, some 50% risk carriers from HBOC families also opted for 
PM/(I)BR without having received a conclusive DNA test result. Follow-up data are 
prospectively collected in a central database.  
 High-risk women who decided for PM/(I)BR and/or P(B)SO were invited to participate 
in an ongoing follow-up study on the psychosocial impact of prophylactic surgery. The 
purpose of the follow-up study was to explore the psychosocial effects of prophylactic 
surgery, being either PM/(I)BR, P(B)SO or both. Prophylactic surgery had to be performed 
at the Erasmus University MC - Daniel den Hoed Cancer Centre. Clinical and laboratory 
evaluation established absence of recurrent disease after a history of breast cancer by 
(chest X-ray, ultrasound liver, bone scan, liver functions and determination of 
Ca15.3/Ca125). Previously unaffected women with a clinical diagnosis or suspicion of 
cancer before prophylactic surgery were not eligible for participation in this psychological 
study. The study was supported by the Netherlands’ Organization for Health Research and 
Development (ZonMw, grant no. 210-00-013) and the institutional review board of the 
Erasmus MC gave approval of the study (protocol no. DDHK 98-15).  
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9.2.2 Procedure 
Physicians provided eligible patients with both verbal and written information on the 
purposes of the study. All participants who consented were each given a unique 
identification code that could only be encrypted by the main researcher of the project. 
 Participants received questionnaires by mail on the following moments: 2-4 weeks 
before prophylactic surgery (T0), and 6 and 12 months after prophylactic surgery (T1 and 
T2 respectively). The questionnaire consisted of questions on demographic data, the 
Utrecht Coping Scale
25
, the Impact of Event Scale
26
 and the Hospital Anxiety and 
Depression Scale
27
. All questionnaires, except the questionnaire assessing demographic 
data, were administered at every measurement moment. Consistent with prior results
29
, 
the scores on the Utrecht Coping List were constant over time. Therefore, we used only 
the scores of the baseline measurement for analysis. 
 
9.2.3 Biographical and medical data 
Age, marital status, offspring, educational level, profession, carrier status, history of breast 
cancer and type of prophylactic surgery were recorded during the first assessment 
moment (T0).  
 
9.2.4 Coping  
The Utrecht Coping List (UCL)
25
 was used to assess coping strategies. It is a general coping 
questionnaire that addresses 7 coping strategies: Active Coping (i.e. taking action to solve 
a problem; 7 items); Palliative Reaction Pattern (i.e. seeking distraction; 8 items); 
Avoidance and Awaiting (8 items); Seeking Social Support (6 items); Passive Reaction 
Pattern (i.e. not taking or not feeling able to take action; 7 items); Expressing Emotions (3 
items); and reassuring oneself by having Comforting Thoughts (5 items). Participants were 
presented with the following answer possibilities: 1 (seldom or never); 2 (sometimes); 3 
(often); and 4 (very often). The UCL has a number of sufficiently consistent and 
independent scales covering most areas of coping
28
. The validity and reliability of the UCL 
have been found to be good
29
.  
 
9.2.5 Cancer-related distress  
The revised Impact of Events Scale (IES) is a well-recognised measure
26,30-32
 for intrusive 
and avoidant thoughts, feelings, and behaviour about breast- and/or ovarian cancer. The 
score range for the scale ‘Intrusion’ (7 items) is 0 to 35 and for the scale ‘Avoidance’ (8 
items) 0 to 40. All items are scored as follows: 0 (not at all); 1 (seldom); 3 (sometimes); 
and 5 (often). 
 
9.2.6 General distress 
General distress was measured with the Hospital Anxiety and Depression Scale (HADS)
27
. 
The HADS consists of a scale that assesses anxiety (7 items) and a scale that assesses 
depression (7 items), respectively. Every item has four item-specific answer possibilities, 
specifically formulated to relate to the item.  The scores range from 0 to 21, for both 
scales. Validities and reliabilities have proven to be sufficient
33,34
. 
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9.2.7 Statistical analyses 
Significant differences on biographical variables (i.e. age, level of education, marital status, 
employment, children and being religious) and medical variables (i.e. carrier status, type 
of surgery, history of breast cancer) between participants and dropouts were determined 
through Pearson’s χ2 tests. Missing values were estimated using the ‘maximum likelihood’ 
method. The basic data were analysed using the SPSS 11.0 statistical package (SPSS Inc., 
Chicago). 
 To simultaneously determine the effect of the seven coping strategies on distress, the 
conventional MANOVA- and regression approaches are insufficient. Hence, the data were 
analysed using the method of Structural Equation Modelling (SEM), i.c. growth modelling 
approach. This approach enables estimating the level and trend of distress, as well as to 
estimate the impact of the coping strategies on distress. An underlying principle of SEM 
concerning assessments across time is that individuals may differ not only on level but also 
on trend of distress. We used the M-Plus 3.1 program
35
. This programme enables to 
simultaneously analyse several outcome variables assessed across time. 
 The course of distress was specified in terms of intrusion and avoidance (i.e. breast 
cancer specific distress; IES), and anxiety and depression (i.e. general distress; HADS). 
These four specifications of distress resulted in four different courses to be analysed. 
Baseline measurement (T0) was used as the reference moment. The analyses were 
executed in two steps. 
 First we fixed the correlation between the intercept and the trend at 0.00 for the four 
different courses, meaning that the intercept was independent of the corresponding 
trend. Additionally, we restricted the autocorrelations between the observed outcome 
variables to be of first order, which implied that for all four observed outcomes variables 
the autocorrelation of the T0 with T1 was fixed to be equal to the autocorrelation 
between T1 and T2. Second, based on the model identified in the first step, the predictive 
potentialities of the seven UCL-scales was estimated for the four outcome variables, to be 
distinguished in baseline and trend for all of them. As measures of model performance, χ2 
test was used for determining the adequacy of the model-fit. A non-significant p-value 
(p>0.05) and the ratio of 
df
2χ
<1.5 would represent an adequate model fit. To provide for 
reliable evaluations of the model, we used the Comparative Fit Index (CFI>0.95), the 
Tucker-Lewis Index (TLI>0.95), the Root Mean Square Error of Approximation (RMSEA ≈ 
0.05) and the Standardised Root Mean Square Residual (SRMR < 0.05). 
 A t-value equal or greater than +/-2 was considered significant. The related 
standardised regression coefficients (γ) represent the significant relationships in the most 
plausible model. 
 
9.3 Results 
9.3.1 Study population 
Between August 1999 and January 2003, 100 out of 147 eligible women enrolled in the 
study (68%). After inclusion, two women appeared to have a clinical diagnosis of cancer 
before prophylactic surgery, and their data were not included in the analysis. 
Furthermore, only data from women who filled out at least 75% of all items in each 
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questionnaire were used in this analysis, resulting in the final study group of 82 women. 
Characteristics of the study group are shown in Table 1. For comparison, the 
characteristics of the dropout women (n=16) have been included into Table 1. There were 
no differences between the dropout group and the study group with respect to age, 
marital status, having children, employment, mutation carrier status, a history of cancer, 
and type of prophylactic surgery.  
 
Table 1 
Characteristics of the study group (n=82) and the dropout group (n=16) 
 
    
 Participants Dropouts  
 
(n=82) (n=16)  
M Sd M Sd df F p 
Age 
(in years) 
43 ±8.6 43 ±8.9 96 .22 ns 
 n % n % df χ2 p 
Marital state Married or co-habiting 73 89 13 81 3 6.44 ns 
 Single or divorced   9 11 3 19 
Children Yes 68 83 11 73 1 .77 ns 
 No 14 17 4 27 
Religious  33 40 - - - - - 
Education Low/Average 61 75 - - - - - 
 High 20 25   
Current job Yes 55 69 9 82 1 .79 ns 
 No 25 31 2 18 
Carrier status BRCA1/2 mutation 58 71 12 80 4 1.51 ns 
 50% risk carrier 24 29 3 20 
 History of cancer No 52 63 10 63 2 5.23 ns 
 Breast cancer 30 37 5 31 
 Ovarian cancer 0 0 1 6 
Type of PS
1
 PM/(I)BR 34 42 4 27 4 1.64 ns 
 P(B)SO 19 23 4 27 
 PM/(I)BR+P(B)SO 9 11 3 20 
 PM/(I)BR before P(B)SO 5 6 1 7 
 PM/(I)BR after P(B)SO 15 18 3 20 
         
 
1
 PS: prophylactic surgery; PM/(I)BR: prophylactic mastectomy; P(B)SO: prophylactic (bilateral) salpingo-oophorectomy; 
PM/(I)BR+P(B)SO: prophylactic mastectomy and salpingo-oophorectomy simultaneously performed; PM/(I)BR before/after P(B)SO: 
prophylactic mastectomy performed before/after oophorectomy (time elapsed undefined) 
 
The mean age at the time of prophylactic surgery was 43 years for both participants and 
dropouts. The majority of all women were married or living together with a partner 
(89%/81%) and had children (83%/73%). The latter figures are high, compared to the 
Dutch population (resp. 62% and 36%). Having a job was reported by 
participants/dropouts in 67%/82% respectively, while vocational training or university 
education was reported in 25% and active religious involvement in 40% of the women.  
Most of the women were identified BRCA1/2 mutation carriers (71%/80%), and the 
majority had opted for PM/(I)BR, with or without P(B)SO.  
 Because the dropout women answered several questionnaires incompletely, possible 
significant differences between both groups regarding education, religion, the UCL, the IES 
and the HADS were not analysable. 
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Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
1 Active Coping
2 Palliative Reaction .27
3 Avoidance -.22 .37
4 Social Support .21 .17 -.15
5 Passive Reaction -.19 .23 .31 .07
6 Expression Emotions .18 .07 -.09 .35 .08
7 Comforting Thoughts .31 .54 .25 -.08 -.13 -.05
8 Intrusion (T0) .05 .39 .13 .15 .49 -.03 .07
9 Intrusion (T1) -.08 09 -.02 .18 25 -.14 -.23 .48
10 Intrusion (T1) -.07 .10 .19 .05 .19 -.08 -.00 .43 .61
11 Avoidance (T0) .06 .40 .34 -.21 .43 -.10 .15 .57 .33 .34
12 Avoidance (T1) -.10 .14 .16 -.28 .36 -.28 -.03 .27 .51 .36 .56
13 Avoidance (T2) -.04 .25 .21 -.37 .29 -.31 .18 .24 .37 .43 .60 .72
14 Anxiety (T0) -.04 .19 .16 -.09 .64 -.06 -.02 .62 .29 .16 .55 .36 .31
15 Anxiety (T1) -.10 .19 .15 -.08 .51 -.14 -.04 .42 .51 .30 .40 .52 .39 .52
16 Anxiety (T2) -.02 .06 .09 -.17 .40 .03 .11 .42 .31 .45 .37 .30 .41 .55 .63
17 Depression (T0) -.12 .20 .26 -.10 .70 .02 -.03 .55 .18 .19 .50 .36 .35 .82 .53 .51
18 Depression (T1) .02 .04 .17 -.15 .48 -.17 -.17 .35 .45 .41 .42 .54 .46 .42 .74 .54 .54
19 Depression (T2) -.05 .13 .22 -.19 .43 -.02 .15 .35 .19 .35 .36 .31 .38 .45 .55 .70 .56 .65
Mean 19 19 15 14 11 6 13 11 7 7 9 7 6 6 5 5 4 3 3
Sd 3 4 3 4 2 1 2 9 7 7 8 8 7 4 4 3 3 3 3
Table 2 
Correlation matrix of determinant and outcome variables (2-4 weeks before prophylactic surgery (T0), 6 
months after (T1) and 12 months after prophylactic surgery (T2)) 
 
 
 
 
 
 
 
 
 
 
 
9.3.2 Modelling 
The mean scores, the standard variations and the estimated intercorrelations of both the 
outcome and predictor variables are presented in Table 2. The intercorrelations were 
significant at the 0.01 significance level (two-tailed). The performance of the model, in 
which the prognostic potentialities of the UCL-scales were explored, was satisfying 
(χ
2
=80.05, df=55, P=0.02; =1.46; CFI=0.97; TLI=0.91;RMSEA=0.08; and SRMR=0.05).  
 Figure 1 shows the impact of coping strategies on the levels and the trends of distress. 
The values that are shown are the standardised regression coefficients (γ) . With respect 
to the level of psychological distress, a positive and substantial relationship between the 
UCL-subscale ‘Passive reaction pattern’ (not taking action) and all distress measures was 
found at baseline. Thus, women utilising a passive coping strategy reported more intrusive 
thoughts (γ=0.59) and avoidant behaviour (γ=0.48), and felt more depressed (γ=0.86) and 
fearful (γ=0.83) before prophylactic surgery.  
 To a lesser degree, a palliative reaction pattern and seeking social support were related 
to psychological distress at the baseline measurement moment. This means that women 
who had high scores on the UCL subscale ‘palliative reaction pattern’ (seeking distraction) 
reported more intrusion (γ=0.42) and avoidance (γ=0.39) before prophylactic surgery. In 
addition, women who had high scores on the subscale ‘seeking social support’ reported 
less avoidant behaviour at baseline (γ=-0.37). 
 A ‘passive reaction pattern’ was associated with persistent high levels of psychological 
distress after prophylactic surgery. We observed that passive coping was inversely related 
with intrusion (γ=-0.69), depression (γ=-0.65), and anxiety (γ=-0.53). This indicates that 
passive coping was associated with less decrease of the level of distress over time. 
 
  
df
2χ
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Figure 1 
Coping model – the impact of coping (UCL) on baseline levels and course of ‘Intrusion’ and ‘Avoidance’ (IES) 
and ‘Depression’ and ‘Anxiety’ (HADS) in genetically predisposed women (n=82) 
 
 
 
 
 
9.4 Discussion 
In this paper, we present a model of coping and distress of women who opt for PM/(I)BR 
and/or P(B)SO. We hypothesized that emotion-focused coping strategies would 
predominate both at baseline and at follow-up in order to regulate the general and 
cancer-related distress that accompanies the (residual) threat of developing breast cancer 
or ovarian cancer. In line with our expectations, we found strong relationships with 
emotion-focused coping (passive coping and seeking social support) at baseline. However, 
also a strong relationship with problem-focused coping (palliative coping) was found. 
 First, the strong, positive relationship between passive coping and distress at baseline 
contradicted our hypothesis. Clearly, this emotion-focused coping strategy was not 
alleviating distress prior to surgery. The distinct presence of passive coping strategies in 
this cohort might imply that the women in our cohort needed emotion-focused coping in 
order to regulate the distress accompanying this threatening situation. This is concordant 
with Pieterse et al.
36
, who elaborated on the correspondence of ‘learned helplessness’ (i.e. 
responding passively to an uncontrollable stressor) with passive coping. However, since 
passive coping led to more distress at baseline, tailor-fit psychological support should be 
offered, that focuses on adapting other, active-oriented coping strategies prior to surgery. 
Active
Coping
Palliative 
Reaction 
Pattern
Avoidance, 
Awaiting
Seeking 
Social 
Support
Passive 
Reaction 
Pattern
Expression of 
Emotions
Comforting 
Thoughts
Avoidance
(baseline level)
Depression 
(baseline level)
Anxiety
(baseline level)
Intrusion 
(baseline level)
Intrusion 
(course)
Avoidance
(course)
Depression 
(course)
Anxiety 
(course)
-.37
-.69 -.65 -.53
.42 .59 .48 .86 .83.39
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Second, the positive relationships between palliative coping and intrusion and avoidance 
at baseline indicated that women adapting this coping strategy experienced more cancer-
related intrusive thoughts and were more inclined to engage in a pattern of avoidant 
behaviour regarding breast cancer or ovarian cancer at the baseline assessment than 
women using other coping strategies. Obviously, this problem-focused coping strategy 
was by no means effective in adequately reducing cancer-related distress. Pieterse et al.
36
 
also reported a connection between palliative coping and intrusion and avoidance in their 
cohort of women who are at increased risk of developing breast cancer and/or ovarian 
cancer. Their cohort opted for regular breast surveillance, and therefore faced other 
issues surrounding the threat of cancer in the long run. At our baseline assessment 
however, (i.e. before prophylactic surgery), both cohorts are similar in the overwhelming 
threat of developing cancer. We agree with their explanation that by continuously trying 
to divert oneself from one’s problem at hand, the problem remains constantly present, 
thereby enlarging distress.  
 Third, the model established a negative relationship between seeking social support 
and avoidance at baseline. Clearly, the more an emotion-focused way of coping like 
seeking social support was employed, the less confrontations with breast cancer and 
ovarian cancer were avoided. In this respect, seeking social support was successful in 
alleviating distress, thereby confirming our hypothesis. 
 Finally, only passive coping was discernibly and negatively related to distress after 
surgery, indicating that this way of coping was associated with less decrease of the level of 
distress over time. Apparently, this type of emotion-focussed coping strategy was 
ineffective in reducing both cancer-related and general distress.  
 Though the CSM proved right in its theory that emotions that accompany the health 
threat are dealt with by using emotion-focused coping strategies, these results underline 
that not all emotion-focused coping strategies were adequate in itself. Clearly, passive 
coping was not alleviating distress, though it seemed to be the most distinguishable 
coping strategy amongst other emotion-focused coping strategies. Since generally few 
experiences in life are equally life-threatening, we hypothesize that these results indicate 
that most women had no experience in coping with the overwhelming emotions that 
came with the threat of developing breast cancer and/or ovarian cancer. The women who 
let themselves (passively) overwhelm, experienced more distress while awaiting surgery, 
and achieved less decrease in distress over time. Would these women have been coached 
in bending their passive reaction pattern into more active-oriented emotion-focused 
coping strategies, these relationships would probably not have been standing out so 
clearly. The absence of relationships between distress and most other emotion-focused 
strategies does not per se prove them inadequate. It might indicate that women who did 
not strongly employ passive coping might have used multiple emotion-focused coping 
strategies simultaneously, thereby not having one of them standing out so strongly as 
passive coping did. Future research in larger cohorts should corroborate this. 
 A limitation of this study is that the sample is too small to account for the possible role 
of demographic variables in the analysis. Other than age and education
37-39
, other 
biographical variables such as marital status, children, religion, and profession, as well as 
medical variables such as BRCA1/2 mutation carrier status, history of cancer, type of 
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prophylactic surgery, hormone replacement therapy, and menopausal status might play a 
role in coping with distress. In light of these previous findings, women who are dealing 
with the complex situation of being at increased risk of breast and/or ovarian cancer due 
to a genetic susceptibility might benefit from good education about the subject of being at 
risk, the process of prophylactic surgery and the possible consequences of that option. 
Being aware of this, we hold it in our opinion that further investigation is warranted to 
examine whether one of these variables is of discriminating value. 
 In conclusion, both palliative and passive coping strategies can be considered as less 
favourable ways of stress management in high-risk women who have opted for PM/(I)BR 
and/or P(B)SO. Furthermore, seeking social support alleviates the level of psychological 
distress in this group of women. In our opinion, these findings are important for clinical 
practice, and need to be addressed in the pre-operative counselling of every woman 
considering prophylactic surgery because of an increased risk of breast and ovarian 
cancer. We would like to propose that for the purpose of assessment of these and other 
items, an appointment with a psychologist or social worker should be incorporated in the 
working-up process towards prophylactic surgery. In case vulnerability is identified, it is 
worthwhile to offer and incorporate extra counselling sessions in order to try to mirror the 
negative attitudes for specific women and to focus on more positive, active-orientated 
habits and coping strategies.  
 While we emphasize that determination of the way of coping is important to 
incorporate as part of the working up process before prophylactic surgery in this women, 
it certainly must be further debated who should identify passive coping styles and 
subsequent distress. Is it the physician’s task or should preference be given to a 
psychosocial worker? The outcome of the debate may depend on time (is it realistic to 
expect that the physician comprehensively explores the coping styles?), tools (does the 
physician have the adequate tools to efficiently identify coping strategies?), and the 
capacity (are there enough physicians or psychosocial workers available?). 
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10 
Discussion 
 
 
 
Before the mid-nineties, prophylactic surgery, consisting of PM/(I)BR and/or P(B)SO, was 
only occasionally done in women belonging to families with a strong history of breast and 
ovarian cancer, also because many clinicians doubted that genes were important in the 
breast and ovarian cancer risks of the respective women. The identification of the breast 
cancer susceptibility genes BRCA1 and BRCA2 as the explanation for an autosomal 
dominant inheritance of breast and ovarian cancer and an increased risk of breast and 
ovarian cancer already occurring at a young age for women from respective families 
transformed prophylactic surgery into an important and recognized option for high-risk 
women. Consequently, from 1995 onwards an increasing number of, mainly retrospective, 
studies investigated factors related to satisfaction with prophylactic surgery and the 
effects of prophylactic surgery on psychological well-being, body image and sexual 
functioning. The conducted studies very soon showed a fast decision for and a high uptake 
of PM/(I)BR and P(B)SO by both mutation carriers and 50% risk carriers. Patients asked for 
concrete information about the procedures and its possible consequences in order to 
make an informed choice about whether or not undergoing prophylactic surgery. Also 
physicians needed information on the psychosocial aspects of PM/(I)BR and P(B)SO in 
order to be able to provide adequate care and identify those women who might benefit 
from additional psychological support before and after prophylactic surgery. 
 The current study on the psychosocial impact of prophylactic surgery in high-risk 
women is the first prospective study that addressed the aspects of both PM/(I)BR and 
P(B)SO. This is important because many high-risk women utilize one or both options, with 
on the one hand different and on the other hand overlapping issues and consequences. 
Until now, only few other studies have been prospectively conducted, and concentrated 
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either on PM/(I)BR
1
 or on P(B)SO
2,3
. Moreover, the partners of the women opting for and 
undergoing prophylactic surgery were also included in our study. Data on this group 
regarding PM/(I)BR and P(B)SO provides unique information enabling health-care 
professionals to better understand the impact of the decision for and the sequelae of 
prophylactic surgery also on the spouse, thereby facilitating adequate and appropriate 
counselling for both partners.  
 Motivations leading to the decision to undergo prophylactic surgery, distress in high-
risk women who have undergone prophylactic surgery and satisfaction with the procedure 
and its impact on life have been previously investigated in various patient groups and with 
various study designs. Our study corroborates earlier findings and adds new insights into 
the psychosocial processes in women being at increased risk for breast and ovarian cancer 
in the period before and after PM/(I)BR and P(B)SO. 
 
10.1 New insights 
10.1.1 Satisfaction with PM/(I)BR 
From previous retrospective studies, satisfaction rates with PM/(I)BR varied between 70% 
and 100%
4-12
, although the exact percentages and the types of breast reconstruction in 
the different studies was mostly not specified. In our retrospective study on 114 high-risk 
women of whom all underwent PM/(I)BR at our institute between 1994 and 2002, only 
very few women expressed regrets about PM/(I)BR (5%), whereas the satisfaction rate 
with the final cosmetic result was only 60%. Despite the latter observation, most women 
indicated that they still would decide for PM and (I)BR if they had to face the same choice 
again. Apparently, other factors like the risk-reduction obtained by the removal of all 
breast tissue and relief of fear for the development of cancer prevailed above the 
sometimes disappointing cosmetic and physical outcomes of the surgical procedure.  
 Another major finding of our study was that nearly half of all women experienced 
adverse effects regarding the sexual relationship, which was unrelated to satisfaction with 
the procedure. This finding was significantly associated with perceived lack of information, 
expectations that were not met, ongoing physical complaints and limitations in daily life, 
altered feelings of femininity and body image, and perception of the partner’s negative 
view of the sexual attractiveness of his wife. Effects of PM/(I)BR on the sexual relationship 
were only incidentally addressed before
6,14,16
, but did not focus on PM with (I)BR 
specifically. Our data clearly show that after PM/(I)BR women may experience (lasting) 
pain or discomfort due to the procedure or its complications, or may feel less feminine 
and suffer from an altered body image. How all this might interfere with the (different 
aspects of the) sexual relationship deserves further study. Our findings underscore that 
potential alteration of the sexual relationship is worthwhile to address as part of the 
information given during the decision-making period and pre-surgical counselling. With 
respect to the findings of our study, it has to be said that P(B)SO was sometimes done in 
the same procedure or often in the same time period, making it difficult to distinguish 
between the effects of major and acute hormonal changes and the surgical effects on 
body shape, complaints, and perceptions. 
 Also, the data of our study indicate that proper and sufficient information about the 
procedure and its possible aftermaths is one of the common and important factors related 
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to satisfaction with the (cosmetic) outcome as well as the alterations on the sexual 
relationship. This also has been reported by Frost
6
. Further, clear information also helped 
to obtain a more accurate view of the different outcomes, as shown in a retrospective 
study done on effects of P(B)SO
17
. In our opinion and in view of our data, appropriate 
information about the potential problems of and after PM/(I)BR and/or P(B)SO will lead to 
enhanced acceptation and hence higher satisfaction with the actual outcomes. This 
requires the collective and unanimous efforts of the different specialists and healthcare 
workers at the multidisciplinary family cancer clinic, involved in the care of high-risk 
women. This might include an appointment with the psychologist aiming at further 
exploration of the way all information is processed and assimilated. Hereto, an 
institutional protocol should be elaborated.  
 
10.1.2 Motivations for prophylactic surgery 
In Chapter 5, we described the results of the first prospective analysis of the motivations 
for prophylactic surgery in relation to emotional distress before and after the surgical 
interventions. We hypothesized that women with combined cognitive and emotional 
motivations would have less emotional distress than women with purely cognitive 
motivations. However, both groups had similar levels and courses of emotional distress 
during the phase of prophylactic surgery until six months after surgery, with the exception 
of the course of avoidant behaviour. Women expressing fear for cancer as a motivation for 
prophylactic surgery experienced more depressive thoughts and feelings prior to surgery 
than women who did not express fear for cancer. Moreover, women expressing fear 
experienced a greater decline in avoidant behavior in the first six months after surgery 
whereas the non-fear group showed a decline between six and twelve months after 
surgery. Although fear is a strong predictor for opting for prophylactic surgery, we 
speculate that the group of women who did not express fear as motivation may have been 
already adjusted to the prospect of the risk-reducing effect of prophylactic surgery, or 
they may have suppressed their emotions regarding breast cancer and ovarian cancer. 
Clearly, this speculation needs to be further studied. 
 
10.1.3 Emotional distress before and after prophylactic surgery 
Our results described in Chapter 6 corroborate previous results
1,6
 that women opting for 
prophylactic surgery have higher levels of anxiety and cancer-related distress before 
prophylactic surgery than women opting for regular surveillance. After PM/(I)BR, anxiety 
and cancer-related distress were significantly reduced, mainly within the first six months 
after prophylactic surgery, which is also in line with previous observations
1,2,6,9,14,18-20
. No 
significant changes in distress scores were observed before and after P(B)SO. The latter 
has not previously been reported, and suggests that the impact of PM/(I)BR is greater 
than the impact of P(B)SO. Therefore, at our institution it has been agreed on that women 
opting for PM/(I)BR are seen by the psychologist before surgery, which is not the case 
anymore for women opting for P(B)SO. 
 As we found that a minority of women after prophylactic surgery is experiencing 
continuing elevated distress at a clinically significant level, we looked in Chapter 8 for 
predictors of ongoing distress after prophylactic surgery. As others observed
16
, cancer-
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related distress prior to surgery was predictive for post-surgical distress both at 6 and at 
12 months. Moreover, being a mutation carrier or having a personal history of breast 
cancer was predictive of high cancer-related distress, six months after surgery. The 
distress in these women might be explained by other factors such as personality, coping, 
life circumstances, or a lack of trust that prophylactic surgery has reduced the risk of 
developing (recurrent) cancer. Future research is needed regarding other risk factors 
impeding the devolution of general and cancer-related distress after prophylactic surgery.  
 Finally, coping strategies were shown to be related to emotional distress both before 
and after surgery. First, having comforting thoughts was predictive of less cancer-related 
distress at six months following prophylactic surgery (Chapter 8). Second, when studying 
the role of coping strategies in relation to distress, we found a strong association between 
passive coping and both cancer-related and general distress (Chapter 9). Passive coping 
strategies did neither reduce distress prior to surgery, and led to less decrease of distress 
after surgery. Strikingly, no other association was found between post-surgical distress 
and any other coping strategies. This might indicate that women not strongly using passive 
coping applied multiple other coping strategies, resulting in none of them standing out as 
strongly as passive coping did. 
 
10.1.4 Distress in partners of high-risk women who opt for prophylactic surgery 
To our knowledge, distress in partners of high-risk women in relation to the period before 
and after prophylactic surgery of their wife (Chapter 7) has not been previously studied. 
Scores on intrusion gradually decreased over the one year period after prophylactic 
surgery, while the courses of avoidance, anxiety and depression showed no changes 
between subsequent assessments. Reassuringly, most partners showed overall normal 
levels of distress both prior to and after prophylactic surgery of their wives. The latter 
observation is interesting, because earlier studies showed that these couples go through a 
stressful period once the health threat for the wife becomes clear
14,21
. Apparently, most 
men were able to adjust rapidly to the knowledge of their spouses‘ increased cancer risk. 
Still, 10% of the partners have clinically relevant levels of emotional distress up to one 
year after prophylactic surgery, and may be candidates for extra support.  
 Factors associated with increased emotional distress in partners were fatherhood, high 
educational level and having a spouse with a BRCA1/2 mutation or a history of breast 
cancer. Also, the distress level of the spouse proved to be predictive of the distress level of 
the partner (unpublished results). These findings stress the importance of assessing the 
distress level of partners of women opting for prophylactic surgery in order to identify 
those partners who may benefit from psychosocial support. 
 
10.2 Limitations of the current study and suggestions for further research 
Partly as a consequence of clinical reality, both the retrospective and the prospective 
study had a number of limitations. First, both study cohorts were heterogeneous with 
respect to medical history and treatment. Second, the questions in the retrospective 
questionnaire did not differentiate between immediate and delayed breast 
reconstruction. Third, the women in our studies underwent breast reconstruction by 
means of implants performed in one institution, making any comparisons with 
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(immediate) breast reconstruction using autologous tissue, and comparisons with other 
institutions impossible. Currently, a collaborative, multicenter prospective study is 
performed to study breast reconstruction using either implants or autologous tissue by 
means of DIEP flap. The prospective study covered a follow-up period after surgery of 
twelve months which is too short to draw definite conclusions. A study on the long term 
aspects of PM/(I)BR in the same study cohort is now ongoing at our institute.  
 
10.3 Clinical relevance 
The most important conclusion from our study is that the majority of high-risk women go 
through prophylactic surgery without major adverse physical or psychological 
consequences. In this respect, PM/(I)BR has a greater impact than P(B)SO. Though 
increased prior to prophylactic surgery, emotional distress regained normal levels in most 
women. Also, most women did not regret their decision, even when they were not 
satisfied with the cosmetic result of breast reconstruction. Finally, partners of high-risk 
women were well able to keep emotional distress within normal limits regarding their 
wife’s risk and her decision to undergo prophylactic surgery. 
 Still, special attention is justified to the subgroups of high-risk women and their 
partners who are vulnerable to increased distress, both before and after surgery. 
Counselling should preferably be done with both partners present, and the high-risk 
woman and her partner should be offered psychosocial support separate or together, 
especially when one or both are displaying increased levels of emotional distress prior to 
surgery or when the wife has adapted a passive coping strategy. Special attention might 
also be given to couples of whom the high-risk female partner is an identified mutation 
carrier, mainly in the follow-up period shortly after prophylactic surgery. Also, couples 
with children might be offered additional counselling. Finally, issues such as body image 
and the sexual relationship should be addressed prior to prophylactic surgery, as well as 
the way both partners deal with problems with those issues, not only individually but also 
as a couple.  
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Summary 
 
 
 
Introduction 
Breast and ovarian cancer are frequent female cancers, mostly manifesting after 50 years 
of age. About 5-10% of affected women have a primarily genetically determined form, 
mainly by mutations in the BRCA1/2 genes, transmitted as autosomal dominant traits with 
a risk of 50% for each child. These mutations became identifiable from the mid nineties of 
the previous century. The age of onset of breast cancer is from 25 years of age with a high 
risk for bilateral disease, and often associated with ovarian cancer from 35 years of age. A 
woman with a BRCA1/2 mutation has a lifetime risk of 39-85% for breast cancer. 
Moreover, the ovarian cancer risk is 40-63% for BRCA1 and 11-20% for BRCA2 mutation 
carriers. In about 25% of families showing multigenerational transmission of the disease, 
identifiable mutations are present. The other families are usually classified as Hereditary 
Breast and Ovarian Cancer (HBOC) families and their risk estimates are based upon family 
data and empirical risk tables. 
 Prophylactic surgery, being prophylactic mastectomy with or without (immediate) 
breast reconstruction (PM/(I)BR) and prophylactic (bilateral) salpingo-oophorectomy 
(P(B)SO), are the most effective  risk-reducing measures used by BRCA1/2 mutation 
carriers and women from HBOC families (‘high-risk women’). These measures are highly 
effective in reducing the risk and mortality of breast and ovarian cancer at a relatively 
young age. However associated sequelae as peri- and post-surgical complications and the 
emotional and physical impact must not be neglected. 
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The study 
This thesis reports results of a retro- and prospective observational study (PREVOM-B 
study) on the psychological impact of PM and P(B)SO in high-risk women. The study 
started in 1999 at the Erasmus Medical Center-Daniel den Hoed Cancer Centre, Rotterdam 
(the Netherlands). It is the first single center follow-up study on PM/(I)BR and P(B)SO, 
including partners of the women. The study was funded by the Netherlands’ Organization 
for Health Research and Development (ZonMw, grant no. 210-00-013). The retrospective 
study included 114 women, the prospective part 97 women.  
 
Chapter 1 addresses the background of hereditary breast and ovarian cancer and the 
management options for high-risk women. Regular physical surveillance of the breasts and 
ovaries have important limitations and chemoprevention also cannot prevent metastatic 
disease. Prophylactic surgery and its uptake show the importance of this option. 
 Chapter 2 reviews the literature on the psychosocial impact of PM/(I)BR or P(B)SO. Part 
of previous experience was obtained in retrospective series of PM/(I)BR and P(B)SO before 
BRCA analysis for precise risk identification was possible. The role of hormone 
replacement therapy (HRT) and a personal history of breast cancer as variables in previous 
research are also discussed in this chapter.  
 The research questions of the PREVOM-B study (Chapter 3) included satisfaction and 
effects on the sexual relationship of prophylactic mastectomy and breast reconstruction 
(PM/(I)BR), and the motivations, levels and courses of distress and coping in women 
opting for PM/(I)BR and P(B)SO. 
 
Retrospective analysis 
The retrospective part of the study addressed satisfaction with PM/(I)BR in 114 women 
who underwent the procedure between 1994 and 2002 (Chapter 4). Satisfaction was 
reported by 60% of the women, lower than reported by others. We found that 
dissatisfaction was more often reported by women who felt insufficiently informed prior 
to PM/(I)BR, and who would not opt for breast reconstruction again. Also women who 
experienced adverse physical consequences such as peri- and post-surgical complications, 
women who experienced limitations in daily life and women who reported that their 
breasts did not feel ‘like their own’ after PM/(I)BR were less satisfied.  
 Adverse effects of PM/(I)BR on sexuality were reported by a relevant number of 
women (n=40; 44%). This is a higher frequency than usually reported. Perceived lack of 
information, discrepant expectations, ongoing complaints and limitations, the perception 
that the reconstructed breasts did not feel like one’s own and altered feelings of 
femininity were associated with sexual dissatisfaction. The partner’s reactions, that were 
perceived as negative about the woman’s femininity and sexuality, and not opting for 
breast reconstruction again were also contributing factors. Though apparently PM/(I)BR 
had negative consequences for some, most women would opt for this procedure again 
(95% for PM, 80% for (I)BR). The results of the retrospective study indicate that 
preoperative counseling might benefit from addressing changes in body image and 
sexuality after PM/(I)BR and from recognizing potential risk factors in women at risk for 
breast and ovarian cancer. 
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Prospective analysis 
The prospective part of our study on motivations, distress and coping obtained 
assessments  a month prior to (baseline; T0), at six months after (T1) and at twelve 
months after prophylactic surgery (T2) (Chapters 5-9). Assessments included 
questionnaires  and interviews  with  high-risk women and their partners separately. The 
prospective study showed that most women and their partners had no major untoward 
emotional effects after prophylactic surgery. The course of their adaptation and 
experiences is summarized below. 
  Motivations of 36 high-risk women were compared with their scores on cancer-related 
(Impact of Events Scale (IES)) and general distress (Hospital Anxiety and Depression Scale 
(HADS)). The motivations were categorized in emotional-cognitive motivations (EC group) 
and cognitive motivations (C group). Both groups were compared on subscales of the 
distress questionnaires: intrusion and avoidance for the IES and anxiety and depression for 
the HADS. We found no relationship between motivations and levels and courses of 
distress.  
 Women who reported ‘fear for developing cancer’ were analyzed separately and 
compared with the others. Their ‘fear’ resulted in significantly more preoperative 
depression but less avoidance afterwards.  
 We hypothesized that women without preoperative fear of cancer either worked 
through their anxieties before entering the study, or that they suppressed their feelings of 
distress. Pre-operative counseling might focus on recognizing both a strong fear of cancer 
and on possible suppressed feelings, in order to avoid future emotional problems. 
 
The analysis on the levels and courses of general and cancer-related distress in 78 high-
risk women (Chapter 6) revealed that anxiety and cancer-related distress were 
significantly reduced after PM/(I)BR, but not after P(B)SO. Clinically elevated levels of 
anxiety and cancer-related distress at one year after surgery were reported by 10-20% 
women after PM/(I)BR and 19-27% after P(B)SO. Being a mutation carrier and coping by 
comforting thoughts were predictive for increased distress at the half year assessment. 
Cancer-related and general distress levels at baseline were predictive for elevated 
emotional distress up to one year post-surgery (Chapter 8). Women who tended to use 
passive and palliative coping strategies and who lacked seeking social support showed 
more increased pre-operative distress. Passive coping also led to less decrease of distress 
at one year after prophylactic surgery (Chapter 9). 
 
Pre- and post-surgery, the majority of 61 partners of high-risk women showed average 
distress scores, all within normal levels (Chapter 7). Possibly they received sufficient 
information and psychological support before and after the procedure. However, a small 
group of partners (2-10%) showed clinical cancer-related and general distress up to one 
year after prophylactic surgery of their wife. Increased post-operative distress was 
amongst others associated with fatherhood, and mutation status and previous cancer of 
the wife. 
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Conclusions 
In conclusion, genetic testing for mutations in the BRCA1/ 2 breast cancer genes, choices 
on options for risk reduction and prophylactic surgery may have a great physical and 
psychological impact in some women (Chapter 10). Long-term studies in the Rotterdam 
and other groups show how most women and their partners receive sufficient information 
and support to realize their most wanted gain of health. 
 The results of the PREVOM-B study provide a number of checkpoints, as improvement 
for the pre- and postsurgical counselling on PM/(I)BR and P(B)SO in high-risk women. 
These involve the information on the physical and psychological impact of PM/(I)BR and 
P(B)SO. High-risk women may benefit from pre- and postsurgical counselling and distress 
screening to help them effectively cope with feelings of distress and other possible 
adverse consequences of prophylactic surgery. Both before and after prophylactic surgery, 
special attention is warranted for high-risk women and their partners who are at an 
individually determined risk of feelings of anxiety and depression and/or cancer-related 
distress. For partners, the distress about the future of children at risk of being a mutation 
carrier is a factor for long term awareness. All these subjects warrant future research, and 
have relevance to all other genetic diseases. 
 
Based on the results as presented in this thesis, two large prospective studies are 
currently underway: 1) the long-term effects of prophylactic surgery in the same cohort of 
women and partners; and 2) the various surgical options for breast reconstruction such as 
implants or autologous tissue and their effects on patient satisfaction, body image and 
distress. 
 
  
 
 
 
Samenvatting 
 
 
 
Introductie 
Borst- en eierstokkanker zijn frequent optredende ziektes bij vrouwen, die zich meestal na 
het 50e levensjaar manifesteren. Bij 5-10% van de betrokken vrouwen is er een duidelijke 
erfelijke aanleg aanwezig. Deze vrouwen met een verhoogde kans op borst- en 
eierstokkanker hebben meestal een aantoonbare mutatie in één van de borstkankergenen  
BRCA1 of BRCA2. Hun kinderen hebben 50% kans de afwijkende erfelijke eigenschap te 
erven. Een draagster van een verandering in het BRCA1 of BRCA2 gen heeft gedurende 
haar leven 39-85% kans op borstkanker. Bovendien is het risico op het ontwikkelen van 
eierstokkanker 40-63% bij BRCA1 mutatie draagsters en 11-20% bij BRCA2 mutatie 
draagsters. Een genmutatie wordt in ongeveer 25% van geteste families gevonden. Voor 
vrouwen uit families met borst- en eierstokkanker, waarin nog geen genverandering 
aantoonbaar is, is de risicobepaling afhankelijk van de familiegegevens. Soms zijn de 
risico’s zodanig verhoogd, dat ook zij kiezen voor een preventieve operatie. 
 Omdat regelmatige controle een uitgezaaide vorm van kanker niet kan voorkomen, 
kiest een deel van de betrokken vrouwen voor een operatie uit voorzorg: preventieve 
mastectomie (verwijdering van borstklierweefsel) met of zonder (directe) 
borstreconstructie (PM/(I)BR) en preventieve (bilaterale) salpingo-ovariëctomie (P(B)SO; 
(dubbelzijdige) verwijdering van eierstokken en eileiders). Hoewel deze ingrepen zeer 
effectief zijn in het reduceren van het risico op kanker en sterfte op een relatief jonge 
leeftijd, kunnen er complicaties optreden tijdens en na de operatie. Bovendien mag men 
de emotionele gevolgen van een dergelijke radicale ingreep niet verwaarlozen.  
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De studie 
In 1999 is in de Daniel den Hoed Kliniek van het Erasmus MC in Rotterdam een onderzoek 
gestart (de PREVOM-B studie) dat tot doel had de psychosociale gevolgen van PM/(I)BR en 
P(B)SO bij deze groep vrouwen in kaart te brengen. Het is het eerste ‘single-centre’ follow-
up onderzoek naar de psychosociale gevolgen van PM/(I)BR en P(B)SO bij vrouwen met 
een verhoogd risico op borst- en eierstokkanker en hun partners. Het onderzoek werd 
gesubsidieerd door Zorgonderzoek Nederland (ZonMw, grant no. 210-00-013). Dit 
proefschrift doet verslag van de resultaten van dat onderzoek. 
 Hoofdstuk 1 beschrijft de achtergrond van erfelijke borst- en eierstokkanker en de 
keuzes die draagsters kunnen maken met betrekking tot regelmatige controle, 
chemopreventie en preventieve chirurgie. Ook wordt beschreven hoe vaak vrouwen 
kiezen voor preventieve chirurgie en welke factoren een rol spelen bij die keuze.  
 Hoofdstuk 2 toont een overzicht van de literatuur over de psychosociale gevolgen van 
PM/(I)BR en P(B)SO. Die ervaringen zijn nog beperkt, omdat een systematisch aanbod van 
die optie ontstond na de ontdekking van de BRCA1 en BRCA2 mutaties in de negentiger 
jaren van de vorige eeuw. Tevens zijn de beperkingen van hormoonvervangende therapie 
(HRT) na eierstokverwijdering aan de orde, als ook de rol van het eerder behandeld zijn 
voor borstkanker.  
 De onderzoeksvragen van de PREVOM-B studie (Hoofdstuk 3) betreffen de motivaties, 
tevredenheid en psychologische gevolgen zoals distress
1
 en angst voor kanker bij vrouwen 
met een hoog risico op erfelijk borst- eierstokkanker voor en na de preventieve operatie. 
Ook de aanwezigheid en mate van distress bij partners van deze vrouwen werd 
onderzocht. 
 
Retrospectieve analyse 
In het retrospectieve deel werd aan 114 vrouwen die PM/(I)BR ondergingen tussen 1994 
en 2002 (Hoofdstuk 4) terugblikkend gevraagd naar hun tevredenheid met de procedure. 
Slechts 60% van hen zei tevreden te zijn met de resultaten van PM/(I)BR, lager dan elders. 
Een relevant aantal vrouwen (n=40; 44%) rapporteerde een negatief effect van de 
operaties op hun seksuele relatie, terwijl die in andere studies weinig tot niet gevonden 
werden. De ontevredenheid met zowel de operatie als de seksuele relatie ten gevolge van 
PM/(I)BR bleek met een aantal factoren samen te hangen. Ontevreden vrouwen, in 
vergelijking met de overigen 1) zouden minder vaak opnieuw voor borstreconstructie 
kiezen ; 2) hadden vaker het gevoel onvoldoende geïnformeerd te zijn voorafgaand aan de 
operatie; 3) rapporteerden vaker complicaties en lichamelijke klachten; 4) voelden zich 
meer beperkt in hun dagelijks leven als gevolg van de operatie; en 5) vonden hun borsten 
vaker als ‘niet eigen’ aanvoelen. Vrouwen met negatieve gevolgen voor hun seksuele 
relatie hadden daarbij ook vaker 1) verwachtingen die niet uitkwamen; 2) veranderde 
                                                      
1
 De vertaling van ‘distress’ is ‘pijn, leed, verdriet’. In dit proefschrift wordt met distress ‘zorgen, spanningen’ 
bedoeld. Kanker-gerelateerde distress verwijst naar indringende, verstorende (intrusieve) gedachten en 
gevoelens en vermijdend gedrag met betrekking tot borst- en eierstokkanker, en algemene distress verwijst 
naar gevoelens van angst en depressie. Vanwege het gebrek aan een adequate vertaling van ‘distress’ in het 
Nederlands zal het Engelse woord ‘distress’ in deze samenvatting gehandhaafd worden. 
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gevoelens van vrouwelijkheid; en 3) het idee dat de partner haar niet meer vrouwelijk en 
seksueel aantrekkelijk vond na de operatie. In de totale onderzoeksgroep bleek er geen 
relatie tussen ontevredenheid met de operatie en ontevredenheid met de seksuele relatie 
te zijn en zouden de meeste vrouwen opnieuw kiezen voor PM/(I)BR (95% voor PM, 80% 
voor (I)BR). De resultaten van deze retrospectieve studie pleiten ervoor, om tijdens de 
pre-operatieve counselling de mogelijke negatieve veranderingen in lichaamsbeleving en 
seksualiteit te bespreken, zodat mogelijke risicofactoren tijdig gesignaleerd kunnen 
worden.  
 
Prospectieve analyse 
In het prospectieve deel van de PREVOM-B studie (Hoofdstuk 5-9) werden vrouwen 
gevolgd van voorafgaand aan de preventieve operatie (T0) tot zes (T1) en twaalf maanden 
(T2) na de operatie. Steeds werden vragenlijsten afgenomen en werden alle 
deelneemsters en hun partners apart van elkaar geïnterviewd. De resultaten illustreren 
dat de meeste vrouwen en hun partners deze ingrepen goed doorstaan zonder 
verregaande emotionele gevolgen. Het verloop van hun aanpassing en ondervonden 
problemen worden hieronder samengevat. 
 In Hoofdstuk 5 werden de motivaties van 36 vrouwen vergeleken met  hun kanker-
gerelateerde (Impact of Events Scale; IES) en algemene ‘distress’ (Hospital Anxiety and 
Depression Scale; HADS). De motivaties werden in twee groepen gecategoriseerd: 1) de EC 
groep: mensen die zowel emotionele als rationele (‘cognitieve’) motivaties rapporteerden; 
en 2) de C groep, mensen die alleen cognitieve motivaties rapporteerden. Vervolgens 
werd voor beide groepen het verband onderzocht met de subschalen van de IES (intrusie 
en vermijding) en de HADS (angst en depressie). Er bleek geen relatie te zijn tussen de 
soort motivaties en het niveau of verloop van distress.  
 Een aparte analyse werd gedaan van vrouwen die ‘angst voor kanker’ noemden als 
motivatie, in vergelijking met de overige vrouwen. Die angst leidde tot beduidend meer 
depressieve gevoelens vóór de operatie maar minder neiging tot vermijding ná de 
operatie. De overige vrouwen scoorden in de verschillende tests binnen normale grenzen.  
 Deze resultaten leidden tot de hypothese dat vrouwen die vóór de operatie geen angst 
voor kanker aangaven ofwel al eerder (voorafgaand aan de studie) hun angsten zodanig 
verwerkt hadden dat die geen distress meer veroorzaakten, ofwel distress onderdrukten. 
Bij pre-operatieve counselling zal vooral gelet kunnen worden op sterke angst voor kanker 
enerzijds of ontbreken van enige vorm van distress anderzijds om toekomstige emotionele 
problemen op tijd te kunnen onderkennen. 
 
Resultaten met betrekking tot het vóórkomen en verloop van kanker-gerelateerde en 
algemene distress bij 78 vrouwen (Hoofdstuk 6) lieten zien dat er een significante 
vermindering van angst en kanker-gerelateerde distress was na PM/(I)BR; na P(B)SO was 
die er niet. Klinisch relevante angst en kanker-gerelateerde distress was tot een jaar na de 
preventieve operatie aanwezig bij 10-20% van de PM/(I)BR vrouwen en bij 19-27% van de 
P(B)SO vrouwen. Kanker-gerelateerde en algemene distress vóór de operatie bleken 
voorspellend voor verhoogde distress een jaar na de preventieve operatie (Hoofdstuk 8). 
Mutatiedraagsters merkten daarbij vaak alsnog een daling van verhoogde distress tussen 
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6-12 maanden na de operatie. Vrouwen die geruststellende gedachten hanteerden bij het 
omgaan met dreiging van kanker (‘coping’) hadden een half jaar na de operatie meer 
distress dan vrouwen met een andere benaderingswijze. De relatie tussen coping en 
distress werd ook onderzocht in Hoofdstuk 9. Vrouwen die een passieve en palliatieve 
coping toepasten en geen sociale steun zochten bleken meer last van distress vóór de 
operatie te hebben. Bovendien bleek passieve coping onvoldoende om duidelijke distress 
na de preventieve operatie te verminderen. 
 
De 61 partners van vrouwen met verhoogde erfelijke risico’s hadden voorafgaand aan en 
na de preventieve operatie (Hoofdstuk 7) gemiddeld normale waarden voor hun mate van 
distress. Mogelijk hadden zij voldoende aan de informatievoorziening en de eventuele 
psychosociale steun voor en na de ingreep. Een kleine groep partners (2-10%) had tot een 
jaar na de preventieve operatie van hun vrouw klinisch zorgelijke kanker-gerelateerde of 
algemene distress. Oorzakelijke factoren waren onder andere vaderschap, en 
mutatiedragerschap of een voorafgaande borstkanker van de vrouw.  
 
Conclusies 
Erfelijkheidsonderzoek naar dragerschap van een afwijkend borstkankergen, keuzen t.a.v. 
risicovermindering en het ondergaan van operaties uit voorzorg kunnen ingrijpende en 
psychisch belastende ingrepen blijken voor sommige vrouwen (Hoofdstuk 10). Langdurig 
onderzoek in de Rotterdamse kliniek en elders toont dat de meeste vrouwen en hun 
partners voldoende informatie en begeleiding krijgen om deze gebeurtenissen goed te 
doorstaan en een gezondheidswinst te realiseren die past bij de gemaakte keuze. 
 De resultaten van het PREVOM-B onderzoek geeft goede aanknopingspunten om in de 
gesprekken voorafgaand aan preventieve operaties voor te bereiden op de lichamelijke en 
psychologische effecten van borstverwijdering en reconstructie, en de verwijdering van 
eierstokken en eileiders. Pre- en post-operatieve counselling en distress screening is 
relevant voor vrouwen met een verhoogde kans op borst- en eierstokkanker om hen te 
begeleiden bij het effectief omgaan met distress en andere mogelijke negatieve gevolgen 
van een preventieve operatie. Tijdens het traject rondom de preventieve operatie is 
aandacht nodig voor de groep vrouwen en hun partners die een individueel bepaalde, 
verhoogde kans hebben om extra angst, depressiviteit of kanker-gerelateerde distress te 
ervaren. Er is met name aandacht nodig voor partners van deze vrouwen, als de 
consequenties voor opgroeiende kinderen duidelijk worden. Deze onderwerpen zijn ook 
belangrijk voor andere genetische ziekten, en zullen nader onderzocht moeten worden in 
toekomstig onderzoek. 
 
Vervolgonderzoek vindt thans plaats naar 1) de langere termijn effecten van preventieve 
chirurgie in de in dit proefschrift beschreven groep; en 2) de psychosociale effecten van 
verschillende vormen van borstreconstructie zoals implantaten versus borstreconstructie 
met lichaamseigen weefsel. 
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Dankwoord 
 
 
 
Het madeliefje (Bellis Perennis) is een veldbloem met witte blaadjes die het hele jaar in 
bloei is aan te treffen
*
. De madeliefjes in dit proefschrift staan symbool voor alle vrouwen, 
die me openhartig deelgenoot hebben gemaakt van hun overwegingen, zorgen, hoop, 
geluk en verdriet rondom de preventieve operatie. Net als een madeliefje, hebben zij in 
moeilijke omstandigheden het hoofd hoog gehouden en bleken ze veerkrachtig in de 
periode voorafgaand maar ook na de ingrijpende preventieve operatie. Mijn dank gaat uit 
naar hen en hun partners voor hun onmisbare persoonlijke bijdrage aan de 
verwezenlijking van het onderzoek. 
 
Mijn proefschrift is eindelijk daar! 
 
Prof. dr. A. Tibben, beste Aad, als mijn promotor en dagelijks begeleider ben je altijd zeer 
betrokken geweest bij de opzet en uitvoering van het project. Ook nadat het onderzoek 
officieel was geëindigd in 2004 heb je zonder enige terughoudendheid regelmatig tijd 
besteed aan het samen met mij bespreken en beschrijven van de onderzoeksresultaten. Ik 
heb veel van je geleerd en waardeer niet alleen je professionele inbreng maar ook je 
persoonlijke betrokkenheid. 
 Prof. dr. M.F. Niermeijer, tijdens mijn sollicitatiegesprek met u was ik enigszins 
geïntimideerd door uw kennis en voorkomen. In de loop der jaren is dat gevoel veranderd 
in een enorm respect voor de uitgebreidheid van uw kennis op genetisch, medisch en 
psychologisch gebied. Mijn grote dank voor uw onmisbare deskundige inbreng en vooral 
uw bijzondere betrokkenheid gedurende de afrondingsfase van dit proefschrift.  
                                                      
*
 Uit: Van Dale (www.vandale.nl) en Wikipedia (nl.wikipedia.org) 
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Dr. C. Seynaeve, beste Caroline, bij aanvang van het project zorgde je ervoor dat ik een 
aantal weken mocht meelopen met verschillende disciplines in de Daniel den Hoed Kliniek 
en het Josephine Nefkens Instituut. Dat was een bijzonder kijkje in de keuken en een 
onmisbare start voor het onderzoek. Gedurende de uitvoering van het project hield je me 
altijd scherp met je kritische vragen, die je bleef stellen tot de laatste dag voordat dit werk 
ter drukke ging. Het proefschrift is een stuk pittiger geworden dankzij jouw inbreng!  
 Dank aan de kleine commissie. Prof. C.W. Burger, beste Curt, de afgelopen jaren heb ik 
je leren kennen als iemand bij wie zowel de kwaliteit van onderzoek en de kwaliteit van de 
opleiding geneeskunde aan het hart gaan. Dank dat je tijdens je ‘sabbatical leave’ bereid 
was om mijn proefschrift te lezen en te beoordelen. Prof. J. Passchier, beste Jan, als 
afdelingshoofd van Medische Psychologie en Psychotherapie (MPP) toonde je geregeld 
belangstelling voor het project en droeg je eraan bij dat de voortgang niet stagneerde. Ik 
waardeer het zeer dat je al die jaren een vinger aan de pols hebt gehouden. Prof. J.G.M. 
Klijn, beste Jan, jouw steun op het congres in San Antonio in 2003 is memorabel. Jij liet in 
de dagen voor de presentatie geen gelegenheid onbenut om me een hart onder de riem 
te steken zodat ik de zenuwen voor mijn presentatie de baas kon worden. Nogmaals dank 
daarvoor, en natuurlijk ook voor de tijd die je hebt gestoken in het project. 
 Dr. A.R. Van Gool, beste Arthur, ik wil jou bedanken voor de vele uren die je hebt 
besteed aan het lezen en analyseren van de interviews. Jouw betrokkenheid bij het 
project was onmisbaar, alsook je altijd goede humeur. Dr. Duivenvoorden, beste Hugo, jou 
wil ik bedanken voor je bevlogenheid, je enthousiasme en je welwillendheid om mij 
herhaaldelijk uit te leggen wat ook alweer de beste analyse was voor mijn data en 
waarom. Je gaf altijd weer een steuntje in de rug op momenten dat het me allemaal even 
boven het hoofd groeide. Dr. P.G. Frets, beste Petra, jij was de eerste 2 jaar mijn dagelijks 
begeleider. Dank voor de prettige samenwerking! Dr. A.N. van Geel en dr. M.B. Menke-
Pluijmers, beste Bert en Marian, jullie wil ik bedanken voor jullie niet aflatende 
belangstelling voor en inbreng in het project. Dank aan An Claessens, Ellen Crepin en 
Cecile Brekelmans, deskundigen op het medisch gedeelte van het project. Onze 
besprekingen waren niet alleen nuttig maar ook heel gezellig. Alice en Ankey, dank voor 
jullie toewijding aan het project. Het was met name een hele klus om alle op cassette 
opgenomen interviews over te zetten op papier, maar jullie hebben het geklaard! 
  
Collega’s van de afdelingen MPP en OiG, mede dankzij jullie aanwezigheid ga ik met 
plezier naar mijn werk. Dank voor jullie warme belangstelling en alle open deuren!  
 
Litanja, jij hebt met je onderzoek het pad geëffend voor mijn project en me 
geïntroduceerd in wereld van de psycho-oncologie. Ik vond het altijd erg leuk om met jou 
op stap te gaan, als collega’s en ook nog na jouw promotie. Saskia en Leonieke, dank voor 
de gezelligheid. Ik heb grote bewondering voor jullie professionele vaardigheden maar 
nog meer voor jullie persoonlijke veerkracht! Vivian en Jacqueline, ik heb goede 
herinneringen aan de gezellige drukte op onze kamer bij MPP. Iris, Reinier en Marleen, 
collega’s op het gebied van de psychosociale genetica, ik herinner me onze dappere 
poging de zogenoemde psychogenetische werkgroep draaiende te houden, vooral dank 
voor alle gesprekken en adviezen. Samantha, je gaat me net voor. Leuk om elkaar op dit 
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moment te ontmoeten in ons moederschap en de afronding van onze proefschriften. 
Silvia, wij hebben samen heel wat van de wereld gezien en zijn in veel hilarische situaties 
terecht gekomen, met als kernpunten onze (congres)bezoeken aan San Antonio en New 
Orleans, onze voorliefde voor Starbucks en onze zoektocht naar ‘wat is nou eigenlijk een 
Creool?’. Wat hebben we gelachen! Maar we hebben ook vele serieuze gesprekken 
gevoerd. Als ik even niet verder kan met een artikel denk ik altijd aan jouw simpele maar 
gouden tip: ‘Wat wil je nou precies zeggen?’ Alle andere informatie kan zonder pardon 
gewist worden. We kunnen niet meer ‘live’ koffieleuten nu jij met Ruurd in Vancouver 
woont. Thank God there’s Skype! 
 
Lieve vrienden, jullie zijn het beste bewijs dat vriendschap niet afhankelijk is van de 
hoeveelheid contactmomenten per (10) jaar. Ik verheug me erop om eindelijk weer eens 
met jullie af te spreken!  
 
Arti, Barbara, Natasja en Yuut, ook al staan jullie niet gevieren naast mij tijdens de 
promotie, jullie zijn zonder uitzondering de paranimfen in mijn leven. Dank voor jullie 
warme vriendschap, die decennia geleden begon en wat mij betreft nooit voorbij gaat. 
Onze lange telefoongesprekken zijn het bewijs dat we elkaar echt veel te weinig zien. Of 
raken we gewoon nooit uitgepraat? Menno, Rogier en Ilja, ook al lopen we ieder een eigen 
kant op, we vinden elkaar steeds ergens terug. Bij jullie kan ik zonder reserves mijn eigen 
(niet altijd even aardige) ik zijn en dat maakt onze vriendschap uniek en bijzonder. Het is 
altijd leuker als jullie erbij zijn! 
 
Pa en ma, hoe minder ik kind ben, hoe meer ik jullie ga waarderen als ouders. Op jullie 
opvoeding zijn mijn normen en waarden gestoeld, door jullie is mijn arbeidsethos 
gevormd. In moeilijke tijden zorgen jullie voor mij en in goede tijden laten jullie me vrij. 
Dank voor jullie steun en luisterend oor, ik hoop dat we nog heel lang van jullie mogen 
genieten! Ard-Jan en Jolanda, bij jullie kan ik op ieder moment van de dag even stoom af 
komen blazen en daar maak ik geregeld gebruik van. Fijn dat jullie er zijn. Niet verhuizen, 
hoor! 
 
Martijn, levenspartner, ‘mijn vriendje’. Ik dank je voor je onvoorwaardelijke liefde en 
steun. Je hebt me zoveel mogelijk de ruimte gegeven om het proefschrift af te ronden. 
Ook wil ik je bedanken voor je redactionele inbreng en je kritische vragen over de inhoud. 
Ik kan me geen betere voorbereiding op mijn promotie wensen! Quinten en Yanna, mijn 
mooie, lieve, slimme kinderen, wat ben ik trots op jullie! Na vandaag hoeft mamma niet 
meer op de ‘katuter’ te werken en gaan we ongelimiteerd knuffelen en spelen. Lieve baby 
in mijn buik, jij bent in ons gezin nu al onmisbaar. Jullie zijn mijn verleden, heden en 
toekomst en vandaag is de eerste dag van de rest van ons leven! 
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